EurekaMag Full Text Articles Chapter 58,648

Vitale, V.; Monami, M.; Mannucci, E. 2016: Prostanoids in patients with peripheral arterial disease: a meta-analysis of placebo-controlled randomized clinical trials. Journal of Diabetes and its Complications 30(1): 161-166

Hoang, K.G.; Allison, S.; Murray, M.; Petrovic, N. 2015: Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors. Microvascular Research 101: 127-134

Uchimura, K.; Kitamura, K. 2015: Prostasin (PRSS8) as a new pathological factor. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 523-533

Frederiksen-Møller, B.; Jørgensen, J.S.; Hansen, M.R.; Krigslund, O.; Vogel, L.K.; Andersen, L.B.; Jensen, B.L. 2016: Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women. Journal of Hypertension 34(2): 298-306

Small, H.Y.; Currie, G.E.; Delles, C. 2016: Prostasin, proteases, and preeclampsia. Journal of Hypertension 34(2): 193-195

Aggarwal, S.; Dabla, P.K.; Arora, S. 2013: Prostasin: An Epithelial Sodium Channel Regulator. Journal of Biomarkers 2013: 179864

Zijlstra, C.; Stoorvogel, W. 2016: Prostasomes as a source of diagnostic biomarkers for prostate cancer. Journal of Clinical Investigation 126(4): 1144-1151

Mogielnicka-Brzozowska, M.; Strzeżek, R.; Wasilewska, K.; Kordan, W. 2015: Prostasomes of canine seminal plasma - zinc-binding ability and effects on motility characteristics and plasma membrane integrity of spermatozoa. Reproduction in Domestic Animals 50(3): 484-491

Saez, F.; Sullivan, R. 2016: Prostasomes, post-testicular sperm maturation and fertility. Frontiers in Bioscience 21(7): 1464-1473

Ronquist, G. 2015: Prostasomes: their Characterisation: Implications for Human Reproduction: Prostasomes and Human Reproduction. Advances in Experimental Medicine and Biology 868: 191-209

McAllister, S.C.; Beneri, C. 2015: Prostate Abscess in an Adolescent with AIDS. Global Pediatric Health 2: 2333794x15582260

Roy, S.; Ambelil, M.; Ayala, G.; Buja, L.M. 2016: Prostate Adenocarcinoma Metastasis to the Bilateral Ureters: a Rare but Potentially Important Finding. Annals of Clinical and Laboratory Science 46(4): 425-427

Satherley, L.K.; Sun, P.-H.; Ji, K.E.; Mason, M.; Hargest, R.; Jiang, W.G.; Ye, L. 2016: Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient Survival. Anticancer Research 36(3): 1227-1235

Kably, I.; Pereira, K.; Chong, W.; Bhatia, S. 2016: Prostate Artery Embolization (PAE) in the Management of Refractory Hematuria of Prostatic Origin Secondary to Iatrogenic Urological Trauma: a Safe and Effective Technique. Urology 88: 218-221

Noor, A.; Fischman, A.M. 2016: Prostate Artery Embolization as a new Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016. Current Urology Reports 17(7): 51

Mirakhur, A.; McWilliams, J.P. 2017: Prostate Artery Embolization for Benign Prostatic Hyperplasia: Current Status. Canadian Association of Radiologists Journal 68(1): 84-89

Yu, S.C.H.; Cho, C.C.M.; Hung, E.H.Y.; Chiu, P.K.F.; Yee, C.H.; Ng, C.F. 2017: Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy. Cardiovascular and Interventional Radiology 40(1): 33-40

Bhatia, S.; Kava, B.; Pereira, K.; Kably, I.; Harward, S.; Narayanan, G. 2015: Prostate Artery Embolization for Giant Prostatic Hyperplasia. Journal of Vascular and Interventional Radiology: Jvir 26(10): 1583-1585

Gaylis, F.; Nasseri, R.; Fink, L.; Calabrese, R.; Dato, P.; Cohen, E. 2016: Prostate Biopsy Complications: a Dual Analysis. Urology 93: 135-140

Pryalukhin, A.E.; Vandromme, A.; Dellmann, A.; Donhuijsen, K.; Hammerer, P.G. 2015: Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods. Urologia Internationalis 95(2): 203-208

Torkko, K.C.; Wilson, R.S.; Smith, E.E.; Kusek, J.W.; van Bokhoven, A.; Lucia, M.S. 2015: Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study. Journal of Urology 194(2): 454-461

Khani, F.; Epstein, J.I. 2015: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes. American Journal of Surgical Pathology 39(10): 1383-1389

Ghafoori, M.; Velayati, M.; Aliyari Ghasabeh, M.; Shakiba, M.; Alavi, M. 2015: Prostate Biopsy Using Transrectal Ultrasonography; the Optimal Number of Cores Regarding Cancer Detection Rate and Complications. Iranian Journal of Radiology: a Quarterly Journal Published by the Iranian Radiological Society 12(2): E13257

Whitson, J.M.; Murray, K.S.; Thrasher, J.B. 2016: Prostate Biopsy is Associated with an Increased Risk of Erectile Dysfunction. Journal of Urology 196(1): 21-23

Orio, P.F.; Nguyen, P.L.; Buzurovic, I.; Cail, D.W.; Chen, Y-Wei. 2016: Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training. International Journal of Radiation Oncology Biology Physics 96(3): 624-628

Haroun, R.R.; Nance, J.W.; Fishman, E.K. 2016: Prostate Brachytherapy seed migration to the Bladder presenting with Gross Hematuria. Journal of Radiology Case Reports 10(1): 22-26

Doddamani, D.; Kayastha, A. 2008: Prostate Cancer - What's New?. Medical Journal Armed Forces India 64(1): 51-56

Vines, A.I.; Hunter, J.C.; Carlisle, V.A.; Richmond, A.N. 2017: Prostate Cancer Ambassadors: Enhancing a Theory-Informed Training Program for Informed Decision-Making. Journal of cancer education: the official journal of the American Association for Cancer Education 32(3): 454-459

Vines, A.I.; Hunter, J.C.; Carlisle, V.A.; Richmond, A.N. 2017: Prostate Cancer Ambassadors: Process and Outcomes of a Prostate Cancer Informed Decision-Making Training Program. American journal of men's health 11(1): 54-62

Duscharla, D.; Bhumireddy, S.R.; Lakshetti, S.; Pospisil, H.; Murthy, P.V.L.N.; Walther, R.; Sripadi, P.; Ummanni, R. 2016: Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential new Biomarkers. Plos one 11(3): E0150253

Huesch, M.D.; Ong, M.K. 2016: Prostate Cancer Care Before and After Medicare Eligibility. Inquiry: a Journal of Medical Care Organization Provision and Financing 53

Otsuki, H.; Kimura, T.; Yamaga, T.; Kosaka, T.; Suehiro, J.-I.; Sakurai, H. 2017: Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters. Prostate 77(2): 222-233

Lazzeri, M. 2015: Prostate Cancer Claims for a Personalized Medicine. North American Journal of Medical Sciences 7(10): 436-437

Oderda, M.; Faletti, R.; Battisti, G.; Dalmasso, E.; Falcone, M.; Marra, G.; Palazzetti, A.; Zitella, A.; Bergamasco, L.; Gandini, G.; Gontero, P. 2016: Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: a Comparative Study. Urologia Internationalis 97(2): 230-237

Khan, S.; Mahara, A.; Hyams, E.S.; Schned, A.R.; Halter, R.J. 2016: Prostate Cancer Detection Using Composite Impedance Metric. IEEE Transactions on Medical Imaging 35(12): 2513-2523

Rosenkrantz, A.B.; Parikh, N.; Kierans, A.S.; Kong, M.X.; Babb, J.S.; Taneja, S.S.; Ream, J.M. 2016: Prostate Cancer Detection Using Computed very High b-value Diffusion-weighted Imaging: how High Should we Go?. Academic Radiology 23(6): 704-711

Filella, X.; Foj, L. 2016: Prostate Cancer Detection and Prognosis: from Prostate Specific Antigen (PSA) to Exosomal Biomarkers. International Journal of Molecular Sciences 17(11)

Feng, Z-Yan.; Wang, L.; Min, X-De.; Wang, S-Gang.; Wang, G-Ping.; Cai, J. 2016: Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2. Chinese Medical Journal 129(20): 2451-2459

Tombal, B.F.; Van Nieuwenhove, S.; Lecouvet, F.E. 2015: Prostate Cancer Diagnosis Using MR/Ultrasound-Fusion Guided Biopsy: Ending the "Needle in a Haystack" Conundrum?. JAMA Oncology 1(6): 831-832

Chelluri, R.; Kilchevsky, A.; George, A.K.; Sidana, A.; Frye, T.P.; Su, D.; Fascelli, M.; Ho, R.; Abboud, S.F.; Turkbey, B.; Merino, M.J.; Choyke, P.L.; Wood, B.J.; Pinto, P.A. 2016: Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling. Journal of Urology 196(1): 62-67

Luque, J.S.; Ross, L.; Gwede, C.K. 2016: Prostate Cancer Education in African American Barbershops: Baseline Client Survey Results and Differences in Decisional Conflict and Stage of Decision Making. American journal of men's health 10(6): 533-536

Ashorobi, O.S.; Frost, J.; Wang, X.; Roberson, P.; Lin, E.; Volk, R.J.; Lopez, D.S.; Jones, L.A.; Pettaway, C.A. 2017: Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. American Journal of Men's Health 11(1): 82-91

Schade, G.R.; Holt, S.K.; Zhang, X.; Song, D.; Wright, J.L.; Zhao, S.; Kolb, S.; Lam, H.-M.; Levin, L.; Leung, Y.-K.; Ho, S.-M.; Stanford, J.L. 2016: Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy. Journal of Urology 195(6): 1760-1766

Rouvière, O.; Chapelon, J.-Y.; Crouzet, S.éb.; Gelet, A. 2017: Prostate Cancer Focal Therapy: just because you can Does not Mean you Should. European Urology 71(1): 35-36

Wallis, C.J.D.; Nam, R.K. 2015: Prostate Cancer Genetics: a Review. Ejifcc 26(2): 79-91

Epstein, J.I. 2016: Prostate Cancer Grading: a Contemporary Photomontage. American Journal of Surgical Pathology 40(1): 137

Kryvenko, O.N.; Epstein, J.I. 2016: Prostate Cancer Grading: a Decade After the 2005 Modified Gleason Grading System. Archives of Pathology and Laboratory Medicine 140(10): 1140-1152

Zhang, L.; Wu, C.; Hoffman, R.M. 2015: Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells. Plos one 10(11): E0140721

Kilcoyne, A.; Harisinghani, M.G.; Mahmood, U. 2016: Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(Suppl. 3): 105s-110s

Lindenberg, L.; Choyke, P.; Dahut, W. 2016: Prostate Cancer Imaging with Novel PET Tracers. Current Urology Reports 17(3): 18

Wei, X.X.; Fong, L.; Small, E.J. 2015: Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions. Expert Review of Vaccines 14(12): 1529-1541

Doonan, B.P.; Haque, A. 2015: Prostate Cancer Immunotherapy: Exploiting the HLA Class Ii Pathway in Vaccine Design. Journal of Clinical and Cellular Immunology 6(4)

Shen, N.; Zhao, J.; Schipper, J.L.; Zhang, Y.; Bepler, T.; Leehr, D.; Bradley, J.; Horton, J.; Lapp, H.; Gordan, R. 2018: Divergence in DNA Specificity among Paralogous Transcription Factors Contributes to Their Differential In Vivo Binding. Cell Systems 6(4): 470-483.E8

Jemal, A.; Fedewa, S.A.; Ma, J.; Siegel, R.; Lin, C.C.; Brawley, O.; Ward, E.M. 2015: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. JAMA 314(19): 2054-2061

Owens, O.L.; Jackson, Déa.D.; Thomas, T.L.; Friedman, D.B.; Hébert, J.R. 2015: Prostate Cancer Knowledge and Decision Making Among African-American Men and Women in the Southeastern United States. International journal of men's health 14(1): 55-70

Anderson, T.; Wallace, T.; Aung, M.; Jolly, P.E. 2015: Prostate Cancer Knowledge, Attitudes and Screening Practices among Men in Western Jamaica. West Indian Medical Journal 65(1): 67-77

Morrison, B.F.; Aiken, W.D.; Mayhew, R.; Gordon, Y.; Odedina, F.T. 2017: Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 32(2): 352-356

Chen, H.; Sutedjo, J.; Wang, L.; Yin, X. 2016: Prostate Cancer Magnetic Resonance Spectroscopy Imaging at 1.5 and 3.0 T: a Meta-Analysis. Technology in Cancer Research and Treatment 15(4): 625-631

Shah, V.A.; Rixey, A.; Dusing, R. 2016: Prostate Cancer Metastases to Inguinal Lymph Nodes Detected by Attenuation-Corrected 11C-Acetate PET/CT. Journal of Nuclear Medicine Technology 44(1): 46-48

Xiao, H.; Tan, F.; Adunlin, G.; Ali, A.A.; Goovaerts, P.; Huang, Y.; Gwede, C. 2014: Prostate Cancer Overall Survival: Multilevel Analysis of a Population-Based Cancer Registry Data. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A733

Zaorsky, N.G.; Shaikh, T.; Ruth, K.; Sharda, P.; Hayes, S.B.; Sobczak, M.L.; Hallman, M.A.; Smaldone, M.C.; Chen, D.Y.T.; Horwitz, E.M. 2017: Prostate Cancer Patients with Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment with Radiation Therapy. Clinical Genitourinary Cancer 15(2): 326-335.E3

Gentile, N.; Johansen, M.E. 2016: Prostate Cancer Patients' Survival Expectations With and Without Their Chosen Treatment. Annals of Family Medicine 14(3): Iii-Iii

Spyropoulos, E.; Kotsiris, D.; Spyropoulos, K.; Panagopoulos, A.; Galanakis, I.; Mavrikos, S. 2017: Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial Clinical Efficacy Evaluation Data Presentation of a Simple Novel Mathematical Simulation Modelling Method, Devised to Predict the Outcome of Prostate Biopsy on an Individual Basis. Clinical genitourinary cancer 15(1): 129-138.e1

Hamilton, Z.; Parsons, J.Kellogg. 2016: Prostate Cancer Prevention: Concepts and Clinical Trials. Current Urology Reports 17(4): 35

Kenfield, S.A.; Stampfer, M.J. 2015: Prostate Cancer Progression: the Smoking Gun?. European Urology 68(6): 957-958

Gandaglia, G.; Bray, F.; Cooperberg, M.R.; Karnes, R.J.; Leveridge, M.J.; Moretti, K.; Murphy, D.G.; Penson, D.F.; Miller, D.C. 2016: Prostate Cancer Registries: Current Status and Future Directions. European Urology 69(6): 998-1012

Wang, K.-S.; Zuo, L.; Owusu, D.; Pan, Y.; Luo, X. 2014: Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia. Journal of Schizophrenia Research 1(1)

Anonymous 2016: Prostate Cancer Risk Loci Are Associated with Gene Regulatory Mechanisms. Cancer Discovery 6(5): OF13

Eggener, S.E.; Cifu, A.S.; Nabhan, C. 2015: Prostate Cancer Screening. JAMA 314(8): 825-826

Mulhem, E.; Fulbright, N.; Duncan, N. 2015: Prostate Cancer Screening. American Family Physician 92(8): 683-688

Goins, R.Turner.; Schure, M.B.; Noonan, C.; Buchwald, D. 2015: Prostate Cancer Screening Among American Indians and Alaska Natives: The Health and Retirement Survey, 1996-2008. Preventing chronic disease 12: E123

Eggener, S. 2016: Prostate Cancer Screening Biomarkers: An Emerging Embarrassment of 'Riches'?. European Urology 70(1): 54-55

Mkanta, W.N.; Ndjakani, Y.; Bandiera, F.C.; Blumenthal, D.S.; Nseyo, U.O.; Asal, N.R. 2015: Prostate Cancer Screening and Mortality in Blacks and Whites: a Hospital-based Case-Control Study. Journal of the National Medical Association 107(2): 32-38

Tabayoyong, W.; Abouassaly, R. 2015: Prostate Cancer Screening and the Associated Controversy. Surgical Clinics of North America 95(5): 1023-1039

Morrison, B.F.; Aiken, W.; Mayhew, R.; Gordon, Y.; Reid, M. 2016: Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic. Journal of Cancer Epidemiology 2016: 2606805

Misra-Hebert, A.D.; Kattan, M.W. 2016: Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter. Frontiers in Oncology 6: 235

Obana, M.; O'Lawrence, H. 2015: Prostate Cancer Screening: Psa test Awareness among Adult Males. Journal of Health and Human Services Administration 38(1): 17-43

Prasad, V. 2015: Prostate Cancer Screening: the Pendulum has Swung, and the Burden of Proof Is with Proponents. American Family Physician 92(8): 678-680

Jaworska, D.; Król, W.; Szliszka, E. 2015: Prostate Cancer Stem Cells: Research Advances. International Journal of Molecular Sciences 16(11): 27433-27449

Lin, X.; Farooqi, A.A.; Qureshi, M.Z.; Romero, M.A.; Tabassum, S.; Ismail, M. 2016: Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution. Archivum Immunologiae et Therapiae Experimentalis 64(3): 217-223

Ojo, D.; Lin, X.; Wong, N.; Gu, Y.; Tang, D. 2015: Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer. Cancers 7(4): 2290-2308

Han, Y.; Rand, K.A.; Hazelett, D.J.; Ingles, S.A.; Kittles, R.A.; Strom, S.S.; Rybicki, B.A.; Nemesure, B.; Isaacs, W.B.; Stanford, J.L.; Zheng, W.; Schumacher, F.R.; Berndt, S.I.; Wang, Z.; Xu, J.; Rohland, N.; Reich, D.; Tandon, A.; Pasaniuc, B.; Allen, A.; Quinque, D.; Mallick, S.; Notani, D.; Rosenfeld, M.G.; Jayani, R.S.; Kolb, S.; Gapstur, S.M.; Stevens, V.L.; Pettaway, C.A.; Yeboah, E.D.; Tettey, Y.; Biritwum, R.B.; Adjei, A.A.; Tay, E.; Truelove, A.; Niwa, S.; Chokkalingam, A.P.; John, E.M.; Murphy, A.B.; Signorello, L.B.; Carpten, J.; Leske, M.C.; Wu, S.-Y.; Hennis, A.J.M.; Neslund-Dudas, C.; Hsing, A.W.; Chu, L.; Goodman, P.J.; Klein, E.A.; Zheng, S.L.; Witte, J.S.; Casey, G.; Lubwama, A.; Pooler, L.C.; Sheng, X.; Coetzee, G.A.; C 2016: Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Journal of the National Cancer Institute 108(7)

Valdagni, R.; Van Poppel, H.; Aitchison, M.; Albers, P.; Berthold, D.; Bossi, A.; Brausi, M.; Denis, L.; Drudge-Coates, L.; De Santis, M.; Feick, Günther.; Harrison, C.; Haustermans, K.; Hollywood, D.; Hoyer, M.; Hummel, H.; Mason, M.; Mirone, V.; Müller, S.C.; Parker, C.; Saghatchian, M.; Sternberg, C.N.; Tombal, B.; van Muilekom, E.; Watson, M.; Wesselmann, S.; Wiegel, T.; Magnani, T.; Costa, A. 2015: Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology. Critical reviews in oncology/hematology 95(2): 133-143

Jena, R. 2016: Prostate Cancer Virtual Special Issue. Clinical Oncology ) 28(3): 163-164

Matsugasumi, T.; Baco, E.; Palmer, S.; Aron, M.; Sato, Y.; Fukuda, N.; Süer, E.; Bernhard, J-Christophe.; Nakagawa, H.; Azhar, R.A.; Gill, I.S.; Ukimura, O. 2015: Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume. Journal of Urology 194(4): 957-965

Bird, V.Y.; Domino, P.M.; Sutkowski, R.; Stillings, S.A.; Trejo-Lopez, J.A. 2016: Prostate Cancer with Metastatic Lytic Bone Lesions: Positive Bone Scan Post Docetaxel Chemotherapy in the Setting of Clinically Successful Treatment. Urology Case Reports 6: 12-14

Tuck, S.P. 2017: Prostate Cancer and Fracture: Identifying at-Risk Groups. Journal of Clinical Densitometry: the Official Journal of the International Society for Clinical Densitometry 20(2): 196-197

Lolkema, M.; Debets, R.; de Wit, R. 2017: Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?. European Urology 71(5): 788-789

Spees, C.K.; Kelleher, K.J.; Abaza, R.; Clinton, S.K. 2015: Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy. Urology Case Reports 3(2): 21-23

Olsen, G.W.; Ley, C.A. 2015: Prostate Cancer and PFOA. Journal of Occupational and Environmental Medicine 57(6): E60

Kilpeläinen, T.P.; Talala, K.; Raitanen, J.; Taari, K.; Kujala, P.; Tammela, T.L.J.; Auvinen, A. 2016: Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer. American Journal of Epidemiology 184(10): 720-731

Carson, C.C.; Kirby, R. 2015: Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?. Journal of Urology 194(6): 1527-1528

Jaiswal, S.; Sarmad, R.; Arora, S.; Dasaraju, R.; Sarmad, K. 2015: Prostate Cancer for the Internist. North American Journal of Medical Sciences 7(10): 429-435

Nwaneri, A.C.; McBeth, L.; Hinds, T.D. 2016: Prostate Cancer in African American Men: The Effect of Androgens and micro RNAs on Epidermal Growth Factor Signaling. Hormones and Cancer 7(5-6): 296-304

Skalski, M.; Gierej, B.; Ziarkiewicz-Wróblewska, B.; Hołówko, W.; Krawczyk, M. 2016: Prostate Cancer in Deceased Liver Donors. Transplantation Proceedings 48(5): 1378-1380

Roussel, B.; Ouellet, G.M.; Mohile, S.G.; Dale, W. 2015: Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy. Clinics in Geriatric Medicine 31(4): 615-629

Pakzad, R.; Rafiemanesh, H.; Ghoncheh, M.; Sarmad, A.; Salehiniya, H.; Hosseini, S.; Sepehri, Z.; Afshari-Moghadam, A. 2016: Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics. Asian Pacific Journal of Cancer Prevention: Apjcp 17(2): 839-843

Gestaut, M.M.; Pruszynski, J.E.; Swanson, G.P. 2017: Prostate Cancer in Patients with High Prostate-Specific Antigen Levels but Otherwise Very-Low-Risk Disease Behaves like Prostate Cancer in High-Risk Patients. Clinical Genitourinary Cancer 15(4): 445-449

Raslau, D.; Abu Dabrh, A.M.; Summerfield, D.T.; Wang, Z.; Steinkraus, L.W.; Murad, M.H. 2016: Prostate Cancer in Pilots. Aerospace Medicine and Human Performance 87(6): 565-570

Hilal, L.; Shahait, M.; Mukherji, D.; Charafeddine, M.; Farhat, Z.; Temraz, S.; Khauli, R.; Shamseddine, A. 2015: Prostate Cancer in the Arab World: a View from the Inside. Clinical Genitourinary Cancer 13(6): 505-511

Borgmann, H.; Wölm, J-Henning.; Vallo, S.; Mager, R.; Huber, J.; Breyer, J.; Salem, J.; Loeb, S.; Haferkamp, A.; Tsaur, I. 2017: Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 32(1): 135-140

Fabre, B.; Grosman, H.; Gonzalez, D.; Machulsky, N.F.; Repetto, E.M.; Mesch, V.; Lopez, M.A.; Mazza, O.; Berg, G. 2016: Prostate Cancer, High Cortisol Levels and Complex Hormonal Interaction. Asian Pacific Journal of Cancer Prevention: Apjcp 17(7): 3167-3171

Mohler, J.L.; Armstrong, A.J.; Bahnson, R.R.; D'Amico, A.V.; Davis, B.J.; Eastham, J.A.; Enke, C.A.; Farrington, T.A.; Higano, C.S.; Horwitz, E.M.; Hurwitz, M.; Kane, C.J.; Kawachi, M.H.; Kuettel, M.; Lee, R.J.; Meeks, J.J.; Penson, D.F.; Plimack, E.R.; Pow-Sang, J.M.; Raben, D.; Richey, S.; Roach, M.; Rosenfeld, S.; Schaeffer, E.; Skolarus, T.A.; Small, E.J.; Sonpavde, G.; Srinivas, S.; Strope, S.A.; Tward, J.; Shead, D.A.; Freedman-Cass, D.A. 2016: Prostate Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network: Jnccn 14(1): 19-30

Ong, S.Y.; Taverna, J.; Jokerst, C.; Enzler, T.; Hammode, E.; Rogowitz, E.; Green, M.R.; Babiker, H.M. 2015: Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix. Case Reports in Oncological Medicine 2015: 212543

Fuhrman-Luck, R.A.; Stansfield, S.H.; Stephens, C.R.; Loessner, D.; Clements, J.A. 2016: Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1. Journal of Proteome Research 15(8): 2466-2478

Delude, C. 2016: Prostate Cancer: a new Twist on Active Surveillance. Journal of the National Cancer Institute 108(5)

Mandaliya, H.; Sung, J.; Hill, J.; Samali, R.; George, M. 2015: Prostate Cancer: Cases of Rare Presentation and Rare Metastasis. Case Reports in Oncology 8(3): 526-529

Kgatle, M.M.; Kalla, A.A.; Islam, M.M.; Sathekge, M.; Moorad, R. 2016: Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy. Prostate Cancer 2016: 5653862

Muller, B.G.; Shih, J.H.; Sankineni, S.; Marko, J.; Rais-Bahrami, S.; George, A.Koruthu.; de la Rosette, J.J.M.C.H.; Merino, M.J.; Wood, B.J.; Pinto, P.; Choyke, P.L.; Turkbey, B. 2015: Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology 277(3): 741-750

Park, S.Y.; Jung, D.C.; Oh, Y.T.; Cho, N.H.; Choi, Y.D.; Rha, K.H.; Hong, S.J.; Han, K. 2016: Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers. Radiology 280(1): 108-116

Pinkney, S.; Fan, M.; Chan, K.; Koczmara, C.; Colvin, C.; Sasangohar, F.; Masino, C.; Easty, A.; Trbovich, P. 2014: Multiple Intravenous Infusions Phase 2b: Laboratory Study. Ontario Health Technology Assessment Series 14(5): 1-163

Kayat Bittencourt, L.; Litjens, G.; Hulsbergen-van de Kaa, C.A.; Turkbey, B.; Gasparetto, E.Leandro.; Barentsz, J.O. 2015: Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging. Radiology 276(2): 479-489

Dias, J.ão.L.; Pina, J.ão.M.ãe.; João, R.; Fialho, J.; Carmo, S.; Leal, C.íl.; Bilhim, T.; Marques, R.M.; Pinheiro, L.ís.C. 2015: Prostate Cancer: the Role of Multiparametric Magnetic Resonance Imaging. Acta Medica Portuguesa 28(2): 240-249

Rosenkrantz, A.B.; Ream, J.M.; Nolan, P.; Rusinek, H.; Deng, F.-M.; Taneja, S.S. 2015: Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy. AJR. American Journal of Roentgenology 205(6): 1208-1214

Hötker, A.M.; Mazaheri, Y.; Zheng, J.; Moskowitz, C.S.; Berkowitz, J.; Lantos, J.E.; Pei, X.; Zelefsky, M.J.; Hricak, H.; Akin, O. 2015: Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRi. European Radiology 25(9): 2665-2672

Uzan, J.; Nahum, A.E.; Syndikus, I. 2016: Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio. Clinical Oncology 28(3): 165-170

Pisco, J.ão.; Bilhim, T.; Pinheiro, L.C.; Fernandes, L.úc.; Pereira, J.é; Costa, N.V.; Duarte, M.; Oliveira, A.ón.G. 2016: Prostate Embolization as an Alternative to Open Surgery in Patients with Large Prostate and Moderate to Severe Lower Urinary Tract Symptoms. Journal of Vascular and Interventional Radiology: Jvir 27(5): 700-708

Chapelon, J.-Y.; Rouvière, O.; Crouzet, S.éb.; Gelet, A. 2016: Prostate Focused Ultrasound Therapy. Advances in Experimental Medicine and Biology 880: 21-41

Schwen, Z.R.; Tosoian, J.J.; Sokoll, L.J.; Mangold, L.; Humphreys, E.; Schaeffer, E.M.; Partin, A.W.; Ross, A.E. 2016: Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men. Urology 90: 136-140

Chiu, P.K.-F.; Lai, F.M.-M.; Teoh, J.Y.-C.; Lee, W.-M.; Yee, C.-H.; Chan, E.S.-Y.; Hou, S.-M.; Ng, C.-F. 2016: Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy. Annals of Surgical Oncology 23(8): 2707-2714

Loeb, S.; Shin, S.S.; Broyles, D.L.; Wei, J.T.; Sanda, M.; Klee, G.; Partin, A.W.; Sokoll, L.; Chan, D.W.; Bangma, C.H.; van Schaik, R.H.N.; Slawin, K.M.; Marks, L.S.; Catalona, W.J. 2017: Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer. Bju International 120(1): 61-68

Sivanandan, M.A.; Walker, G.; Sundar, S. 2016: Prostate Hypofractionated Radiotherapy Trial Results Need to be Interpreted with Caution due to Undertreatment of the Control Arm in the CHHiP Trial. Clinical Oncology 28(12): 797

Rosenkrantz, A.B.; Oto, A.; Turkbey, B.; Westphalen, A.C. 2016: Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look. Ajr. American Journal of Roentgenology 206(6): 1179-1183

Renard-Penna, Rëlle.; Mozer, P.; Cornud, Fçois.; Barry-Delongchamps, N.; Bruguière, E.; Portalez, D.; Malavaud, B. 2015: Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology 275(2): 458-468

Perera, M.; Katelaris, N.; Murphy, D.G.; McGrath, S.; Lawrentschuk, N. 2017: Prostate Imaging Reporting and Data System score of four or more: active surveillance no more. Bju International 119(1): 9-12

Kao, P.-F.; Weng, J.-H.; Hsiao, P.-C.; Kao, Y.-L. 2016: Prostate Lymphoma Complicated with Prostatorectal Fistula and Multifocal Infection After Chemotherapy. Clinical Nuclear Medicine 41(3): 247-248

Czarniecki, M.; Jakuciński, M.; Królicki, L. 2016: Prostate MRI - an update for the referring urologist. Central European Journal of Urology 69(2): 162-169

Steiger, P.; Thoeny, H.C. 2016: Prostate MRI based on PI-RADS version 2: how we review and report. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 16: 9

Rosenkrantz, A.B.; Taneja, S.S. 2015: Prostate MRi can reduce overdiagnosis and overtreatment of prostate cancer. Academic Radiology 22(8): 1000-1006

Manley, B.J.; Brockman, J.A.; Raup, V.T.; Fowler, K.J.; Andriole, G.L. 2016: Prostate MRI: a national survey of Urologist's attitudes and perceptions. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(3): 464-471

Zakian, K.L.; Hatfield, W.; Aras, O.; Cao, K.; Yakar, D.; Goldman, D.A.; Moskowitz, C.S.; Shukla-Dave, A.; Tehrani, Y.M.; Fine, S.; Eastham, J.; Hricak, H. 2016: Prostate MRSi predicts outcome in radical prostatectomy patients. Magnetic Resonance Imaging 34(5): 674-681

Rosenkrantz, A.B.; Verma, S.; Choyke, P.; Eberhardt, S.C.; Eggener, S.E.; Gaitonde, K.; Haider, M.A.; Margolis, D.J.; Marks, L.S.; Pinto, P.; Sonn, G.A.; Taneja, S.S. 2016: Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. Journal of urology 196(6): 1613-1618

Deng, J.; Auchtung, J.M.; Konstantinidis, K.T.; Caro-Quintero, A.; Brettar, I.; Höfle, M.; Tiedje, J.M. 2018: Divergence in Gene Regulation Contributes to Sympatric Speciation of Shewanella baltica Strains. Applied and Environmental Microbiology 84(4)

Dulaney, C.R.; Osula, D.O.; Yang, E.S.; Rais-Bahrami, S. 2016: Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine. Prostate Cancer 2016: 4897515

Cooper, C.S.; Clark, J.; Brewer, D.S.; Edwards, D.R. 2016: Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients. European Urology 69(2): 229-230

Ecke, T.H.; Huang-Tiel, H.-J.; Golka, K.; Selinski, S.; Geis, B.C.; Koswig, S.; Bathe, K.; Hallmann, S.; Gerullis, H. 2016: Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. International Journal of Molecular Sciences 17(11)

Panach-Navarrete, J.; Carratalá-Calvo, A.; Valls-González, L.; Sales-Maicas, Mía..Ángeles.; Martínez-Jabaloyas, Jé.María. 2015: Prostate Specific Antigen (PSA) use in a national health department. Archivos Espanoles de Urologia 68(8): 647-654

Chen, R.; Sjoberg, D.D.; Huang, Y.; Xie, L.; Zhou, L.; He, D.; Vickers, A.J.; Sun, Y.; Sun, Y.; Huang, Y.; Xie, L.; Zhou, L.; He, D.; Ding, Q.; Wei, Q.; Shao, P.; Tian, Y.; Sun, Z.; Fu, Q.; Ma, L.; Zheng, J.; Ye, Z.; Ye, D.; Xu, D.; Hou, J.; Xu, K.; Yuan, J.; Gao, X.; Liu, C.; Pan, T.; Gao, X.; Ren, S.; Xu, C.; Vickers, A.J.; Roobol, M.J.; Hugosson, J.; Jones, J.S.; Kattan, M.W.; Klein, E.; Hamdy, F.; Neal, D.; Donovan, J.; Parekh, D.J.; Ankerst, D.; Bartsch, G.; Klocker, H.; Horninger, W.; Benchikh, A.; Salama, G.; Villers, A.; Freedland, S.J.; Moreira, D.M.; Schröder, F.H.; Lilja, H.; Cronin, A.M. 2017: Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts. Journal of Urology 197(1): 90-96

Salman, J.W.; Schoots, I.G.; Carlsson, S.V.; Jenster, G.; Roobol, M.J. 2015: Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects. Advances in Experimental Medicine and Biology 867: 93-114

Shoaibi, A.; Rao, G.A.; Cai, B.; Rawl, J.; Haddock, K.S.; Hébert, J.R. 2017: Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer. Prostate 77(2): 173-184

Pabisiak, K.; Ostrowski, M.; Kram, A.; Safranow, K.; Słojewski, M.; Ciechanowski, K. 2016: Prostate Specific Antigen-Positive Deceased Organ Donor: a Pathologist Is Indispensable. Transplantation Proceedings 48(7): 2450-2453

Rhee, H.; Thomas, P.; Shepherd, B.; Gustafson, S.; Vela, I.; Russell, P.J.; Nelson, C.; Chung, E.; Wood, G.; Malone, G.; Wood, S.; Heathcote, P. 2016: Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. Journal of Urology 196(4): 1261-1267

Huang, Y.; Hamana, T.; Liu, J.; Wang, C.; An, L.; You, P.; Chang, J.Y.F.; Xu, J.; McKeehan, W.L.; Wang, F. 2015: Prostate Sphere-forming Stem Cells Are Derived from the P63-expressing Basal Compartment. Journal of Biological Chemistry 290(29): 17745-17752

Kim, S.H.; Park, W.S.; Kim, S.H.; Park, B.; Joo, J.; Lee, G.K.; Joung, J.Y.; Seo, H.K.; Chung, J.; Lee, K.H. 2016: Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy. Plos one 11(3): E0151646

Kabarriti, A.E.; Guzzo, T.J.; Wein, A.J. 2014: Prostate Stromal Tumor of Uncertain Malignant Potential: Case Report With 5-Year Follow-up. Urology Case Reports 2(2): 43-44

Yang, Q.; Lin, H.; Wu, S.; Lei, F.; Zhu, X.; Song, L.; Hong, M.; Guo, L. 2015: Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes. Plos one 10(8): E0136448

Porcaro, A.Benito.; Novella, G.; Cacciamani, G.; De Marchi, D.; Corsi, P.; De Luyk, Nò.; Bizzotto, L.; Processali, T.; Cerasuolo, M.; Tamanini, I.; Cerruto, M.Angela.; Brunelli, M.; Siracusano, S.; Artibani, W. 2017: Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set. Urologia Internationalis 98(1): 22-27

Gravas, S. 2016: Prostate Volume as a Risk Factor for Lower Urinary Tract Symptoms: the Quest Continues. European Urology 69(5): 892-893

De Assis, A.é M.; Maciel, M.S.; Moreira, A.M.; de Paula Rodrigues, V.C.; Antunes, A.A.; Srougi, M.; Cerri, G.G.; Carnevale, F.C. 2017: Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization. Cardiovascular and Interventional Radiology 40(2): 245-251

Figueiredo, J.Chaves.; Richter, J.; Borja, N.; Balaca, A.; Costa, S.; Belo, S.; Grácio, M.Amélia. 2015: Prostate adenocarcinoma associated with prostatic infection due to Schistosoma haematobium. Case report and systematic review. Parasitology Research 114(2): 351-358

Kim, I-Kyu.; Lee, D-Hwan.; Cho, H-Young.; Seo, J-Hoon.; Park, S-Hoon.; Kim, J-Mee. 2016: Prostate adenocarcinoma mandibular metastasis associated with numb chin syndrome: a case report. Journal of the Korean Association of Oral and Maxillofacial Surgeons 42(5): 301-306

Dembowski, J.; Hackemer, P.ł; Winkler, A.; Otlewska, A.; Tupikowski, K.; Zdrojowy, R. 2015: Prostate and Bladder Cancer Coexistence in Patients Undergoing Radical Cystoprostatectomy. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 24(4): 657-662

Ilunga Tshiswaka, D.; Donley, T.; Okafor, A.; Memiah, P.; Mbizo, J. 2017: Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey. Journal of Community Health 42(3): 612-623

Dorin, R.P.; Wiener, S.; Harris, C.D.; Wagner, J.R. 2015: Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?. Prostate 75(7): 673-678

Anonymous 2002: Prostate awareness goes public. Nursing Standard 1987) 16(29): 6-6

Verma, V.; Chen, S.; Zhou, S.; Enke, C.A.; Wahl, A.O. 2017: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 193(1): 38-45

Vitrani, M.-A.; Baumann, M.; Reversat, D.; Morel, G.; Moreau-Gaudry, A.; Mozer, P. 2016: Prostate biopsies assisted by comanipulated probe-holder: first in man. International Journal of Computer Assisted Radiology and Surgery 11(6): 1153-1161

Reddy, B.N.; Bessede, T.; Reddy, A.; Nair, S.; Tewari, A.K.; Rastinehad, A.R. 2016: Prostate biopsies: Available technique, approaches and diagnostic accuracy. Archivos Espanoles de Urologia 69(6): 302-310

Arias-Stella, J.A.; Shah, A.B.; Montoya-Cerrillo, D.; Williamson, S.R.; Gupta, N.S. 2015: Prostate biopsy and radical prostatectomy Gleason score correlation in heterogenous tumors: proposal for a composite Gleason score. American Journal of Surgical Pathology 39(9): 1213-1218

Schreiber, D.; Wong, A.T.; Rineer, J.; Weedon, J.; Schwartz, D. 2015: Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study. Journal of Clinical Pathology 68(6): 453-457

Loeb, S. 2016: Prostate biopsy decisions: one-size-fits-all approach with total PSA is out and a multivariable approach with the Prostate Health Index is in. Bju International 117(3): 383

Sitpura, K.; Salmo, E. 2016: Prostate biopsy handling: special tiss1ue embedding technique with sponges affects the yield of prostatic tissue available for microscopic examination. Gulf Journal of Oncology 1(21): 46-48

Song, G.; Fang, D.; Ji, G.J.; Yu, W.; Zhao, C.L.; Li, X.S.; Shan, G.Z.; Li, S.Q.; He, Q.; Xin, Z.C.; Wang, X.Y.; Zhou, L.Q. 2016: Prostate biopsy results and clinicopathological characteristics of the 55 years or younger patients. Zhonghua Yi Xue Za Zhi 96(40): 3218-3221

Kuplevatskiy, V.I.; CherkashiN, M.A.; Roshchin, D.A.; Berezina, N.A.; Vorob'ev, N.A. 2016: Prostate biopsy under magnetic resonance imaging guidance. Vestnik Rentgenologii i Radiologii 97(1): 48-55

Rashid, A. 2015: Prostate biopsy, childhood vaccination, oral health, and medical tourism. British Journal of General Practice: the Journal of the Royal College of General Practitioners 65(636): 363

Roberts, M.J.; Doi, S.A. 2016: Prostate biopsy, targeted prophylaxis and infectious complications: a critique of methods used. Bju International 117(5): 719-721

Enzmann, T.; Tokas, T.; Korte, K.; Ritter, M.; Hammerer, P.; Franzaring, L.; Heynemann, H.; Gottfried, H.-W.; Bertermann, H.; Meyer-Schwickerath, M.; Wirth, B.; Pelzer, A.; Loch, T. 2015: Prostate biopsy: Procedure in the clinical routine. Der Urologe. Ausg. a 54(12): 1811-1820; Quiz: 1821-1822

Burruni, R.; Cerantola, Y.; Meuwly, J.-Y.; Tawadros, T.; Jichlinski, P.; Valerio, M. 2015: Prostate biopsy: which strategy for which patient?. Revue Medicale Suisse 11(497): 2288-2290; 2292

Cheng, J.; Xiong, W.; Gu, Y.; Chia, S.C.; Wang, Y.; Huang, W.; Zhou, J.; Zhou, Y.; Gao, W.; Tay, K.J.; Ho, H. 2014: Prostate boundary segment extraction using cascaded shape regression and optimal surface detection. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2014: 2886-2889

Mensah, J.E.; Yarney, J.; Vanderpuye, V.; Akpakli, E.; Tagoe, S.; Sasu, E. 2016: Prostate brachytherapy in Ghana: our initial experience. Journal of Contemporary BrachyTherapy 8(5): 379-385

Thompson, S.R.; Delaney, G.P.; Gabriel, G.S.; Izard, M.A.; Hruby, G.; Jagavkar, R.; Bucci, J.; Barton, M.B. 2015: Prostate brachytherapy in new South Wales: patterns of care study and impact of caseload on treatment quality. Journal of Contemporary BrachyTherapy 6(4): 344-349

Wallner, K.E.; Merrick, G.S.; Galbreath, R.W.; Butler, W.M.; Brammer, S.G.; Allen, Z.A.; Adamovich, E. 2016: Prostate brachytherapy in men greater than or equal to 75 years of age. Journal of Clinical Oncology 26(15_Suppl): 16069-16069

Minehan, K.J.; Furutani, K.; McNamara, K.; Groshek, D.; Mitchell, E.; Price, M.; Emme, M.; Harms, T. 2016: Prostate brachytherapy post implant dosimetry: Timing matters. Journal of Clinical Oncology 24(18_Suppl): 14597-14597

Bece, A.; Bucci, J. 2016: Prostate brachytherapy: Why do we ignore the evidence?. Journal of Medical Imaging and Radiation Oncology 60(4): 528-530

Gu, M.; Li, W.; Chen, Q.; Chen, Y.; Xu, M.; Wang, Z. 2015: Prostate calculi can higher urinary retention probability and worsen uncomfortable feeling after prostate biopsy but not predict cancer. International Journal of Clinical and Experimental Medicine 8(4): 6282-6286

Cole, E. 2015: A do-it-yourself drive to spread the D word. Nursing Standard: 29(46): 18-19

James, M.L. 2006: Prostate cancer (early). Bmj Clinical Evidence 2006

Attard, G.; Parker, C.; Eeles, R.A.; Schröder, F.; Tomlins, S.A.; Tannock, I.; Drake, C.G.; de Bono, J.S. 2016: Prostate cancer. Lancet 387(10013): 70-82

Anonymous 2016: Prostate cancer. Nursing Standard: 1987) 30(40): 17

Hackshaw-McGeagh, L.; Lane, J.Athene.; Persad, R.; Gillatt, D.; Holly, J.M.P.; Koupparis, A.; Rowe, E.; Johnston, L.; Cloete, J.; Shiridzinomwa, C.; Abrams, P.; Penfold, C.M.; Bahl, A.; Oxley, J.; Perks, C.M.; Martin, R. 2016: Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial. Trials 17(1): 123

Grigorean, V.T.; Nita, G.R.; Nita, R.A.R.; Popescu, M.; Sandu, A.M.; Lupascu, C.D.; Ciuhu, A.-N. 2013: Prostate cancer - peculiarities of the process of adaptation to the disease. Clujul Medical 86(2): 133-137

Füeßl, H.S. 2015: Prostate cancer - unexpected prevalence. MMW Fortschritte der Medizin 157(19): 38

Wang, Y.; Yin, J.; Qu, X.; Mu, Y.; Teng, S. 2015: Prostate cancer Lncap stem-like cells demonstrate resistance to the hydros-induced apoptosis during the formation of spheres. Biomedicine and PharmacoTherapy 74: 1-8

Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy. Canadian Journal of Urology 22(6): 8056-8062

Kawada, T. 2016: Prostate cancer among East Asian men: Screening and management strategies. Urologic Oncology 34(7): 333

Anderson, B.; Marshall-Lucette, S. 2016: Prostate cancer among Jamaican men: exploring the evidence for higher risk. British Journal of Nursing 25(19): 1046-1051

Yamashita, S. 2016: Prostate cancer and epigenetics. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 75-79

Malik, S.S.; Masood, N.; Yasmin, A. 2015: Prostate cancer and glutathione S-transferase deletions. Excli Journal 14: 1049-1054

Shiozawa, S.; Horie, S. 2014: Prostate cancer and metabolic syndrome. Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2234-2240

Grigore, A.D.; Ben-Jacob, E.; Farach-Carson, M.C. 2015: Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?. Frontiers in Oncology 5: 37

Shiota, M.; Yokomizo, A. 2016: Prostate cancer and oxidative stress. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 71-74

King, A.J.L.; Evans, M.; Moore, T.H.M.; Paterson, C.; Sharp, D.; Persad, R.; Huntley, A.L. 2015: Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. European Journal of Cancer Care 24(5): 618-634

Rosenberg, M.T.; Spring, A.C.; David Crawford, E. 2015: Prostate cancer and the PCP: the screening dilemma. International Journal of Clinical Practice 69(12): 1438-1447

Storm, M.; Sheng, X.; Arnoldussen, Y.Jildouw.; Saatcioglu, F. 2016: Prostate cancer and the unfolded protein response. Oncotarget 7(33): 54051-54066

Sokal, D.C.; Labrecque, M.; Belker, A.M.; Faraday, M.M.; Honig, S.; Marmar, J.L.; Ross, L.S.; Sandlow, J.I.; Sharlip, I.D. 2015: Prostate cancer and vasectomy: déjà vu!. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(6): 669-670

Xue, W.-J.; Ying, X.-L.; Jiang, J.-H.; Xu, Y.-H. 2014: Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis. Journal of Cancer Research and Therapeutics 10 Suppl: C218-C221

Moradi Sardareh, H.; Goodarzi, M.T.; Yadegar-Azari, R.; Poorolajal, J.; Mousavi-Bahar, S.H.; Saidijam, M. 2014: Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals. Urology Journal 11(6): 1952-1958

Wang, F.-B.; Chen, R.; Ren, S.-C.; Shi, X.-L.; Zhu, Y.-S.; Zhang, W.; Jing, T.-L.; Zhang, C.; Gao, X.; Hou, J.-G.; Xu, C.-L.; Sun, Y.-H. 2017: Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy. Asian Journal of Andrology 19(2): 238-243

Somwaru, A.S.; Alex, D.; Zaheer, A. 2016: Prostate cancer arising in ectopic prostatic tissue within the left seminal vesicle: a rare case diagnosed with multi-parametric magnetic resonance imaging and magnetic resonance imaging-transrectal ultrasound fusion biopsy. Bmc Medical Imaging 16: 16

Guttilla, A.; Bortolami, A.; Evangelista, L. 2015: Prostate cancer as a chronic disease: cost-effectiveness and proper follow-up. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(4): 439-445

Vargas, H.A.; Schor-Bardach, R.; Long, N.; Kirzner, A.N.; Cunningham, J.D.; Goldman, D.A.; Moskowitz, C.S.; Sosa, R.E.; Sala, E.; Panicek, D.M.; Hricak, H. 2017: Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdominal Radiology 42(1): 271-277

Pommier, P.; Guérif, S.; Peiffert, D.; Créhange, G.; Hannoun-Lévi, J.-M.; de Crevoisier, R. 2016: Prostate cancer brachytherapy. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 20 Suppl: S210-S215

Sierra, Mónica.S.; Soerjomataram, I.; Forman, D. 2016: Prostate cancer burden in Central and South America. Cancer Epidemiology 44 Suppl. 1: S131-S140

Alberti, C. 2016: Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications. European Review for Medical and Pharmacological Sciences 20(6): 1001-1002

Suhovskih, A.V.; Kashuba, V.I.; Klein, G.; Grigorieva, E.V. 2017: Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways. Cell Adhesion and Migration 11(1): 39-53

Stratton, D.; Moore, C.; Zheng, L.; Lange, S.; Inal, J. 2015: Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles. Biochemical and Biophysical Research Communications 460(3): 511-517

Trama, A.; Botta, L.; Nicolai, N.; Rossi, P.Giorgi.; Contiero, P.; Fusco, M.; Lodde, M.; Pannozzo, F.; Piffer, S.; Puppo, A.; Seeber, A.; Tumino, R.; Valdagni, R.; Gatta, G. 2016: Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study. European Journal of Cancer 67: 91-98

Pettenati, C.; Jannot, A.-S.; Hurel, S.; Verkarre, V.; Kreis, H.; Housset, M.; Legendre, C.; Méjean, A.; Timsit, M.-O. 2016: Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study. Clinical Transplantation 30(8): 964-971

Hashim, D.; Boffetta, P.; Galsky, M.; Oh, W.; Lucchini, R.; Crane, M.; Luft, B.; Moline, J.; Udasin, I.; Harrison, D.; Taioli, E. 2018: Prostate cancer characteristics in the World Trade Center cohort, 2002-2013. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 27(4): 347-354

Pellizzon, A.C. 2016: Prostate cancer considered low or intermediate risk for biochemical failure according to the rtog-astro phoenix definition: Results of the use of neoadjuvant androgen deprivation before high-dose rate brachytherapy and external beam radiotherapy. Journal of Clinical Oncology 26(15_Suppl): 16121-16121

Cash, H.; Günzel, K.; Maxeiner, A.; Stephan, C.; Fischer, T.; Durmus, T.; Miller, K.; Asbach, P.; Haas, M.; Kempkensteffen, C. 2016: Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. Bju International 118(1): 35-43

Osses, Dël.F.; van Asten, J.J.; Kieft, G.J.; Tijsterman, J.D. 2017: Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score. World Journal of Urology 35(2): 207-212

Türk, Z.; Hollberg, H.; Dill, T.; Kaspers, I.; Isbarn, H. 2015: Prostate cancer detection rates: comparison of standard biopsy with prompt rebiopsy and a one-time extended biopsy. Der Urologe. Ausg. a 54(1): 28-33

Teoh, J.Y.; Yuen, S.K.; Tsu, J.H.; Wong, C.K.; Ho, B.S.; Ng, A.T.; Ma, W.-K.; Ho, K.-L.; Yiu, M.-K. 2015: Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?. Asian Journal of Andrology 17(5): 821-825

Mussi, T.C.; Garcia, R.G.; Queiroz, M.R.G.; Lemos, G.C.; Baroni, R.H. 2016: Prostate cancer detection using multiparametric 3 - tesla MRi and fusion biopsy: preliminary results. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(5): 897-905

Filson, C.P.; Natarajan, S.; Margolis, D.J.A.; Huang, J.; Lieu, P.; Dorey, F.J.; Reiter, R.E.; Marks, L.S. 2016: Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer 122(6): 884-892

Lee, A.; Chia, S.J. 2015: Prostate cancer detection: the impact of obesity on Asian men. Urologic Oncology 33(6): 266.E17

Marchena, C.L.; Urcia, S.I.; Canelo-Aybar, C. 2015: Prostate cancer detection: the effect of obesity on Asian men. Urologic Oncology 33(10): 422-423

Muller, B.G.; de Bruin, D.M.; Brandt, M.J.; van den Bos, W.; van Huystee, S.; Faber, D.J.; Savci, D.; Zondervan, P.J.; de Reijke, T.M.; Laguna-Pes, M.P.; van Leeuwen, T.G.; de la Rosette, J.J.M.C.H. 2016: Prostate cancer diagnosis by optical coherence tomography: first results from a needle based optical platform for tissue sampling. Journal of Biophotonics 9(5): 490-498

Muller, B.G.; de Bruin, D.M.; van den Bos, W.; Brandt, M.J.; Velu, J.F.; Bus, M.T.J.; Faber, D.J.; Savci, D.; Zondervan, P.J.; de Reijke, T.M.; Pes, P.L.; de la Rosette, J.; van Leeuwen, T.G. 2015: Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography. Journal of Medical Imaging 2(3): 037501

Eccleston, M.E. 2015: Prostate cancer diagnostic options: Past, present, and future. Mlo: Medical Laboratory Observer 47(3): 30-31

Sharma, S.; Zapatero-Rodríguez, J.; O'Kennedy, R. 2017: Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnology Advances 35(2): 135-149

Yamauchi, F.I.; Penzkofer, T.; Fedorov, A.; Fennessy, F.M.; Chu, R.; Maier, S.E.; Tempany, C.M.C.; Mulkern, R.V.; Panych, L.P. 2015: Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRi sequence. Magnetic Resonance Imaging 33(5): 525-530

Capanna, C.; Chujutalli, R.; Murray, S.; Lwin, K.; Aung, M.; Jolly, P. 2015: Prostate cancer educational intervention among men in western Jamaica. Preventive Medicine Reports 2: 788-793

Yegnasubramanian, S. 2016: Prostate cancer epigenetics and its clinical implications. Asian Journal of Andrology 18(4): 549-558

De Crevoisier, R.; Pommier, P.; Latorzeff, I.; Chapet, O.; Chauvet, B.; Hennequin, C. 2016: Prostate cancer external beam radiotherapy. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 20 Suppl: S200-S209

Kaufmann, S.; Bedke, J.; Gatidis, S.; Hennenlotter, J.; Kramer, U.; Notohamiprodjo, M.; Nikolaou, K.; Stenzl, A.; Kruck, S. 2016: Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade IIi (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer. World Journal of Urology 34(4): 509-515

Rocco, B.; Boeri, L. 2016: Prostate cancer gene 3 assay in the magnetic resonance imaging (MRI)/ultrasonography fusion target biopsy era: a future to believe in. Bju International 118(5): 672-673

Anonymous 2016: Prostate cancer gene test aids treatment precision. Nursing Standard: 1987) 30(48): 16

Minardi, D.; Mazzucchelli, R.; Scarpelli, M.; Massari, F.; Ciccarese, C.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. 2016: Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3. Future Oncology 12(12): 1431-1433

Gasparrini, S.; Mazzucchelli, R.; Scarpelli, M.; Massari, F.; Raspollini, M.R.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. 2017: Prostate cancer grading in 2016. Minerva Urologica e Nefrologica 69(1): 1-4

Delahunt, B.; Egevad, L.; Grignon, D.J.; Srigley, J.R.; Samaratunga, H. 2016: Prostate cancer grading: recent developments and future directions. Bju International 117(Suppl 4): 7-8

Zhao, K.; Wang, C.; Hu, J.; Yang, X.; Wang, H.; Li, F.; Zhang, X.; Zhang, J.; Wang, X. 2015: Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model. Science China. Life Sciences 58(7): 666-673

Zhu, C.; Xu, Q.; Pan, D.; Xu, Y.; Liu, P.; Yang, R.; Wang, L.; Sun, X.; Luo, S.; Yang, M. 2016: Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Contrast Media and Molecular Imaging 11(2): 99-105

Renard Penna, R.; Brenot-Rossi, I.; Salomon, L.; Soulié, M. 2015: Prostate cancer imaging: MRi and nuclear imaging. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(15): 933-946

Turkbey, B.; Choyke, P.L. 2016: Prostate cancer imaging: a special focus issue from Future Oncology. Future Oncology 12(21): 2389-2391

Gounder, S.K.; Chang, V.T.; Hoover, D.; Gonzalez, M.L.; Ahmed, S.; Finch-Cruz, C.; Duque, L.; Zhong, F.; Toomey, K.; Kasimis, B.S. 2016: Prostate cancer immunohistochemical (IHC) stains and survival in stage D3 patients (pts). Journal of Clinical Oncology 26(15_Suppl): 22187-22187

Jazayeri, S.Behzad.; Samadi, D.B. 2017: Prostate cancer in African Americans: Early oncological and functional outcomes after robotic prostatectomy. International Journal of Urology: Official Journal of the Japanese Urological Association 24(3): 236-237

Tourinho-Barbosa, R.Rocha.; Pompeo, A.Carlos.Lima.; Glina, S. 2016: Prostate cancer in Brazil and Latin America: epidemiology and screening. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(6): 1081-1090

Restrepo, J.Alejandro.; Bravo, L.Eduardo.; García-Perdomo, H.Andrés.; García, L.Stella.; Collazos, P.; Carbonell, J. 2014: Prostate cancer in Cali, Colombia, 1962-2011: incidence, mortality and survival. Salud publica de Mexico 56(5): 440-447

Fukuoka, T. 2014: Prostate cancer in a patient with multiple pulmonary metastases alone and respiratory symptoms. Journal of Rural Medicine: Jrm 9(1): 27-31

Kinnear, N.J.; Kichenadasse, G.; Plagakis, S.; O'Callaghan, M.E.; Kopsaftis, T.; Walsh, S.; Foreman, D. 2016: Prostate cancer in men aged less than 50 years at diagnosis. World Journal of Urology 34(11): 1533-1539

Szot, W.; Kostkiewicz, M.; Zając, J.; Owoc, A.; Bojar, I. 2014: Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan. Annals of Agricultural and Environmental Medicine: Aaem 21(4): 888-892

Eke, N. 2012: Prostate cancer in the West African sub-region, the need to know. Journal of the West African College of Surgeons 2(3): X-Xii

Huang, T-Hao.; Kuo, J-Yih.; Huang, Y-Hsiu.; Chung, H-Jen.; Huang, W.J.S.; Wu, H.H.H.; Chang, Y-Hwa.; Lin, A.T.L.; Chen, K-Kuo. 2017: Prostate cancer in young adults-Seventeen-year clinical experience of a single center. Journal of the Chinese Medical Association 80(1): 39-43

Welton, M.; Robb, S.W.; Shen, Y.; Guillebeau, P.; Vena, J. 2015: Prostate cancer incidence and agriculture practices in Georgia, 2000-2010. International journal of occupational and environmental health 21(3): 251-257

Pina, F.; Castro, C.; Ferro, A.; Bento, M.J.; Lunet, N. 2017: Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 26(5): 404-410

Grosclaude, P.; Belot, A.; Daubisse Marliac, L.; Remontet, L.; Leone, N.; Bossard, N.; Velten, M. 2015: Prostate cancer incidence and mortality trends in France from 1980 to 2011. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(9): 536-542

Zhou, C.K.; Check, D.P.; Lortet-Tieulent, J.; Laversanne, M.; Jemal, A.; Ferlay, J.; Bray, F.; Cook, M.B.; Devesa, S.S. 2016: Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. International Journal of Cancer 138(6): 1388-1400

Karczmarek-Borowska, Bżenna.; Radziszewska, A. 2015: Prostate cancer incidence in Podkarpackie province in 2002-2011. Przeglad Epidemiologiczny 69(1): 65-72 163-7

Vaarala, M.H.; Mehik, A.; Ohtonen, P.; Hellström, P.A. 2016: Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up. Oncology letters 12(2): 1149-1153

Liu, Z-Hua.; Li, C.; Kang, L.; Zhou, Z-Yang.; Situ, S.; Wang, J-Ping. 2015: Prostate cancer incorrectly diagnosed as a rectal tumor: A case report. Oncology Letters 9(6): 2647-2650

Venniyoor, A. 2016: Prostate cancer is not breast cancer. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 37(1): 4-5

Nickens, K.P.; Ali, A.; Scoggin, T.; Tan, S.-H.; Ravindranath, L.; McLeod, D.G.; Dobi, A.; Tacha, D.; Sesterhenn, I.A.; Srivastava, S.; Petrovics, G. 2015: Prostate cancer marker panel with single cell sensitivity in urine. Prostate 75(9): 969-975

Pentyala, S.; Whyard, T.; Pentyala, S.; Muller, J.; Pfail, J.; Parmar, S.; Helguero, C.G.; Khan, S. 2016: Prostate cancer markers: An update. Biomedical Reports 4(3): 263-268

McCarthy, M.T.; Ebrahem, H.; Aibdeen, Z.; Hodnett, P.A.; Mulcahy, E.; Osman, N. 2016: Prostate cancer metastasis to calcaneus: a solitary lesion at an atypical site, dormant for more than 10 years. Jrsm Open 7(10): 2054270416660934

Sui, X.; Hu, Y.; Zhang, C.; Pan, H.; Li, D. 2016: Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncology Letters 12(2): 1074-1078

Ziaee, S.; Chu, G.Chia-Yi.; Huang, J-Ming.; Sieh, S.; Chung, L.W.K. 2015: Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics. Translational Andrology and Urology 4(4): 438-454

Feng, J.; Xu, X.; Li, B.; Brown, E.; Farris, A.B.; Sun, S.-Y.; Yang, J.J. 2014: Prostate cancer metastatic to bone has higher expression of the calcium-sensing receptor (CaSR) than primary prostate cancer. Receptors and Clinical Investigation 1(6)

Sepúlveda, L.; Gorgal, T.; Pires, V.; Rodrigues, F. 2015: Prostate cancer metastatic to the cervical lymph nodes. Case Reports in Urology 2015: 263978

Lorion, R.; Bladou, F.; Spatz, A.; van Kempen, L.; Irani, J. 2016: Prostate cancer microenvironment: its structure, functions and therapeutic applications. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 26(8): 464-476

Torres-Sánchez, L.E.; Espinoza-Giacinto, R.; Rojas-Martínez, R.; Escamilla-Nuñez, C.; Vázquez-Salas, R.A.; Campuzano, J.C.és.; Lazcano-Ponce, E. 2016: Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013. Salud Publica de Mexico 58(2): 179-186

Ilic, M.; Ilic, I. 2016: Prostate cancer mortality in Serbia, 1991-2010: a joinpoint regression analysis. Journal of Public Health 38(2): E63-E67

O'Kane, D.B.; Lawrentschuk, N.; Bolton, D.M. 2016: Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection. Urology Annals 8(2): 255-257

Méry, B.; Vallard, A.; Espenel, S.; Badie, N.; Thiermant, M.; Lambert, V.; Soulier, V.; Piqueres, S.; Del Santo, K.; Ben Mrad, M.; Wang, G.; Diao, P.; Langrand-Escure, J.; Rivoirard, R.; Guy, J.-B.; Guillot, A.; Chanelière, A.-F.; Gonthier, R.; Achour, E.; Fournel, P.; Magné, N. 2016: Prostate cancer of elderly patients: Place and role of geriatric assessment. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 26(9): 524-531

Haraoka, M.; Takamuki, M.; Toyonaga, Y.; Tanaka, M.; Hanazawa, K.; Sakamoto, Y.; Horie, S. 2014: Prostate cancer of unknown primary origin with multiple lymph nodes metastasis; a case report. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 105(4): 212-217

Jia, J.B.; Houshyar, R.; Verma, S.; Uchio, E.; Lall, C. 2016: Prostate cancer on computed tomography: a direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. European Journal of Radiology 85(1): 261-267

Vela, I.; Chen, Y. 2015: Prostate cancer organoids: a potential new tool for testing drug sensitivity. Expert Review of Anticancer Therapy 15(3): 261-263

Beckmann, K.R.; O'Callaghan, M.E.; Ruseckaite, R.; Kinnear, N.; Miller, C.; Evans, S.; Roder, D.M.; Moretti, K. 2017: Prostate cancer outcomes for men who present with symptoms at diagnosis. Bju International 119(6): 862-871

Kweldam, C.F.; Kümmerlin, I.P.; Nieboer, D.; Verhoef, E.I.; Steyerberg, E.W.; Incrocci, L.; Bangma, C.H.; van der Kwast, T.H.; Roobol, M.J.; van Leenders, G.J. 2016: Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma. European Journal of Cancer 66: 26-33

Glaser, A.W.; Corner, J.L. 2015: Prostate cancer outcomes: the three questions. European Urology 67(3): 357-358

Knoll, N.; Wiedemann, A.U.; Schultze, M.; Schrader, M.; Heckhausen, J. 2014: Prostate cancer patients gradually advance goals for rehabilitation after radical prostatectomy: applying a lines-of-defense model to rehabilitation. Psychology and Aging 29(4): 787-792

Ko, S-Hye.; Baeg, M.Ki.; Bae, W.Jin.; Kim, P.; Choi, M-Gyu. 2016: Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms. Oncotargets and Therapy 9: 5611-5617

Gerlich, C.; Schuler, M.; Jelitte, M.; Neuderth, S.; Flentje, M.; Graefen, M.; Krüger, A.; Mehnert, A.; Faller, H. 2016: Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?. Acta Oncologica 55(7): 814-820

Islam, K.M.; Wen, J. 2015: Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis. Prostate Cancer 2015: 829439

Jung, B.; Stoll, C.; Feick, G.; Prott, F.J.; Zell, J.; Rudolph, I.; Huebner, J. 2016: Prostate cancer patients' report on communication about endocrine therapy and its association with adherence. Journal of Cancer Research and Clinical Oncology 142(2): 465-470

Estévez, S.V.áz.; Herranz, U.A.; Calvo, O.F.án.; Afonso Afonso, F.J.; Couto, L.ía.S.é; Quintela, M.ín.L.áz.; Mateos, L.L.ón.; Maciá Escalante, S. 2016: Prostate cancer perspectives after chaarted: Optimizing treatment sequence. Critical Reviews in Oncology/Hematology 107: 119-127

May, E.J.; Viers, L.D.; Viers, B.R.; Kawashima, A.; Kwon, E.D.; Karnes, R.J.; Froemming, A.T. 2016: Prostate cancer post-treatment follow-up and recurrence evaluation. Abdominal Radiology 41(5): 862-876

Xiao, L.-H.; Chen, P.-R.; Gou, Z.-P.; Li, Y.-Z.; Li, M.; Xiang, L.-C.; Feng, P. 2017: Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian Journal of Andrology 19(5): 586-590

Hult, M.; Sandstrøm, H.; Wittendorff, H.-E. 2015: Prostate cancer presenting with diffuse infiltration of metastases to the pancreas. Ugeskrift for Laeger 177(5): V09140491

Yu, X.Q.; Luo, Q.; Smith, D.P.; Clements, M.S.; O'Connell, D.L. 2015: Prostate cancer prevalence in new South Wales Australia: a population-based study. Cancer Epidemiology 39(1): 29-36

Peisch, S.F.; Van Blarigan, E.L.; Chan, J.M.; Stampfer, M.J.; Kenfield, S.A. 2017: Prostate cancer progression and mortality: a review of diet and lifestyle factors. World Journal of Urology 35(6): 867-874

Evans, C.A.; Glen, A.; Eaton, C.L.; Larré, S.ép.; Catto, J.W.F.; Hamdy, F.C.; Wright, P.C.; Rehman, I. 2009: Prostate cancer proteomics: the urgent need for clinically validated biomarkers. PROTEOMICS. Clinical Applications 3(2): 197-212

Dal Pra, A.; Souhami, L. 2016: Prostate cancer radiation therapy: a physician's perspective. Physica Medica: Pm: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics 32(3): 438-445

Coulter, J.A.; Butterworth, K.T.; Jain, S. 2015: Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy. British Journal of Radiology 88(1054): 20150256

Anonymous 2016: Prostate cancer rates decreasing as screening declines. Some experts question the wisdom of reduced screening. Dukemedicine Healthnews 22(2): 6

Hamid, S.; Guillaumier, S.; Shah, T.; Arya, M.; Ahmed, H.U. 2016: Prostate cancer recurrence after Focal Therapy: Treatment options. Archivos Espanoles de Urologia 69(6): 375-383

Golshani, P.; Edalat, F.; Patel, T.H. 2015: Prostate cancer recurrence manifesting as superior vena cava syndrome. Journal of Vascular and Interventional Radiology: Jvir 26(6): 855

McBride, D. 2014: Prostate cancer recurrence risk linked to high lipid levels. Ons Connect 29(4): 10

Mapelli, P.; Panebianco, V.; Picchio, M. 2015: Prostate cancer recurrence: can PSA guide imaging?. European Journal of Nuclear Medicine and Molecular Imaging 42(12): 1781-1783

Lemarchand, C.ém.; Tual, S.év.; Boulanger, M.; Levêque-Morlais, N.ém.; Perrier, S.ép.; Clin, B.én.éd.; Guizard, A.-V.ér.; Velten, M.; Rigaud, E.; Baldi, I.; Lebailly, P. 2016: Prostate cancer risk among French farmers in the AGRICAN cohort. Scandinavian Journal of Work Environment and Health 42(2): 144-152

Kaapu, K.J.; Murtola, T.J.; Määttänen, L.; Talala, K.; Taari, K.; Tammela, T.L.J.; Auvinen, A. 2016: Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial. Cancer Causes and Control: Ccc 27(2): 157-164

Tormey, W.P. 2015: Prostate cancer risk calculators using ERSPC-derived data underestimate the risk if the WHO IRP 96/670 standard is used in prostate-specific antigen analysis. European Urology 68(3): 541-542

Poyet, Cédric.; Hermanns, T. 2016: Prostate cancer risk calculators: still much work ahead. Bju International 118(5): 670-671

Zhou, Y.; Sun, D.; Quan, W.-L.; Ding, N.; Liu, W.; Ma, W.-H.; Wang, X.-P. 2018: Divergence in larval diapause induction between the rice and water-oat populations of the striped stem borer, Chilo suppressalis (Walker) (Lepidoptera: Crambidae). Environmental Science and Pollution Research International 25(29): 29715-29724

Lundon, D.J. 2016: Prostate cancer risk prediction and the persistence of uncertainty. Bju International 117(3): 382

Poyet, Cédric.; Nieboer, D.; Bhindi, B.; Kulkarni, G.S.; Wiederkehr, C.; Wettstein, M.S.; Largo, R.; Wild, P.; Sulser, T.; Hermanns, T. 2016: Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort. Bju International 117(3): 401-408

Luedeke, M.; Rinckleb, A.E.; FitzGerald, L.M.; Geybels, M.S.; Schleutker, J.; Eeles, R.A.; Teixeira, M.R.; Cannon-Albright, L.; Ostrander, E.A.; Weikert, S.; Herkommer, K.; Wahlfors, T.; Visakorpi, T.; Leinonen, K.A.; Tammela, T.L.J.; Cooper, C.S.; Kote-Jarai, Z.; Edwards, S.; Goh, C.L.; McCarthy, F.; Parker, C.; Flohr, P.; Paulo, P.; Jerónimo, C.; Henrique, R.; Krause, H.; Wach, S.; Lieb, V.; Rau, T.T.; Vogel, W.; Kuefer, R.; Hofer, M.D.; Perner, S.; Rubin, M.A.; Agarwal, A.M.; Easton, D.F.; Al Olama, A.A.; Benlloch, S.; Hoegel, J.; Stanford, J.L.; Maier, C. 2016: Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human Molecular Genetics 25(24): 5490-5499

Felker, E.R.; Margolis, D.J.; Nassiri, N.; Marks, L.S. 2016: Prostate cancer risk stratification with magnetic resonance imaging. Urologic Oncology 34(7): 311-319

Blanker, M.H.; Noordzij, M.A.A. 2014: Prostate cancer screening benefit very low, even after 13 years. Nederlands Tijdschrift Voor Geneeskunde 158: A8349

Walker, R.; Louis, A.; Berlin, A.; Horsburgh, S.; Bristow, R.G.; Trachtenberg, J. 2014: Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic. Canadian Urological Association Journal 8(11-12): E783-E788

Naish, J. 1995: Prostate cancer screening considered. Nursing Standard 1987) 9(43): 12-12

Busato, W.F.S.; Almeida, G.L. 2016: Prostate cancer screening in Brazil: should it be done or not?. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(6): 1069-1080

Caicoya, M. 2015: Prostate cancer screening in Europe. Lancet 385(9977): 1507

Ranasinghe, W.K.; Kim, S.P.; Papa, N.P.; Sengupta, S.; Frydenberg, M.; Bolton, D.; Pond, D.; Ried, K.; Marshall, M.J.; Persad, R.; Lawrentschuk, N. 2015: Prostate cancer screening in Primary Health Care: the current state of affairs. Springerplus 4: 78

Guessous, I.; Cullati, S.ép.; Fedewa, S.A.; Burton-Jeangros, C.; Courvoisier, D.S.; Manor, O.; Bouchardy, C. 2016: Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities. Preventive Medicine 82: 83-91

Grönberg, H.; Adolfsson, J.; Aly, M.; Nordström, T.; Wiklund, P.; Brandberg, Y.; Thompson, J.; Wiklund, F.; Lindberg, J.; Clements, M.; Egevad, L.; Eklund, M. 2015: Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study. LANCET. Oncology 16(16): 1667-1676

Murray, N.P.; Reyes, E.; Orellana, N.; Fuentealba, C.; Jacob, O. 2015: Prostate cancer screening in the fit Chilean elderly: a head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy. Asian Pacific Journal of Cancer Prevention: Apjcp 16(2): 601-606

Novoa, C.; Anguita, C.; Badilla-O, Sán.; Aliaga, A.; Reyes, D. 2014: Prostate cancer screening is associated with educational level and knowledge about the disease. Revista medica de Chile 142(9): 1136-1141

Rezaee, M.E.; Ward, C.E.; Odom, B.D.; Pollock, M. 2016: Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012. Preventive Medicine 82: 73-76

Yen, A.M.-F.; Auvinen, A.; Schleutker, J.; Wu, Y.-Y.; Fann, J.C.-Y.; Tammela, T.; Chen, S.L.-S.; Chiu, S.Y.-H.; Chen, H.-H. 2015: Prostate cancer screening using risk stratification based on a multi-state model of genetic variants. Prostate 75(8): 825-835

Lu-Yao, G.L.; Albertsen, P.C.; Stanford, J.L.; Stukel, T.A.; Walker-Corkery, E.S.; Barry, M.J. 2016: Prostate cancer screening, treatment, and outcomes- A population-based study. Journal of Clinical Oncology 24(18_Suppl): 10017-10017

Kearns, J.T.; Gore, J.L. 2016: Prostate cancer screening: Do guidelines matter?. Cancer 122(24): 3760-3761

Kwiatkowski, M.; Randazzo, M.; Kluth, L.; Manka, L.; Huber, A.; Recker, F. 2015: Prostate cancer screening: and yet it moves!. Asian Journal of Andrology 17(3): 437-438

Eisinger, F.; Morère, J.F.; Touboul, C.; Pivot, X.; Coscas, Y.; Blay, J.Y.; Lhomel, C.; Viguier, J. 2015: Prostate cancer screening: contrasting trends. Cancer Causes and Control: Ccc 26(6): 949-952

Mayor, S. 2014: Prostate cancer services vary in England and Wales. LANCET. Oncology 15(13): E593

Boesen, L.; Chabanova, E.; Løgager, V.; Balslev, I.; Mikines, K.; Thomsen, H.S. 2015: Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology. European Radiology 25(6): 1776-1785

Kosaka, T.; Oya, M. 2016: Prostate cancer stem cell and drug resistance. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 45-49

Wu, G.; Wu, D.-l. 2015: Prostate cancer stem cells: advances in current research. Zhonghua Nan Ke Xue 21(2): 170-174

Rybak, A.P.; Bristow, R.G.; Kapoor, A. 2015: Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget 6(4): 1900-1919

Di Zazzo, E.; Galasso, G.; Giovannelli, P.; Di Donato, M.; Di Santi, A.; Cernera, G.; Rossi, V.; Abbondanza, C.; Moncharmont, B.; Sinisi, A.A.; Castoria, G.; Migliaccio, A. 2016: Prostate cancer stem cells: the role of androgen and estrogen receptors. Oncotarget 7(1): 193-208

Krušlin, B.žo.; Ulamec, M.; Tomas, D. 2015: Prostate cancer stroma: an important factor in cancer growth and progression. Bosnian Journal of Basic Medical Sciences 15(2): 1-8

Cuypers, M.; Lamers, R.E.D.; de Vries, M.; Husson, O.; Kil, P.J.M.; van de Poll-Franse, L.V. 2016: Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry. Urologic Oncology 34(11): 482.E11-482.E18

Goonewardene, S.S.; Persad, R.; Young, A.; Grover, L.; Makar, A. 2015: Prostate cancer survivorship and psychosexual care. European Journal of Cancer Care 24(2): 281-282

Resnick, M.J.; Lacchetti, C.; Bergman, J.; Hauke, R.J.; Hoffman, K.E.; Kungel, T.M.; Morgans, A.K.; Penson, D.F. 2015: Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 33(9): 1078-1085

Resnick, M.J.; Lacchetti, C.; Penson, D.F. 2015: Prostate cancer survivorship care guidelines: American Society of Clinical Oncology practice guideline endorsement. Journal of oncology practice 11(3): e445-e449

Ferguson, J.; Aning, J. 2015: Prostate cancer survivorship: a nurse-led service model. British Journal of Nursing 24(18): S14-S21

Hennequin, C.; Bruyère, F.; Sedefdjian, A.; Bourouina, R.; Rouprêt, M. 2015: Prostate cancer treated with androgen deprivation therapy: Care and monitoring in daily practice. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(16): 1132-1139

Drozdz, S.; Schwedas, M.; Salz, H.; Foller, S.; Wendt, T.G. 2016: Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 192(4): 223-231

Ojha, R.P.; Thertulien, R.; Zhou, Y.; Fischbach, L.A. 2016: Prostate cancer treatment and risk of acute myeloid leukemia in a population-based prospective cohort. Journal of Clinical Oncology 26(15_Suppl): 5073-5073

Akaza, H.; Onozawa, M.; Hinotsu, S. 2017: Prostate cancer trends in Asia. World Journal of Urology 35(6): 859-865

Emtage, J.B.; Poch, M.A.; Hutton, M.T.; Emtage, J.B. 2015: Prostate cancer trends in Barbados: An analysis of the Barbados Urologic Diseases Survey database. Cancer Epidemiology 39(6): 825-830

Plonis, J.; Bokums, K.; Cauce, V.; Miklasevics, E.; Vaganovs, P.; Irmejs, A.; Gardovskis, J.; Vjaters, E. 2014: Prostate cancer trends in Latvia during 1990-2012: incidence, prevalence, mortality, and survival rates. Medicina 50(6): 313-317

Carlson, R.H. 2016: Prostate cancer urine assay could spare biopsies. LANCET. Oncology 17(5): E185

Baxevanis, C.N.; Papamichail, M.; Perez, S.A. 2015: Prostate cancer vaccines: the long road to clinical application. Cancer Immunology Immunotherapy: Cii 64(4): 401-408

Konyalioglu, E.; Tarhan, H.; Cakmak, O.; Pala, E.E.; Zorlu, F. 2015: Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer. International Braz J Urol: Official Journal of the Brazilian Society of Urology 41(3): 442-448

Bonde, A.A.; Korngold, E.K.; Foster, B.R.; Westphalen, A.C.; Pettersson, D.R.; Troxell, M.L.; Simko, J.P.; Coakley, F.V. 2016: Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?. Clinical Imaging 40(3): 365-369

Capek, S.; Howe, B.M.; Tracy, J.A.; García, Jín.J.; Amrami, K.K.; Spinner, R.J. 2015: Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report. Journal of Neurosurgery 122(4): 778-783

Storstein, A.; Raspotnig, M.; Vitaliani, R.; Giometto, B.; Graus, F.; Grisold, W.; Honnorat, J.; Vedeler, C.A. 2016: Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. Journal of Neurology 263(5): 1001-1007

Ording, A.G.; Horváth-Puhó, Eébet.; Lash, T.L.; Ehrenstein, V.; Borre, M.; Vyberg, M.; Sørensen, H.T. 2015: Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011. Cancer 121(20): 3692-3699

Bratt, O.; Damber, J-Erik.; Aldehag, A.; Brändström, H. 2015: Prostate cancer--new guidelines and the first care program. Lakartidningen 112

Ummanni, R.; Duscharla, D.; Barett, C.; Venz, S.; Schlomm, T.; Heinzer, H.; Walther, R.; Bokemeyer, C.; Brümmendorf, T.H.; Murthy, P.V.L.N.; Balabanov, S. 2015: Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics 119: 218-229

Wu, F.; Dai, X.; Gan, W.; Wan, L.; Li, M.; Mitsiades, N.; Wei, W.; Ding, Q.; Zhang, J. 2017: Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer Letters 385: 207-214

Cha, H.-R.; Lee, J.H.; Hensel, J.A.; Sawant, A.B.; Davis, B.H.; Lee, C.M.; Deshane, J.S.; Ponnazhagan, S. 2016: Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages. Prostate 76(7): 624-636

Woo, S.; Cho, J.Y.; Ku, J.H.; Kim, S.Y.; Kim, S.H. 2016: Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRi. Acta Radiologica 57(8): 1006-1013

Sabourin, G. 2014: Prostate cancer. Advantages of active surveillance. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(5): 51

Helpap, B.; Bubendorf, L. 2016: Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP). Der Pathologe 37(1): 3-10

Helpap, B.; Bubendorf, L.; Kristiansen, G. 2016: Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP). Der Pathologe 37(1): 11-16

Lasalvia-Prisco, E.M.; Garcia-Giralt, E.; Cucchi, S.; Larrañaga, J.; Wagner, D. 2016: Prostate cancer: Autologous immunotherapy optimized by indoleamine-2,3-dioxygenase (IDO)-inhibitor as immune-tolerance breaker. Journal of Clinical Oncology 24(18_Suppl): 12509-12509

Francini, E.; Taplin, M.-E. 2017: Prostate cancer: Developing novel approaches to castration-sensitive disease. Cancer 123(1): 29-42

Adjakly, M.; Ngollo, M.; Dagdemir, A.; Judes, G.ël.; Pajon, A.; Karsli-Ceppioglu, S.; Penault-Llorca, F.éd.ér.; Boiteux, J.-P.; Bignon, Y.-J.; Guy, L.; Bernard-Gallon, D. 2015: Prostate cancer: the main risk and protective factors-Epigenetic modifications. Annales d'Endocrinologie 76(1): 25-41

Mazeron, J.-J. 2017: Prostate cancer: to treat or not to treat?. Bulletin du Cancer 104(1): 4-5

Li, H.; Xia, J.; Xie, S.; Guo, Y.; Xin, M.; Li, F. 2015: Prostate cancer: a comparison of the diagnostic performance of transrectal ultrasound versus contrast enhanced transrectal ultrasound in different clinical characteristics. International Journal of Clinical and Experimental Medicine 8(11): 21428-21434

Tormey, W.P. 2015: Prostate cancer: active surveillance may prove organisationally impossible. Irish Journal of Medical Science 184(3): 715-717

Desai, M.; John, B.; Evans, G.; Eddy, B. 2015: Prostate cancer: beware of disseminated intravascular coagulation. BMJ Case Reports

Tan, W.; Wu, K. 2016: Prostate cancer: biopsy proven rare sites of metastases. Journal of Clinical Oncology 23(16_Suppl): 4794-4794

Falcinelli, L.; Palumbo, I.; Radicchia, V.; Arcidiacono, F.; Lancellotta, V.; Montesi, G.; Matrone, F.; Zucchetti, C.; Marcantonini, M.; Bini, V.; Aristei, C. 2015: Prostate cancer: contouring target and organs at risk by kilovoltage and megavoltage CT and MRi in patients with and without hip prostheses. British Journal of Radiology 88(1056): 20150509

Yang, D.M.; Kim, H.C.; Kim, S.W.; Jahng, G.-H.; Won, K.Y.; Lim, S.J.; Oh, J.-H. 2016: Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score. Clinical Imaging 40(3): 445-450

Correas, J.-M.; Tissier, A.-M.; Khairoune, A.; Vassiliu, V.; Méjean, A.; Hélénon, O.; Memo, R.; Barr, R.G. 2015: Prostate cancer: diagnostic performance of real-time shear-wave elastography. Radiology 275(1): 280-289

McCoy, O.O.; Prasad, M.M.; Singer, N. 2016: Prostate cancer: endogenous chemical castration. BMJ Case Reports

Montironi, R.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Berardi, R.; Galosi, A.B.; Cheng, L.; Lopez-Beltran, A.; Briganti, A.; Montorsi, F.; Scarpelli, M. 2016: Prostate cancer: from Gleason scoring to prognostic grade grouping. Expert Review of Anticancer Therapy 16(4): 433-440

Morisot, A.; Bessaoud, F.ïz.; Landais, P.; Rébillard, X.; Trétarre, B.; Daurès, J.-P. 2015: Prostate cancer: net survival and cause-specific survival rates after multiple imputation. Bmc Medical Research Methodology 15: 54

Volgareva, G.M. 2015: Prostate cancer: papillomaviruses as a possible cause. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 95-100

Rosenkrantz, A.B.; Verma, S.; Turkbey, B. 2015: Prostate cancer: top places where tumors hide on multiparametric MRi. AJR. American Journal of Roentgenology 204(4): W449-W456

Bayoud, Y.; Loock, P.Y.; Messaoudi, R.; Ripert, T.; Pierrevelcin, J.; Kozal, S.; Leon, P.; Kamdoum, M.; Irène, C.; Menard, J. 2015: Prostate cancer: what about reproducibility of decision made at multidisciplinary team management?. Urology Journal 12(2): 2078-2082

Glina, S.; Pasternak, J. 2015: Prostate cancer: what is the right message?. Einstein 13(4): 7-8

Smith, Z.L.; Soloway, M.S. 2016: Prostate capsule sparing radical cystectomy - a safe procedure for few. Central European Journal of Urology 69(1): 32-33

Tillou, X.; Chiche, L.; Guleryuz, K.; Hervé, S.; Bensadoun, H.; Doerfler, A. 2015: Prostate carcinoma in liver transplant recipients: think about it!. Urologic Oncology 33(6): 265.E9

Bradley, L.H.; Burton, M.; Gokden, M.; Serletis, D. 2015: Prostate carcinoma mimicking a sphenoid wing meningioma. International Journal of Surgery Case Reports 15: 63-65

O'Neil, L.M.; Walsh, S.; Cohen, R.J.; Lee, S. 2015: Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence. Bju International 116(Suppl 3): 42-48

Agheli, A.; Patsiornik, Y.; Chen, Y.; Chaudhry, M.R.; Gerber, H.; Wang, J.C. 2009: Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip. Radiology Case Reports 4(4): 288

Harzendorf, C.; Schmidt, A.; Hirsch, T. 2017: Prostate carcinoma + swelling of the leg = lymphedema : Is the equation correct?. Der Internist 58(4): 402-408

Derraz, F.; Forzy, G.ér.; Delebarre, A.; Taleb-Ahmed, A.; Oussalah, M.; Peyrodie, L.; Verclytte, S. 2015: Prostate contours delineation using interactive directional active contours model and parametric shape prior model. International Journal for Numerical Methods in Biomedical Engineering 31(11)

Lian, J.; Shao, Y.; Potter, L.D.; Chen, R.C.; Holmes, J.A.; Pryser, E.A.; Shen, J.; Shen, D.; Wang, A.Z. 2016: Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy. Medical Physics 43(12): 6569

Rakow-Penner, R.A.; White, N.S.; Margolis, D.J.A.; Parsons, J.Kellogg.; Schenker-Ahmed, N.; Kuperman, J.M.; Bartsch, H.; Choi, H.W.; Bradley, W.G.; Shabaik, A.; Huang, J.; Liss, M.A.; Marks, L.; Kane, C.J.; Reiter, R.E.; Raman, S.S.; Karow, D.S.; Dale, A.M. 2015: Prostate diffusion imaging with distortion correction. Magnetic Resonance Imaging 33(9): 1178-1181

Kim, C.K.; Park, J.J.; Park, B.K. 2016: Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration. European Radiology 26(5): 1450-1456

Baker, M.; Behrens, C.F. 2015: Prostate displacement during transabdominal ultrasound image-guided radiotherapy assessed by real-time four-dimensional transperineal monitoring. Acta Oncologica 54(9): 1508-1514

Boukas, A.; Sunderland, G.J.; Ross, N. 2015: Prostate dural metastasis presenting as chronic subdural hematoma. A case report and review of the literature. Surgical Neurology International 6: 30

Park, J.Wook.; Lee, J.K.; Phillips, J.W.; Huang, P.; Cheng, D.; Huang, J.; Witte, O.N. 2016: Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proceedings of the National Academy of Sciences of the United States of America 113(16): 4482-4487

Moulton, C.R.; House, M.J.; Lye, V.; Tang, C.I.; Krawiec, M.; Joseph, D.J.; Denham, J.W.; Ebert, M.A. 2016: Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications. Radiation Oncology 11(1): 144

Biggs, C.N.; Siddiqui, K.M.; Al-Zahrani, A.A.; Pardhan, S.; Brett, S.I.; Guo, Q.Q.; Yang, J.; Wolf, P.; Power, N.E.; Durfee, P.N.; MacMillan, C.D.; Townson, J.L.; Brinker, J.C.; Fleshner, N.E.; Izawa, J.I.; Chambers, A.F.; Chin, J.L.; Leong, H.S. 2016: Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry. Oncotarget 7(8): 8839-8849

Jones, A.C.; Antillon, K.S.; Jenkins, S.M.; Janos, S.N.; Overton, H.N.; Shoshan, D.S.; Fischer, E.G.; Trujillo, K.A.; Bisoffi, M. 2015: Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. Plos one 10(3): E0119314

Liss, M.A.; Xu, J.; Chen, H.; Kader, A.K. 2015: Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial. Prostate 75(12): 1322-1328

Chiu, P.K.F.; Roobol, M.J.; Teoh, J.Y.; Lee, W.-M.; Yip, S.-Y.; Hou, S.-M.; Bangma, C.H.; Ng, C.-F. 2016: Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume. International Urology and Nephrology 48(10): 1631-1637

De Luca, S.; Passera, R.; Fiori, C.; Bollito, E.; Cappia, S.; Mario Scarpa, R.; Sottile, A.; Franco Randone, D.; Porpiglia, F. 2015: Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. Urologic Oncology 33(10): 424.E17

Morton, G.; Chung, H.T.; McGuffin, M.; Helou, J.; D'Alimonte, L.; Ravi, A.; Cheung, P.; Szumacher, E.; Liu, S.; Al-Hanaqta, M.; Zhang, L.; Mamedov, A.; Loblaw, A. 2017: Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase Ii clinical trial of one fraction of 19Gy or two fractions of 13.5Gy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 122(1): 87-92

Morton, G.C. 2015: Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note. Practical Radiation Oncology 5(4): 238-240

Sivaraman, A.; Sanchez-Salas, R.; Barret, E.; Macek, P.; Validire, P.; Galiano, M.; Rozet, F.; Cathelineau, X. 2015: Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience. World Journal of Urology 33(10): 1475-1479

Silva, S.A.ân.; Gobbo, M.G.ãe.; Pinto-Fochi, M.E.; Rafacho, A.; Taboga, S.ão.R.; Almeida, E.A.; Góes, R.M.; Ribeiro, D.L. 2015: Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF. International Journal of Experimental Pathology 96(1): 21-30

Chapet, O.; Decullier, E.; Bin, S.; Faix, A.; Ruffion, A.; Jalade, P.; Fenoglietto, P.; Udrescu, C.; Enachescu, C.; Azria, D. 2015: Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study. International Journal of Radiation Oncology Biology Physics 91(4): 730-736

Hassanzadeh, E.; Glazer, D.I.; Dunne, R.M.; Fennessy, F.M.; Harisinghani, M.G.; Tempany, C.M. 2017: Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdominal Radiology 42(1): 278-289

Wood, M.; Fonseca, A.; Sampson, D.; Kovendy, A.; Westhuyzen, J.; Shakespeare, T.; Turnbull, K. 2016: Prostate intensity-modulated radiotherapy planning in seven mouse clicks: Development of a class solution for cancer. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 21(6): 567-570

Nagele, U.; Junker, D. 2015: Prostate interdisciplinary communication and mapping algorithm for biopsy and pathology (PIC-MABP) of multiparametric MRI findings. World Journal of Urology 33(7): 1057-1059

Bansal, N.; Duggal, L.; Jain, N.; Jain, S.; Sharma, A.; Arora, N. 2017: Prostate involvement in granulomatosis with polyangitis: a rarity. International Journal of Rheumatic Diseases 20(11): 1841-1842

Majumdar, R.; Mirheydar, H.S.; Palazzi, K.L.; Lakin, C.M.; Albo, M.E.; Parsons, J.K. 2015: Prostate laser vaporization is safe and effective in elderly men. Urology Annals 7(1): 36-40

Hashimoto, T.; Rahul, K.; Takeda, T.; Benfante, N.; Mulhall, J.P.; Hricak, H.; Eastham, J.A.; Vargas, H.A. 2016: Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer. Urologic Oncology 34(12): 530.E9-530.E14

De Visschere, P.; Nezzo, M.; Pattyn, E.; Fonteyne, V.ér.; Van Praet, C.; Villeirs, G. 2015: Prostate magnetic resonance spectroscopic imaging at 1.5tesla with endorectal coil versus 3.0tesla without endorectal coil: comparison of spectral quality. Clinical Imaging 39(4): 636-641

Juneja, P.; Kneebone, A.; Booth, J.T.; Thwaites, D.I.; Kaur, R.; Colvill, E.; Ng, J.A.; Keall, P.J.; Eade, T. 2015: Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative study. Radiation Oncology 10: 215

Kulaksızoğlu, H.; Akand, M.; Kılıç, Öz.; Gül, M.; Kucur, M.; Göktaş, S. 2014: Prostate myths: what is the prostate awareness in the general male population in Turkey?. Turkish Journal of Urology 40(3): 150-155

Abele, J.T.; Moore, R.; Tymchak, W.; Owen, R.J. 2015: Prostate perfusion mapped by technetium-99m macroaggregated albumin after selective arterial injection. Journal of Vascular and Interventional Radiology: Jvir 26(3): 418-425

Stone, B.V.; Shoag, J.; Halpern, J.A.; Mittal, S.; Lewicki, P.; Golombos, D.M.; Bedretdinova, D.; Chughtai, B.; Barbieri, C.E.; Lee, R.K. 2017: Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men. Bju International 119(2): 298-304

Youssef, R.F. 2011: Prostate sparing cystectomy: a procedure with limited indications. Arab Journal of Urology 9(2): 113-114

Aoun, F.; de Saint Aubain Somerhausen, N.; van Velthoven, R.; Peltier, A. 2014: Prostate sparing robot-assisted laparoscopic treatment of leiomyoma of the prostate. Journal of Robotic Surgery 8(4): 389-392

Cao, W.; Li, F.; Yao, J.; Yu, J. 2015: Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. Bmc Cancer 15: 915

Rudnicka, E.; Radowicki, S.; Suchta, K. 2016: Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 32(11): 931-935

Daskivich, T.J.; Regan, M.M.; Kantoff, P.W.; Oh, W.K. 2016: Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy. Journal of Clinical Oncology 24(18_Suppl): 4616-4616

Kole, T.P.; Chen, L.N.; Obayomi-Davies, O.; Kim, J.S.; Lei, S.; Suy, S.; Dritschilo, A.; Collins, S.P. 2015: Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer. Acta Oncologica 54(6): 832-838

Mishra, M.V.; Shirazi, R.; Hertzfeld, K.; Barrett, W. 2016: Prostate specific antigen nadir: A prognostic marker of disease-free survival?. Journal of Clinical Oncology 23(16_Suppl): 4716-4716

Barrio, M.; Fendler, W.P.; Czernin, J.; Herrmann, K. 2016: Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer. Expert Review of Molecular Diagnostics 16(11): 1177-1188

Fawzy, M.S.; Mohamed, R.H.; Elfayoumi, A.-R.R. 2015: Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer. Medical Oncology 32(3): 74

Uotani, T.; Sugimoto, M.; Ichikawa, H.; Tanaka, S.; Nagashima, H.; Uchida, T.; Graham, D.Y.; Yamaoka, Y. 2016: Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. Journal of Digestive Diseases 17(1): 20-27

Jensen, M.M.; Arvaniti, M.; Mikkelsen, J.D.; Michalski, D.; Pinborg, L.H.; Härtig, W.; Thomsen, M.S. 2015: Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. Neurobiology of Aging 36(4): 1629-1638

Li, M.; Yu, X.; Cheng, L.; Huang, Y.; Weng, G. 2015: Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer. International Journal of Clinical and Experimental Medicine 8(8): 13259-13266

Webber, J.P.; Spary, L.K.; Mason, M.D.; Tabi, Z.; Brewis, I.A.; Clayton, A. 2016: Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes. Oncotarget 7(15): 20124-20139

Heaphy, C.M.; Gaonkar, G.; Peskoe, S.B.; Joshu, C.E.; De Marzo, A.M.; Lucia, M.Scott.; Goodman, P.J.; Lippman, S.M.; Thompson, I.M.; Platz, E.A.; Meeker, A.K. 2015: Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate 75(11): 1160-1166

Kinoshita, H.; Matsuda, T. 2016: Prostate systematic biopsy. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 346-349

Shaker, H. 2016: Prostate tissue retrieval after holmium laser enucleation of the prostate; assessment of non-morcellation approaches. Arab Journal of Urology 14(2): 156

Shui, I.M.; Wong, C.-J.; Zhao, S.; Kolb, S.; Ebot, E.M.; Geybels, M.S.; Rubicz, R.; Wright, J.L.; Lin, D.W.; Klotzle, B.; Bibikova, M.; Fan, J.-B.; Ostrander, E.A.; Feng, Z.; Stanford, J.L. 2016: Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. Cancer 122(14): 2168-2177

Steenbergen, P.; Haustermans, K.; Lerut, E.; Oyen, R.; De Wever, L.; Van den Bergh, L.; Kerkmeijer, L.G.W.; Pameijer, F.A.; Veldhuis, W.B.; van der Voort van Zyp, J.R.N.; Pos, F.J.; Heijmink, S.W.; Kalisvaart, R.; Teertstra, H.J.; Dinh, C.V.; Ghobadi, G.; van der Heide, U.A. 2015: Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 115(2): 186-190

Rausch, S.; Hennenlotter, J.ör.; Scharpf, M.; Teepe, K.; Kühs, U.; Aufderklamm, S.; Bier, S.; Mischinger, J.; Gakis, G.; Stenzl, A.; Schwentner, C.; Todenhöfer, T. 2016: Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma. Journal of Cancer Research and Clinical Oncology 142(5): 937-947

Chen, S.-P.; Zhang, L.-S.; Fu, B.-S.; Zeng, X.-C.; Yi, H.-M.; Jiang, N. 2015: Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Medicine 94(4): E423

Yang, L.; Wang, H.; Wang, Y.; He, Z.; Chen, H.; Liang, S.; He, S.; Wu, S.; Song, L.; Chen, Y. 2016: Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma. Oncotarget 7(22): 31878-31891

Lee, J.; Huang, W.; Broering, J.M.; Barron, A.E.; Seo, J. 2015: Prostate tumor specific peptide-peptoid hybrid prodrugs. Bioorganic and Medicinal Chemistry Letters 25(14): 2849-2852

Alcayaga-Miranda, F.; González, P.L.; Lopez-Verrilli, A.; Varas-Godoy, M.; Aguila-Díaz, C.; Contreras, L.; Khoury, M. 2016: Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. Oncotarget 7(28): 44462-44477

Mak, P.; Li, J.; Samanta, S.; Chang, C.; Jerry, D.J.; Davis, R.J.; Leav, I.; Mercurio, A.M. 2015: Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression. Cell Reports 10(12): 1982-1991

Cui, Y.; Ma, W.; Lei, F.; Li, Q.; Su, Y.; Lin, X.; Lin, C.; Zhang, X.; Ye, L.; Wu, S.; Li, J.; Yuan, Z.; Song, L. 2016: Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling. Journal of Pathology 239(3): 297-308

Dinkla, A.M.; Pieters, B.R.; Koedooder, K.; van Wieringen, N.; van der Laarse, R.; Bel, A. 2014: Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema. Radiation Oncology 9: 272

Shin, Y.S.; Choi, H.; Cheon, M.W.; Park, S.C.; Park, J.K.; Kim, H.J.; Jeong, Y.B. 2015: Prostate volume and prostate-specific antigen in men with Parkinson's disease are not different compared to age-matched control group: a prospective, case-controlled multicenter study. Prostate International 3(2): 62-64

Tadin, T.; Spanjol, J.; Muskardin, I.; Fuckar, Z. 2014: Prostate volume and urinary discomforts in elderly. Collegium Antropologicum 38(4): 1119-1122

Woodruff, A.J.; Morgan, T.M.; Wright, J.L.; Porter, C.R. 2016: Prostate volume as an independent predictor of prostate cancer and high-grade disease on prostate needle biopsy. Journal of Clinical Oncology 26(15_Suppl): 5165-5165

Paterson, N.R.; Lavallée, L.T.; Nguyen, L.N.; Witiuk, K.; Ross, J.; Mallick, R.; Shabana, W.; MacDonald, B.; Scheida, N.; Fergusson, D.; Momoli, F.; Cnossen, S.; Morash, C.; Cagiannos, I.; Breau, R.H. 2016: Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens. Canadian Urological Association Journal 10(7-8): 264-268

Li, S-Hui.; Yang, Q-Fang.; Zuo, P-Yuan.; Liu, Y-Wei.; Liao, Y-Hua.; Liu, C-Yun. 2016: Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study. Journal of Huazhong University of Science and Technology. Medical Sciences 36(6): 796-800

Yilmaz, H.; Ustuner, M.; Ciftci, S.; Yavuz, U.; Ozkan, T.A.; Dillioglugil, O. 2014: Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients. International Braz J Urol: Official Journal of the Brazilian Society of Urology 40(5): 613-619

Kranzbühler, B.; Gross, O.; Fankhauser, C.D.; Wettstein, M.S.; Grossmann, N.C.; Hefermehl, L.J.; Zimmermann, M.; Müller, A.; Eberli, D.; Sulser, T.; Poyet, Cédric.; Hermanns, T. 2017: Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry. World Journal of Urology 35(3): 429-435

Commandeur, F.; Acosta, O.; Simon, A.; Mathieu, R.; Fautrel, A.; Gnep, K.; Haigron, P.; de Crevoisier, R. 2015: Prostate whole-mount histology reconstruction and registration to MRi for correlating in-vivo observations with biological findings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2015: 2399-2402

Gomella, L.G. 2016: Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots. Canadian Journal of Urology 23(5): 8429

Stephan, C.; Rittenhouse, H.; Hu, X.; Cammann, H.; Jung, K. 2014: Prostate-Specific Antigen (PSA) Screening and new Biomarkers for Prostate Cancer (PCa). Ejifcc 25(1): 55-78

Coric, J.; Mujic, J.; Kucukalic, E.; Ler, D. 2015: Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men. Open Biochemistry Journal 9: 34-36

Tawfik, A. 2015: Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis. Ontario Health Technology Assessment Series 15(11): 1-37

Nowroozi, M.Reza.; Momeni, S.Ali.; Ohadian Moghadam, S.; Ayati, E.; Mortazavi, A.; Arfae, S.; Jamshidian, H.; Taherimahmoudi, M.; Ayati, M. 2016: Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer. Nephro-Urology Monthly 8(6): E39984

Giacalone, N.J.; Wu, J.; Chen, M.-H.; Renshaw, A.; Loffredo, M.; Kantoff, P.W.; D'Amico, A.V. 2016: Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men with Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(31): 3781-3786

De Vincentis, G.; Follacchio, G.Anna.; Frantellizzi, V.; Liberatore, M.; Monteleone, F.; Cortesi, E. 2016: Prostate-Specific Antigen Flare Phenomenon During 223 Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report. Clinical Genitourinary Cancer 14(5): E529-E533

Ueda, Y.; Matsubara, N.; Tabata, K-Ichi.; Satoh, T.; Kamiya, N.; Suzuki, H.; Kawahara, T.; Uemura, H. 2017: Prostate-Specific Antigen Flare Phenomenon Induced by Abiraterone Acetate in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 15(2): 320-325

Conrad, T.; Paxton, R.J.; Assum, G.ün.; Ayasse, M. 2018: Divergence in male sexual odor signal and genetics across populations of the red mason bee, Osmia bicornis, in Europe. Plos one 13(2): E0193153

Shoag, J.E.; Schlegel, P.N.; Hu, J.C. 2016: Prostate-Specific Antigen Screening: time to Change the Dominant Forces on the Pendulum. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(29): 3499-3501

Musrap, N.; Diamandis, E.P. 2016: Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and its Implications for Antidoping. Clinical Chemistry 62(8): 1066-1074

Kim, J.S.; Ryu, J.-G.; Kim, J.W.; Hwang, E.C.; Jung, S.I.; Kang, T.W.; Kwon, D.; Park, K. 2015: Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?. International Braz J Urol: Official Journal of the Brazilian Society of Urology 41(2): 258-264

Pabisiak, K.; Ostrowski, M.; Kram, A.; Safranow, K.; Myślak, M.; Sieńko, J.; Sulikowski, T.; Ciechanowski, K. 2016: Prostate-Specific Antigen: Nonspecific in Deceased Organ Donors. Transplantation Proceedings 48(5): 1374-1377

Rodriguez, M.; Siwko, S.; Liu, M. 2016: Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion. Current Molecular Medicine 16(6): 526-532

Vamadevan, S.; Shetty, D.; Le, K.; Bui, C.; Mansberg, R.; Loh, H. 2016: Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor. Clinical Nuclear Medicine 41(10): 804-806

Crowley, M.J.P.; Scognamiglio, T.; Liu, Y.-F.; Kleiman, D.A.; Beninato, T.; Aronova, A.; Liu, H.; Jhanwar, Y.S.; Molina, A.; Tagawa, S.T.; Bander, N.H.; Zarnegar, R.; Elemento, O.; Fahey, T.J. 2016: Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma. Journal of Clinical Endocrinology and Metabolism 101(3): 981-987

Bhardwaj, H.; Stephens, M.; Bhatt, M.; Thomas, P.A. 2016: Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma. Clinical Nuclear Medicine 41(12): 968-969

Kobe, C.; Maintz, D.; Fischer, T.; Drzezga, A.; Chang, D.-H. 2015: Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis. Clinical Nuclear Medicine 40(11): 897-898

Hermann, R.M.; Djannatian, M.; Czech, N.; Nitsche, M. 2016: Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?. Case Reports in Oncology 9(2): 457-463

Karandish, F.; Haldar, M.K.; You, S.; Brooks, A.E.; Brooks, B.D.; Guo, B.; Choi, Y.; Mallik, S. 2016: Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids. Acs Omega 1(5): 952-962

Vamadevan, S.; Le, K.; Bui, C.; Mansberg, R. 2016: Prostate-Specific Membrane Antigen Uptake in Small Cleaved B-Cell Follicular Non-Hodgkin Lymphoma. Clinical Nuclear Medicine 41(12): 980-981

Teo, M.Y.; Morris, M.J. 2016: Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancer Journal 22(5): 347-352

Rowe, S.P.; Drzezga, A.; Neumaier, B.; Dietlein, M.; Gorin, M.A.; Zalutsky, M.R.; Pomper, M.G. 2016: Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(Suppl 3): 90s-96s

Stanhiser, J.; Mahdi, H.; Rosa, G.; Harper, H.; Shepard, D.; Rose, P.G.; Roma, A.A. 2016: Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 35(2): 185-190

Kulkarni, P.; Dunker, A.K.; Weninger, K.; Orban, J. 2016: Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer. Asian Journal of Andrology 18(5): 695-703

Roberts, M.J.; Richards, R.S.; Chow, C.W.K.; Doi, S.A.R.; Schirra, H.J.; Buck, M.; Samaratunga, H.; Perry-Keene, J.; Payton, D.; Yaxley, J.; Lavin, M.F.; Gardiner, R.A. 2016: Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International 4(3): 97-102

Gilligan, T.D.; Kennedy, M.W.; Olson, E.; Gerberick, A.; Wilson-Glover, A.; Allen, J.D. 2016: Prostate-cancer (CaP) screening decision aid for black men designed to enhance shared decision-making. Journal of Clinical Oncology 24(18_Suppl): 6059-6059

Tsui, K.-H.; Lin, Y.-H.; Chung, L.-C.; Chuang, S.-T.; Feng, T.-H.; Chiang, K.-C.; Chang, P.-L.; Yeh, C.-J.; Juang, H.-H. 2016: Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells. Cancer Letters 375(1): 142-151

Nour, H.; Abdelrazak, O.; Wishahy, M.; Elkatib, S.; Botto, H. 2011: Prostate-sparing cystectomy: Potential functional advantages and objective oncological risks; a case series and review. Arab Journal of Urology 9(2): 107-112

Liu, X.; Tang, J.; Fei, X.; Li, Q.-Y. 2015: Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less. Iranian Journal of Public Health 44(11): 1466-1472

Rescigno, P.; Lorente, D.; Bianchini, D.; Ferraldeschi, R.; Kolinsky, M.P.; Sideris, S.; Zafeiriou, Z.; Sumanasuriya, S.; Smith, A.D.; Mehra, N.; Jayaram, A.; Perez-Lopez, R.; Mateo, J.; Parker, C.; Dearnaley, D.P.; Tunariu, N.; Reid, A.; Attard, G.; de Bono, J.S. 2016: Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. European Urology 70(5): 724-731

Xie, G.-S.; Lyv, J.-X.; Li, G.; Yan, C.-Y.; Hou, J.-Q.; Pu, J.-X.; Ding, X.; Huang, Y.-H. 2016: Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy. Chinese Medical Journal 129(15): 1800-1804

Kryvenko, O.N.; Diaz, M.; Matoso, A.; Kates, M.; Cohen, J.; Swanson, G.P.; Epstein, J.I. 2016: Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution. Urology 90: 141-147

Wernicke, A.G.; Kim, S.; Liu, H.; Bander, N.H.; Pirog, E.C. 2017: Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Applied Immunohistochemistry and Molecular Morphology: Aimm 25(4): 271-276

Roessner, M.; de Wit, R.; Tannock, I.F.; Yateman, N.; Yao, S-L.; Yver, A.; Eisenberger, M.A. 2016: Prostate-specific antigen (PSA) response as a surrogate endpoint for overall survival (OS): Analysis of the TAX 327 Study comparing docetaxel plus prednisone with mitoxantrone plus prednisone in advanced prostate cancer. Journal of Clinical Oncology 23(16_Suppl): 4554-4554

Ewenighi, C.O.; Dimkpa, U.; Onyeanusi, J.C.; Babtunde, A.; Onoh, L.U.M.; Onoh, G.O.; Ezeugwu, U. 2017: Prostate-specific antigen and its derivatives in young adults occupationally exposed to quarry pollutants in southeastern Nigeria. Archives of Environmental and Occupational Health 72(5): 258-263

Ducatman, A.; Zhang, J.; Fan, H. 2015: Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population. Journal of Occupational and Environmental Medicine 57(1): 111-114

Mazer, S.J.; Hendrickson, B.T.; Chellew, J.P.; Kim, L.J.; Liu, J.W.; Shu, J.; Sharma, M.V. 2018: Divergence in pollen performance between Clarkia sister species with contrasting mating systems supports predictions of sexual selection. Evolution; International Journal of Organic Evolution 72(3): 453-472

Leduc, N.; Atallah, V.; Creoff, M.; Rabia, N.; Taouil, T.; Escarmant, P.; Vinh-Hung, V. 2015: Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: a study of 274 African-Caribbean patients. BrachyTherapy 14(6): 826-833

Yiakoumos, T.; Kälble, T.; Rausch, S. 2015: Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy. Urology Annals 7(4): 433-437

Kang, H.W.; Jung, H.D.; Lee, J.Y.; Kwon, J.K.; Jeh, S.U.; Cho, K.S.; Ham, W.S.; Choi, Y.D. 2016: Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer. Asian Journal of Andrology 18(3): 480-484

Udeh, E.I.; Nnabugwu, I.I.; Ozoemena, F.O.; Ugwumba, F.O.; Aderibigbe, A.S.O.; Ohayi, S.R.; Echetabu, K.N. 2016: Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria. World Journal of Surgical Oncology 14(1): 174

Ghosn, M.; Dagher, A.; El-Karak, F. 2015: Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient. Journal of Biomedical Research 29(5): 420-422

Servoll, E.; Sæter, T.; Vlatkovic, L.; Nesland, J.M.; Waaler, G.; Axcrona, K. 2015: Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience. Scandinavian Journal of Urology 49(3): 218-223

Scotte, F.; Banu, E.; Oudard, S.; Banu, A.; Medioni, J.; Fabre Guillevin, E.; Mejean, A.; Fontaine, E.; Thiounn, N.; Andrieu, J.M. 2016: Prostate-specific antigen doubling-time (PSA DT) before onset of chemotherapy as survival predictor for hormone refractory prostate cancer (HRPC) patients. Journal of Clinical Oncology 23(16_Suppl): 4551-4551

Kim, M.; Lee, J.; Jeong, C.W.; Ku, J.H.; Kim, H.H.; Kwak, C. 2015: Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors in castration-resistant prostate cancer. Urologic Oncology 33(5): 203.E1-9

Park, Y.H.; Choi, I.Y.; Yoon, S.C.; Jang, H.S.; Moon, H.W.; Hong, S.-H.; Kim, S.W.; Hwang, T.-K.; Lee, J.Y. 2015: Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer. Prostate International 3(1): 6-9

Kim, H.J.; Phak, J.H.; Kim, W.C. 2015: Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer. Prostate International 3(4): 118-122

Kim, H.J.; Phak, J.H.; Kim, W.C. 2017: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 13(1): 21-27

Phak, J.Hoon.; Kim, H.Jung.; Kim, W.Chul. 2016: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer. Prostate International 4(1): 25-29

Lee, S.Ho.; Kim, H.Jung.; Kim, W.Chul. 2016: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 12(4): 388-395

Mithal, P.; Howard, L.E.; Aronson, W.J.; Kane, C.J.; Cooperberg, M.R.; Terris, M.K.; Amling, C.L.; Freedland, S.J. 2015: Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology: Official Journal of the Japanese Urological Association 22(4): 362-366

Choi, W.S.; Heo, N.J.; Paick, J.-S.; Son, H. 2016: Prostate-specific antigen lowering effect of metabolic syndrome is influenced by prostate volume. International Journal of Urology: Official Journal of the Japanese Urological Association 23(4): 299-304

Tsumura, H.; Satoh, T.; Ishiyama, H.; Tabata, K.-I.; Komori, S.; Sekiguchi, A.; Ikeda, M.; Kurosaka, S.; Fujita, T.; Kitano, M.; Hayakawa, K.; Iwamura, M. 2016: Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer. Journal of Contemporary BrachyTherapy 8(2): 95-103

Kovalainen, E.; Vaarala, M.H. 2016: Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125i seed brachytherapy for prostate cancer. Molecular and Clinical Oncology 5(5): 647-650

Joob, B.; Wiwanitkit, V. 2015: Prostate-specific antigen obtained from fresh and dried urine. Urology Annals 7(1): 128

Simpkin, A.J.; Donovan, J.L.; Tilling, K.; Athene Lane, J.; Martin, R.M.; Albertsen, P.C.; Bill-Axelson, A.; Ballentine Carter, H.; Bosch, J.L.H.R.; Ferrucci, L.; Hamdy, F.C.; Holmberg, L.; Jeffrey Metter, E.; Neal, D.E.; Parker, C.C.; Metcalfe, C. 2016: Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohorts. Bju International 118(6): 911-918

Wiegel, T.; Bartkowiak, D.; Bottke, D.; Thamm, R.; Hinke, A.; Stöckle, M.; Rübe, C.; Semjonow, A.; Wirth, M.; Störkel, S.; Golz, R.; Engenhart-Cabillic, R.; Hofmann, R.; Feldmann, H.-J.ür.; Kälble, T.; Siegmann, A.; Hinkelbein, W.; Steiner, U.; Miller, K. 2015: Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial. International Journal of Radiation Oncology Biology Physics 91(2): 288-294

Wirth, M.P.; Froehner, M. 2015: Prostate-specific antigen pox virus vaccination for recurrent prostate cancer. European Urology 68(3): 372-373

Arab, D.; Ardestani Zadeh, A.; Mirmohammadkhani, M.; Beiglarzadeh, A. 2016: Prostate-specific antigen rising in Iranian men in correlation with body mass index, fasting blood sugar and blood lipid profile. Journal of Nephropathology 5(4): 134-138

Gin, G.E.; Pereira, J.F.; Weinberg, A.D.; Mehrazin, R.; Lerner, S.M.; Sfakianos, J.P.; Phillips, C.K. 2016: Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: a survey of U.S. transplantation centers. Urologic Oncology 34(2): 57.E9

Valberg, M.; Grotmol, T.; Tretli, S.; Veierød, M.B.; Moger, T.A.; Devesa, S.S.; Aalen, O.O. 2017: Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?. European Journal of Epidemiology 32(6): 511-520

Nderitu, P.; Van Hemelrijck, M.; Ashworth, M.; Mathur, R.; Hull, S.; Dudek, A.; Chowdhury, S. 2016: Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?. Bmj Open 6(7): E011356

Zambon, Jão.Paulo.; Almeida, F.G.; Conceição, R.Dilguerian.O.; Tabone, V.Arevalo.; Kashiwagi, N.Miwa.; Ross, C.L.; Carvalho, Jé.Antônio.Maluf.de. 2014: Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program. International Braz J Urol: Official Journal of the Brazilian Society of Urology 40(6): 745-752

Moss, S.; Melia, J.; Sutton, J.; Mathews, C.; Kirby, M. 2016: Prostate-specific antigen testing rates and referral patterns from general practice data in England. International Journal of Clinical Practice 70(4): 312-318

Albertsen, P.C. 2015: Prostate-specific antigen testing: good or bad?. Oncologist 20(3): 233-235

D'Amico, A.V.; Cullen, J.; Chen, Y.; McLeod, D.G. 2016: Prostate-specific antigen velocity and the odds of detecting gleason 8 to 10 prostate cancer at biopsy. Journal of Clinical Oncology 24(18_Suppl): 4567-4567

Gorday, W.; Sadrzadeh, H.; de Koning, L.; Naugler, C.T. 2015: Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis. Clinical Biochemistry 48(18): 1230-1234

Dickinson, L.; Ahmed, H.U.; Hindley, R.G.; McCartan, N.; Freeman, A.; Allen, C.; Emberton, M.; Kirkham, A.P. 2017: Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urologic Oncology 35(1): 30.E9-30.E15

Kitagawa, Y.; Namiki, M. 2015: Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia. Asian Journal of Andrology 17(3): 475-480

Alberts, A.R.; Schoots, I.G.; Roobol, M.J. 2015: Prostate-specific antigen-based prostate cancer screening: past and future. International Journal of Urology: Official Journal of the Japanese Urological Association 22(6): 524-532

Kim, E.H.; Andriole, G.L. 2015: Prostate-specific antigen-based screening: controversy and guidelines. Bmc Medicine 13: 61

Perico, M.E.; Grasso, S.; Brunelli, M.; Martignoni, G.; Munari, E.; Moiso, E.; Fracasso, G.; Cestari, T.; Naim, H.Y.; Bronte, V.; Colombatti, M.; Ramarli, D. 2016: Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo". Oncotarget 7(45): 74189-74202

Conway, R.E.; Rojas, C.; Alt, J.; Nováková, Z.; Richardson, S.M.; Rodrick, T.C.; Fuentes, J.L.; Richardson, N.H.; Attalla, J.; Stewart, S.; Fahmy, B.; Barinka, C.; Ghosh, M.; Shapiro, L.H.; Slusher, B.S. 2016: Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis 19(4): 487-500

Kiess, A.P.; Banerjee, S.R.; Mease, R.C.; Rowe, S.P.; Rao, A.; Foss, C.A.; Chen, Y.; Yang, X.; Cho, S.Y.; Nimmagadda, S.; Pomper, M.G. 2015: Prostate-specific membrane antigen as a target for cancer imaging and therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(3): 241-268

Bouchelouche, K.; Choyke, P.L. 2016: Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine. Current Opinion in Oncology 28(3): 216-221

Pu, F.; Salarian, M.; Xue, S.; Qiao, J.; Feng, J.; Tan, S.; Patel, A.; Li, X.; Mamouni, K.; Hekmatyar, K.; Zou, J.; Wu, D.; Yang, J.J. 2016: Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRi. Nanoscale 8(25): 12668-12682

Demirkol, M.O.; Acar, Öm.; Uçar, B.; Ramazanoğlu, S.R.; Sağlıcan, Y.şi.; Esen, T.ık. 2015: Prostate-specific membrane antigen-based imaging in prostate cancer: impact on clinical decision making process. Prostate 75(7): 748-757

Maurer, T.; Weirich, G.; Schottelius, M.; Weineisen, M.; Frisch, B.; Okur, A.; Kübler, H.; Thalgott, M.; Navab, N.; Schwaiger, M.; Wester, H.-J.ür.; Gschwend, J.ür.E.; Eiber, M. 2015: Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. European Urology 68(3): 530-534

Stuart, C.H.; Singh, R.; Smith, T.L.; D'Agostino, R.; Caudell, D.; Balaji, K.C.; Gmeiner, W.H. 2016: Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Nanomedicine 11(10): 1207-1222

Mata, C.; Walker, P.M.; Oliver, A.; Brunotte, F.ço.; Martí, J.; Lalande, A. 2016: ProstateAnalyzer: Web-based medical application for the management of prostate cancer using multiparametric MR imaging. Informatics for Health and Social Care 41(3): 286-306

Ferretti, M.; Phillips, J. 2015: Prostatectomy for benign prostate disease: open, laparoscopic and robotic techniques. Canadian Journal of Urology 22(Suppl 1): 60-66

De Bari, B.; Zietman, A.L.; Poortmans, P. 2016: Prostatectomy vs radiation therapy for prostate cancer: the (still) unsolved dilemma. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 119(2): 368

Franchini, F.; Borsari, M.; Frigieri, F.; Castanò, C.; Voci, C. 2015: Prostatectomy: a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques. Value in Health 18(7): A452

Simpson, P. 2015: Prostatectomy: information provision and education for patients. British Journal of Nursing 24(9): S24-S28

Kirschenbaum, A.; Izadmehr, S.; Yao, S.; O'Connor-Chapman, K.L.; Huang, A.; Gregoriades, E.M.; Yakar, S.; Levine, A.C. 2016: Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases. Endocrinology 157(12): 4526-4533

Skala, S.L.; Owens, S.R.; Xiao, H.; Bauman, K.A.; Tomlins, S.A.; Chinnaiyan, A.M.; Shao, L.; Jentzen, J.M.; Gordon, D.; Mehra, R. 2016: Prostatic Adenocarcinoma With Hormone Exposure Related Changes in a Patient With Hepatic Cirrhosis - Value of Autopsy in a Case Report. Urology Case Reports 9: 37-40

Zhou, M.; Magi-Galluzzi, C. 2008: Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal Carcinoma. Surgical Pathology Clinics 1(1): 43-75

Feng, S.; Tian, Y.; Liu, W.; Li, Z.; Deng, T.; Li, H.; Wang, K. 2017: Prostatic Arterial Embolization Treating Moderate-to-Severe Lower Urinary Tract Symptoms Related to Benign Prostate Hyperplasia: a Meta-Analysis. Cardiovascular and Interventional Radiology 40(1): 22-32

Bilhim, T.; Bagla, S.; Sapoval, M.; Carnevale, F.Cesar.; Salem, R.; Golzarian, J. 2015: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia. Radiology 276(1): 310-311

Russo, G.I.; Kurbatov, D.; Sansalone, S.; Lepetukhin, A.; Dubsky, S.; Sitkin, I.; Salamone, C.; Fiorino, L.; Rozhivanov, R.; Cimino, S.; Morgia, G. 2015: Prostatic Arterial Embolization vs Open Prostatectomy: a 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities. Urology 86(2): 343-348

Li, Q.; Duan, F.; Wang, M-Qiang.; Zhang, G-Dong.; Yuan, K. 2015: Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results. Chinese Medical Journal 128(15): 2072-2077

Sun, F.; Crisóstomo, V.ón.; Báez-Díaz, C.; Sánchez, F.M. 2016: Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 1, Pathological Background and Clinical Implications. Cardiovascular and Interventional Radiology 39(1): 1-7

Sun, F.; Crisóstomo, V.ón.; Báez-Díaz, C.; Sánchez, F.M. 2016: Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale. Cardiovascular and Interventional Radiology 39(2): 161-169

Bhatia, S.S.; Dalal, R.; Gomez, C.; Narayanan, G. 2016: Prostatic Artery Embolization After Failed Urological Interventions for Benign Prostatic Obstruction: a Case Series of Three Patients. Cardiovascular and Interventional Radiology 39(8): 1203-1208

Isaacson, A.J.; Raynor, M.C.; Yu, H.; Burke, C.T. 2016: Prostatic Artery Embolization Using Embosphere Microspheres for Prostates Measuring 80-150 cm(3): Early Results from a US Trial. Journal of Vascular and Interventional Radiology: Jvir 27(5): 709-714

Kably, I.; Dupaix, R. 2016: Prostatic Artery Embolization and the Accessory Pudendal Artery. Journal of Vascular and Interventional Radiology: Jvir 27(8): 1266-1268

Gabr, A.H.; Gabr, M.F.; Elmohamady, B.N.; Ahmed, A.-F. 2016: Prostatic Artery Embolization: a Promising Technique in the Treatment of High-Risk Patients with Benign Prostatic Hyperplasia. Urologia Internationalis 97(3): 320-324

Takai, T.; Inamoto, T.; Komura, K.; Tsujino, T.; Matsunaga, T.; Yoshikawa, Y.; Uchimoto, T.; Saito, K.; Tanda, N.; Minami, K.; Uehara, H.; Ibuki, N.; Takahara, K.; Nomi, H.; Kiyama, S.; Azuma, H. 2016: Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical Prostatectomy. Asian Pacific Journal of Cancer Prevention: Apjcp 17(3): 1373-1377

Hooda, A.K.; Sanga, S.; Raychaudhury, N.; Narula, A.S. 2006: Prostatic Cyst : Association with Autosomal Dominant Polycystic Kidney Disease. Medical Journal Armed Forces India 62(3): 273-274

Ringoir, A.; Rappe, B.; Dhaene, K.; Schallier, D. 2016: Prostatic Leiomyoma: A Case Report. Urology Case Reports 9: 45-47

Matsuyama, S.; Nohara, T.; Kawaguchi, S.; Seto, C.; Nakanishi, Y.; Uchiyama, A.; Ishizawa, S. 2015: Prostatic Stromal Tumor of Uncertain Malignant Potential which Was Difficult to Diagnose. Case Reports in Urology 2015: 879584

Costa, N.V.; Pereira, J.é; Fernandes, L.úc.; Bilhim, T.; Pisco, J.ão.M. 2016: Prostatic Tissue Expulsion after Prostatic Artery Embolization. Journal of Vascular and Interventional Radiology: Jvir 27(4): 601-603

Gratzke, C.; Barber, N.; Speakman, M.J.; Berges, R.; Wetterauer, U.; Greene, D.; Sievert, K-Dietrich.; Chapple, C.R.; Patterson, J.M.; Fahrenkrug, L.; Schoenthaler, M.; Sonksen, J. 2017: Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. Bju International 119(5): 767-775

Jones, P.; Rai, B.P.; Aboumarzouk, O.M.; Somani, B.K. 2016: Prostatic Urethral Lift Vs Prostate Arterial Embolization: Novel Nonablative Strategies in the Management of Lower Urinary Tract Symptoms Secondary to Benign Prostate Hyperplasia. Urology 87: 11-17

Bozkurt, A.; Karabakan, M.; Keskin, E.; Hirik, E.; Balci, M.B.C.; Nuhoglu, B. 2016: Prostatic Urethral Lift: a new Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urologia Internationalis 96(2): 202-206

Roehrborn, C.G. 2016: Prostatic Urethral Lift: a Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urologic Clinics of North America 43(3): 357-369

Liang, K.; Guo, W. 2015: Prostatic abscess caused by Mycobacterium tuberculosis and Escherichia coli in a patient with acquired immunodeficiency syndrome. American Journal of the Medical Sciences 350(2): 153-154

Kadoya, Y.; Kenzaka, T. 2016: Prostatic abscess in a patient with ST-elevation myocardial infarction: a case report. Bmc Cardiovascular Disorders 16: 48

Tolosa-Alvarez, A.B.; Romero-Requena, J.M.; Merchan-Cuenda, M. 2016: Prostatic abscess: Clinical case and a literature review. Semergen 42(4): 280-282

Elshal, A.M.; Abdelhalim, A.; Barakat, T.S.; Shaaban, A.A.; Nabeeh, A.; Ibrahiem, E-Housseiny. 2014: Prostatic abscess: Objective assessment of the treatment approach in the absence of guidelines. Arab Journal of Urology 12(4): 262-268

Doreswamy, K.; Karthikeyan, V.S.; Nagabhushana, M.; Shankaranand, B. 2015: Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy. BMJ Case Reports

Zhang, J.; Dong, M.; Hu, X.; Liu, L.; Li, S.; Li, C.; Yang, L.; Xiao, Y.; Pang, S.; Wang, C. 2016: Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report. Oncology Letters 11(1): 792-794

Çakmak, Öz.ür.; Tarhan, H.üs.; Küçük, Ül.ü; İlbey, Y.Öz. 2015: Prostatic adenocarcinoma with initial metastatic spread to the mandible. Turkish Journal of Urology 41(3): 149-151

Zhao, M.; Teng, X.D.; He, X.L.; Cao, D.F. 2016: Prostatic adenocarcinoma: update on 2014 International Society of Urological Pathology Gleason grading system and new prognostic grading groups. Zhonghua Bing Li Xue Za Zhi 45(10): 673-675

Montico, F.; Kido, L.A.; Hetzl, A.C.; Cagnon, V.ér.H.A. 2015: Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Prostate 75(5): 484-499

Yan, W.-h.; Zhang, C.; Al, G.-p.; Shu, Y. 2015: Prostatic arterial embolization for benign prostatic hyperplasia in high-risk aged males. Zhonghua Nan Ke Xue 21(10): 900-903

Wang, M.; Guo, L.; Duan, F.; Yuan, K.; Zhang, G.; Li, K.; Yan, J.; Wang, Y.; Kang, H.; Wang, Z. 2015: Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation. International Journal of Urology: Official Journal of the Japanese Urological Association 22(8): 766-772

Wang, M.; Guo, L.; Duan, F.; Yuan, K.; Zhang, G.; Li, K.; Yan, J.; Wang, Y.; Kang, H. 2016: Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. Bju International 117(1): 155-164

Wang, M.Q.; Guo, L.P.; Zhang, G.D.; Yuan, K.; Li, K.; Duan, F.; Yan, J.Y.; Wang, Y.; Kang, H.Y.; Wang, Z.J. 2015: Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. Bmc Urology 15: 33

Wang, M.Q.; Wang, Y.; Yan, J.Y.; Yuan, K.; Zhang, G.D.; Duan, F.; Li, K. 2016: Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. World Journal of Urology 34(9): 1275-1283

De Assis, A.é M.; Moreira, A.M.; de Paula Rodrigues, V.C.; Yoshinaga, E.M.; Antunes, A.A.; Harward, S.H.; Srougi, M.; Carnevale, F.C. 2015: Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. Journal of Vascular and Interventional Radiology: Jvir 26(1): 87-93

Teoh, J.Y.C.; Chiu, P.K.F.; Yee, C.-H.; Wong, H.-M.; Chan, C.-K.; Chan, E.S.Y.; Hou, S.S.M.; Ng, C.-F. 2017: Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. International Urology and Nephrology 49(2): 197-203

Garzón, W.J.; Andrade, G.; Dubourcq, F.; Abud, D.G.; Bredow, M.; Khoury, H.J.; Kramer, R. 2016: Prostatic artery embolization: radiation exposure to patients and staff. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 36(2): 246-254

De Beule, T.; Carels, K.; Tejpar, S.; Van Cleynenbreugel, B.; Oyen, R.; Maleux, G. 2015: Prostatic biopsy-related rectal bleeding refractory to medical and endoscopic therapy definitively managed by catheter-directed embolotherapy: a case report. Journal of Medical Case Reports 9: 242

Rodríguez-Patrón, R.; González Gordaliza, C.; Sanz-Mayayo, E.; Burgos Revilla, F.J. 2016: Prostatic biopsy: from organ biopsy to lesion biopsy. the role of MRi and MRi based biopsy systems. Archivos Espanoles de Urologia 69(3): 101-116

Lechien, Jérôme.Rene.; Doyen, J.; Khalife, M.; Saussez, S. 2020: Prostatic carcinoma metastatic to frontal and cavernous sinuses: a case report. Brazilian Journal of Otorhinolaryngology 86(3): 383-385

Al Nemer, A.M.; Aldamanhori, R.B. 2015: Prostatic diseases under focus in a university hospital in Eastern Saudi Arabia. A 15-year experience. Saudi Medical Journal 36(11): 1319-1323

Gladwish, A.; Pang, G.; Cheung, P.; D'Alimonte, L.; Deabreu, A.; Loblaw, A. 2014: Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT). Radiation Oncology 9: 262

Gulavita, P.; Hakim, S.W.; Schieda, N.; Breau, R.H.; Morash, C.; Keefe, D.T.; Robertson, S.J.; Mai, K.T.; Belanger, E.C.; Flood, T.A. 2015: Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy. Canadian Urological Association Journal 9(9-10): 302-306

Lacetera, V.; Cardinali, M.; Mantello, G.; Fenu, F.; Sbrollini, G.; Tombolini, F.; Conti, A.; Maggi, S.; Muzzonigro, G.; Galosi, A.B. 2014: Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience. Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 86(4): 349-352

El Abiad, Y.; Alami, M. 2015: Prostatic fossa calculus. Pan African Medical Journal 21: 236

Kumar, S.; Yadav, R.Niwas.; Gupta, P.; Gaspar, B.Louis.; Kakkar, N.; Verma, A.; Parthan, G.; Bhansali, A.; Mukherjee, K.K.; Korbonits, Márta.; Dutta, P. 2015: Prostatic hyperplasia in acromegaly, a myth or reality: a case-control study. European Journal of Endocrinology 173(2): X1

Lee, S.; Yang, G.; Bushman, W. 2015: Prostatic inflammation induces urinary frequency in adult mice. Plos one 10(2): E0116827

Liu, Y.-j.; Song, G.-h.; Zhang, C. 2015: Prostatic inflammation-induced chronic pelvic pain: Roles of substance P and c-fos in the spinal cord. Zhonghua Nan Ke Xue 21(8): 681-686

Tan, G.; Li, J.; Chen, L.; Chen, X.; Zhang, S.; Ke, L.; Liu, J. 2015: Prostatic melioidosis rarely reported in China: two cases report and literatures review. International Journal of Clinical and Experimental Medicine 8(11): 21830-21832

Li, Y.; An, W.; Wei, W.; Liu, M.; Wang, G.; Wang, X. 2015: Prostatic metastases and polycythemia vera on bone magnetic resonance imaging: A case report. Oncology Letters 9(3): 1317-1320

Janowitz, T.; Welsh, S.; Warren, A.Y.; Robson, J.; Thomas, B.; Shaw, A.; Ainsworth, N.L.; Neal, D.E.; Mazhar, D. 2015: Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy. Bmc Research Notes 8: 524

Dellavedova, T. 2016: Prostatic specific antigen. from its early days until becoming a prostate cancer biomarker. Archivos Espanoles de Urologia 69(1): 19-23

Cavaliere, E.; Alaggio, R.; Castagnetti, M.; Scarzello, G.; Bisogno, G. 2014: Prostatic stromal sarcoma in an adolescent: the role of chemotherapy. Rare Tumors 6(4): 5607

Perera, M.; Roberts, M.J.; Doi, S.A.R.; Bolton, D. 2015: Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. European Urology 67(4): 704-713

Garcia, C.; Chin, P.; Rashid, P.; Woo, H.H. 2015: Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate International 3(1): 1-5

Rukstalis, D.B. 2015: Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Canadian Journal of Urology 22(Suppl 1): 67-74

Xu, H.; Liu, C.; Gu, M.; Chen, Y.; Cai, Z.; Chen, Q.; Wang, Z. 2017: Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP). Oncotarget 8(8): 14039-14049

Humphrey, P.A. 2015: Prostatic-type epithelial polyp of the urethra. Journal of Urology 193(6): 2095-2096

Boehm, K.; Valdivieso, R.; Meskawi, M.; Larcher, A.; Schiffmann, J.; Sun, M.; Graefen, M.; Saad, F.; Parent, M.-Él.; Karakiewicz, P.I. 2016: Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study. World Journal of Urology 34(3): 425-430

Patodia, M.; Kumar, M.; Sankhwar, S.; Goel, A.; Singh, S.; Purkait, B. 2015: Prostato-inguinal fistula: An unusual site of voiding. Canadian Urological Association Journal 9(11-12): E821-E822

Sanchez, A.; Rodríguez, D.; Cheng, J-Sian.; McGovern, F.J.; Tabatabaei, S. 2015: Prostato-symphyseal fistula after photoselective vaporization of the prostate: case series and literature review of a rare complication. Urology 85(1): 172-177

Whelan, L.; Mullarkey, E.; Woo, H.H. 2015: Prostatosymphyseal Fistula Treated by Robotic Assisted Radical Prostatectomy. Case Reports in Urology 2015: 582705

Plateau, B.; Ruivard, M.; Montoriol, P-François. 2015: Prostatosymphyseal fistula and osteomyelitis pubis following transurethral resection of the prostate: CT and MRI findings. Journal of Medical Imaging and Radiation Oncology 59(6): 713-715

Geng, T.; Xia, L.; Russo, S.; Kamara, D.; Cowart, L.A. 2015: Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice. Nutrition Research 35(9): 812-822

Tkach, V.V.; Curran, S.S. 2015: Prosthenystera oonastica n. sp. (Digenea: Callodistomidae) from ictalurid catfishes in southeastern United States and molecular evidence differentiating species in the genus across Americas. Systematic Parasitology 90(1): 39-51

Simón-Allué, R.; Hernández-Gascón, B.; Lèoty, L.; Bellón, J.M.; Peña, E.; Calvo, B. 2016: Prostheses size dependency of the mechanical response of the herniated human abdomen. Hernia: the Journal of Hernias and Abdominal Wall Surgery 20(6): 839-848

Bergmeister, K.D.; Hader, M.; Lewis, S.; Russold, M.-F.; Schiestl, M.; Manzano-Szalai, K.; Roche, A.D.; Salminger, S.; Dietl, H.; Aszmann, O.C. 2016: Prosthesis Control with an Implantable Multichannel Wireless Electromyography System for High-Level Amputees: a Large-Animal Study. Plastic and Reconstructive Surgery 137(1): 153-162

Tomšič, A.; Palmen, M.; Versteegh, M.I.M.; van der Kley, F.; Siebelink, H.-M.J.; Berendsen, R.R.; Schalij, M.J. 2016: Prosthesis Dislocation After Transapical Valve-In-Valve Mitral Valve Implantation. Canadian Journal of Cardiology 32(12): 1576.E7-1576.E9

Barbanti, M.; Immè, S.; Ohno, Y.; Gulino, S.; Todaro, D.; Sgroi, C.; Tamburino, C.; Patanè, M.; Pilato, G.; Capodanno, D.; Tamburino, C. 2016: Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm. International Journal of Cardiology 203: 1009-1010

Ackland, D.C.; Patel, M.; Knox, D. 2015: Prosthesis design and placement in reverse total shoulder arthroplasty. Journal of Orthopaedic Surgery and Research 10: 101

Follis, F.; Gandolfo, C.; Santise, G.; Stabile, A.; Benedetto, M.; Cirrincione, G.; Arcadipane, A.; Centineo, L.; Follis, M. 2016: Prosthesis embolization into the left ventricle during transcatheter aortic valve implantation. Journal of Cardiovascular Medicine 17(Suppl 2): E191-E192

Ackland, D.C.; Moskaljuk, A.; Hart, C.; Vee Sin Lee, P.; Dimitroulis, G. 2015: Prosthesis loading after temporomandibular joint replacement surgery: a musculoskeletal modeling study. Journal of Biomechanical Engineering 137(4): 041001

Dou, Q.; Yin, Z.; Sun, L.; Feng, X. 2015: Prosthesis replacement in Mason IIi radial head fractures: a meta-analysis. Orthopaedics and Traumatology Surgery and Research: Otsr 101(6): 729-734

Dahou, A.; Mahjoub, H.ïf.; Pibarot, P. 2016: Prosthesis-Patient Mismatch After Aortic Valve Replacement. Current Treatment Options in Cardiovascular Medicine 18(11): 67

Swinkels, B.M.; de Mol, B.A.; Kelder, J.C.; Vermeulen, F.E.; ten Berg, J.ën.M. 2016: Prosthesis-Patient Mismatch After Aortic Valve Replacement: Effect on Long-Term Survival. Annals of Thoracic Surgery 101(4): 1388-1394

Takagi, H.; Umemoto, T. 2016: Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation. Annals of Thoracic Surgery 101(3): 872-880

Cho, I.J.; Hong, G.R.; Lee, S.H.; Lee, S.; Chang, B.C.; Shim, C.Y.; Chang, H.J.; Ha, J.W.; Chung, N. 2016: Prosthesis-Patient Mismatch after Mitral Valve Replacement: Comparison of Different Methods of Effective Orifice Area Calculation. Yonsei Medical Journal 57(2): 328-336

Oh, J.K.; Zorn, G.L. 2016: Prosthesis-Patient Mismatch: Another Reason for TAVR?. JACC. Cardiovascular Imaging 9(8): 934-936

Stähli, B.E.; Nguyen-Kim, T.D.L.; Gebhard, C.ér.; Erhart, L.; Frauenfelder, T.; Tanner, F.C.; Falk, V.; Landmesser, U.; Nietlispach, F.; Lüscher, T.F.; Maier, W.; Binder, R.K. 2015: Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves. Journal of Heart Valve Disease 24(1): 10-21

Wang, S.; Leng, X.; Zheng, Y.; Zhang, D.; Wu, G. 2015: Prosthesis-guided implant restoration of an auricular defect using computed tomography and 3-dimensional photographic imaging technologies: a clinical report. Journal of Prosthetic Dentistry 113(2): 152-156

Mizia-Stec, K.; Mizia, M.; Sikora-Puz, A.; Gieszczyk-Strózik, K.; Bochenek, T.; Lasota, B.; Chmiel, A.; Chudek, J.; Deja, M.; Płońska-Gościniak, E. 2016: Prosthesis-patient mismatch and left ventricle systolic strain in patients with severe degenerative aortic stenosis, who are undergoing surgical valve replacement. Kardiologia Polska 74(6): 537-546

Kawamoto, N.; Fujita, T.; Hata, H.; Shimahara, Y.; Sato, S.; Kobayashi, J. 2016: Prosthesis-patient mismatch due to small ring annuloplasty in patients with degenerative mitral insufficiency. Journal of Cardiology 68(2): 141-147

Zorn, G.L.; Little, S.H.; Tadros, P.; Deeb, G.M.; Gleason, T.G.; Heiser, J.; Kleiman, N.S.; Oh, J.K.; Popma, J.J.; Adams, D.; Huang, J.; Reardon, M.J. 2016: Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: a randomized trial of a self-expanding prosthesis. Journal of Thoracic and Cardiovascular Surgery 151(4): 1014-1022; 1023.E1-3

Shen, J.; Vallera, D.A.; Wagner, C.R. 2015: Prosthetic Antigen Receptors. Journal of the American Chemical Society 137(32): 10108-10111

Virk, H.Ul.Hassan.; Inayat, F.; Farooq, S.; Ghani, A.Raza.; Mirrani, G.A.; Athar, M.Waqas. 2016: Prosthetic Aortic Valve Endocarditis with Left Main Coronary Artery Embolism: A Case Report and Review of the Literature. North American Journal of Medical Sciences 8(6): 259-262

Lee, C.Y.; Wong, J.K.; Ross, R.E.; Liu, D.C.; Khabbaz, K.R.; Martellaro, A.J.; Gorea, H.R.; Sauer, J.S.; Knight, P.A. 2016: Prosthetic Aortic Valve Fixation Study: 48 Replacement Valves Analyzed Using Digital Pressure Mapping. Innovations 11(5): 327-336

Ramagiri-Vinod, N.; Tahir, H.; Narukonda, S.; Joshi, M. 2016: Prosthetic Arteriovenous Graft Contact Dermatitis Masquerading as an Arteriovenous Graft Infection in a Hemodialysis Patient. Journal of Investigative Medicine High Impact Case Reports 4(3): 2324709616658311

Vitale, M.A.; Fruth, K.M.; Rizzo, M.; Moran, S.L.; Kakar, S. 2015: Prosthetic Arthroplasty Versus Arthrodesis for Osteoarthritis and Posttraumatic Arthritis of the Index Finger Proximal Interphalangeal Joint. Journal of Hand Surgery 40(10): 1937-1948

Nahabedian, M.Y. 2016: Prosthetic Breast Reconstruction with Acellular Dermal Matrices: Achieving Predictability and Reproducibility. Plastic and Reconstructive Surgery. Global Open 4(5): E698

Engelhardt, F.; Zeman, F.; Behr, M.; Hahmel, S. 2016: Prosthetic Complications and Maintenance Requirements in Locator-attached Implant-Supported Overdentures: A Retrospective Study. European Journal of Prosthodontics and Restorative Dentistry 24(1): 31-35

Kamble, V.B. 2014: Prosthetic Correction of Postenucleation Socket Syndrome: A Case Report. Journal of Indian Prosthodontic Society 14(Suppl. 1): 172-176

Kennedy, C.D.; Huang, J.I. 2016: Prosthetic Design in Total Wrist Arthroplasty. Orthopedic Clinics of North America 47(1): 207-218

Martinez, R.M.; Bowen, T.R.; Foltzer, M.A. 2016: Prosthetic Device Infections. Microbiology Spectrum 4(4)

García-País, Mía.José.; Rabuñal, Rón.; Alonso, Mía.Pilar.; Corredoira, J. 2015: Prosthetic Endocarditis Caused by Streptococcus bovis Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 61(7): 1204-1206

Stull, M.C.; Clemens, M.S.; Heafner, T.A.; Watson, J.D.B.; Arthurs, Z.M.; Propper, B.W. 2016: Prosthetic Graft Patency in the Setting of a Polymicrobial Infection in Swine (Sus scrofa). Annals of Vascular Surgery 36: 265-272

Kao, F.-C.; Hsu, Y.-C.; Chen, W.-H.; Lin, J.-N.; Lo, Y.-Y.; Tu, Y.-K. 2017: Prosthetic Joint Infection Following Invasive Dental Procedures and Antibiotic Prophylaxis in Patients with Hip or Knee Arthroplasty. Infection Control and Hospital Epidemiology 38(2): 154-161

Gregg, R.D.; Martin, A.E. 2016: Prosthetic Leg Control in the Nullspace of Human Interaction. Proceedings of the . American Control Conference. American Control Conference 2016: 4814-4821

Abdulhadi, L.Mahmoud. 2014: Prosthetic Management and Analysis of Combined Extraoral-Intraoral Maxillofacial Defects Complicated with Microstomia. A Report of Three Cases. European Journal of Prosthodontics and Restorative Dentistry 22(4): 167-173

Rilo, B.; Fernández-Formoso, N.; DaSilva, L.; Pinho, J.âo.C.; Lago, L. 2015: Prosthetic Management for a Palatal Perforation from Cocaine Abuse. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(7): 586-588

Pinto, A.S.B.; Conceição Pinto, M.E.S.; Melo do Val, C.; Costa Oliveira, L.; Costa de Aquino, C.; Vasconcelos, D.F.P. 2016: Prosthetic Management of a Child with Hypohidrotic Ectodermal Dysplasia: 6-Year Follow-Up. Case Reports in Dentistry 2016: 2164340

Fernandez, T.; Karunakaran, H.; Rodrigues, S.Virginia. 2016: Prosthetic Management of a Nasal Septal Defect using a Custom Made Unilateral Intranasal Stent: A Case Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zd33-Zd34

Bernstein, F. 2015: Prosthetic Manhood in the Soviet Union at the End of World War Ii. Osiris 30: 113-133

Tatar, C.; Tüzün, İs.S.; Karşıdağ, T.; Kızılkaya, M.C.; Yılmaz, E. 2016: Prosthetic Mesh Repair for Incarcerated Inguinal Hernia. Balkan Medical Journal 33(4): 434-440

Burke, M.J.; Parente, E.J. 2016: Prosthetic Mesh for Obliteration of the Nephrosplenic Space in Horses: 26 Clinical Cases. Veterinary Surgery: Vs 45(2): 201-207

Essandoh, M.; Humeidan, M.; Castellon-Larios, K.; George, B.; Zuleta-Alarcon, A.; Daoud, E.G. 2015: Prosthetic Mitral Perivalvular Defect Occlusion with Multiple Amplatzer Devices Using 3D Transesophageal Echocardiography and Fluoroscopic Guidance. Journal of Cardiothoracic and Vascular Anesthesia 29(4): 1029-1032

Maragiannis, D.; Gramze, N.; Ramlawi, B.; Little, S.H. 2015: Prosthetic Mitral Valve Thrombosis. Methodist Debakey Cardiovascular Journal 11(3): 195

Tannure, P.N.; Moraes, G.G.; Borba, M.; Abrahão, A.; Andrade, M.; Fidalgo, T. 2015: Prosthetic Oral Rehabilitation of a Child With S-ECC: A Case Report with Histopathologic Analysis. Journal of Clinical Pediatric Dentistry 39(5): 410-414

Schroeter, T.; Lurz, P.; Kiefer, P.; Wehbe, M.; Dähnert, I. 2015: Prosthetic Pulmonary Valve Stenosis: a Different way to Solve the Problem. Annals of Thoracic Surgery 100(3): 1103-1105

Yoon, H.-I. 2016: Prosthetic Rehabilitation After Fibular Free Flap Surgery of Mandibular Defects in a Patient with Oral Squamous Cell Carcinoma. Journal of Craniofacial Surgery 27(7): E685-E688

Kralovec, M.E.; Houdek, M.T.; Andrews, K.L.; Shives, T.C.; Rose, P.S.; Sim, F.H. 2015: Prosthetic Rehabilitation After Hip Disarticulation or Hemipelvectomy. American Journal of Physical Medicine and Rehabilitation 94(12): 1035-1040

Rehani, U.; Adlakha, V.K.; Chandna, P.; Agarwal, A.; Rana, V.; Malik, P. 2010: Prosthetic Rehabilitation in Marble Bone Disease. International Journal of Clinical Pediatric Dentistry 3(3): 207-210

Picos, A.Monica.; Donca, V.; Picos, A. 2014: Prosthetic Rehabilitation in Partially Edentulous Elders - A Case Report. Clujul Medical 87(3): 203-206

Agrawal, K.K.; Aggarawal, H.; Singh, K. 2014: Prosthetic Rehabilitation of Amputated Thumb: a Simplified Approach. Journal of Indian Prosthodontic Society 14(Suppl 1): 260-263

Chander, K.Subash.; Komala, J.; Reddy, R.; Umair, M.; Rajender, K.; Venkatesh, K. 2015: Prosthetic Rehabilitation of Bilateral External Nasal Valve Area after Nasal Reconstruction for a Congenitally Missing Nose: A Clinical Report. Journal of International Oral Health: Jioh 7(Suppl. 1): 80-82

Dathan, P.C.; Kumar, T.Mohan.; Ravindran, S.; Nair, K.Chandrasekharan.; Kumar, A. 2016: Prosthetic Rehabilitation of Lower Limb with RTV Siliconee Using Prosthodontic Clinical and Laboratory Techniques - A Case Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zd35-Zd37

Janya, S.; Gubrellay, P.; Purwar, A.; Khanna, S. 2014: Prosthetic Rehabilitation of Ocular Defect resulting from Pediatric Retinoblastoma. International Journal of Clinical Pediatric Dentistry 7(3): 209-212

Rolski, D.; Kostrzewa-Janicka, J.; Nieborak, R.; Przybyłowska, D.; Stopa, Z.; Mierzwińska-Nastalska, E. 2016: Prosthetic Rehabilitation of Patients After Surgical Treatment of Maxillary Tumors with Respect to Upper Airway Protection. Advances in Experimental Medicine and Biology 885: 83-88

Shakya, P.; Chotprasert, N.; Srithavaj, T. 2016: Prosthetic Rehabilitation of Squamous Cell Carcinoma of Orbit: A Clinical Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zj16-Zj17

Artopoulou, I.Ioanna.; Lemon, J.C. 2016: Prosthetic Rehabilitation of a Complex Maxillofacial Defect as an Alternative to Surgical Reconstruction: A Case History Report. International Journal of Prosthodontics 29(3): 227-229

Moretto, G.; Pupo, Y.M.; Bueno, A.L.N.; Araujo, F.O. 2016: Prosthetic Rehabilitation of a Patient with Gastroesophageal Reflux Disease: Five-Year Follow-up. Operative Dentistry 41(2): 132-137

Raju, M.; Shetty, M.; Prasad D, K. 2014: Prosthetic Rehabilitation of a Patient with Congenitally Deformed Ears. Journal of Indian Prosthodontic Society 14(Suppl 1): 264-267

Putanikar, N.Y.; Patil, A.G.; Shetty, P.K.; Nagaral, S.; Mithaiwala, H.I. 2015: Prosthetic Rehabilitation of a Patient with Ocular Defect using Semi-customized Prosthesis: A Case Report. Journal of International Oral Health: Jioh 7(4): 81-84

Mian, S.Z.; Agranat, J.S.; Jacobs, D.S. 2016: Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment for Complications After LASIK. Eye and Contact Lens 42(6): 371-373

Chahal, J.S.; Heur, M.; Chiu, G.B. 2017: Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy. Eye and Contact Lens 43(4): 240-244

Refatllari, A.; Likaj, E.; Dumani, S. 2016: Prosthetic Subclavian-Aortic Bypass as a Safe Surgical Technique for the Coarctation of the Aorta in Adults. Open Access Macedonian Journal of Medical Sciences 4(1): 47-49

Passia, N.; Kern, M. 2015: Prosthetic Treatment Concepts for the Reduced Dentition in German Dental Schools. International Journal of Prosthodontics 28(4): 425-431

Yokokawa, T.; Ohara, T.; Takashio, S.; Sakamoto, M.; Wada, Y.; Nakamura, K.; Takahama, H.; Amaki, M.; Hasegawa, T.; Sugano, Y.; Kanzaki, H.; Yasuda, S.; Ogawa, H.; Fujita, T.; Kobayashi, J.; Okamoto, Y.; Matsuyama, T.-A.; Ishibashi-Ueda, H.; Anzai, T. 2016: Prosthetic Valve Dysfunction 35 Years after Mitral Valve Replacement with a Starr-Edwards Caged-disc Valve. Internal Medicine 55(5): 479-483

Bartley, P.; Angelakis, E.; Raoult, D.; Sampath, R.; Bonomo, R.A.; Jump, R.L.P. 2016: Prosthetic Valve Endocarditis Caused by Bartonella henselae : A Case Report of Molecular Diagnostics Informing Nonsurgical Management. Open Forum Infectious Diseases 3(4): Ofw202

Stephens, J.L.; Boulemden, A.; Richens, D.; Turner, D.P.J. 2016: Prosthetic Valve Endocarditis Following Dental Extractions. Journal of Cardiac Surgery 31(5): 321-323

Tanioka, H.; Iwata, K.; Marumoto, A.; Kaneko, M. 2015: Prosthetic Valve Endocarditis using Immunosuppressive Agent for Atopic Dermatitis;Report of a Case. Kyobu Geka. Japanese Journal of Thoracic Surgery 68(5): 383-386

Furukawa, N.; Scholtz, W.; Scholtz, S.; Faber, L.; Ensminger, S.; Gummert, J.; Börgermann, J. 2015: Prosthetic Valve Escaping During Transcatheter Aortic Valve Implantation. Innovations 10(6): 425-427

Garg, J.; Palaniswamy, C.; Pinnamaneni, S.; Sarungbam, J.; Jain, D. 2016: Prosthetic Valve Thrombosis: Diagnosis and Management. American Journal of Therapeutics 23(1): E252-E255

Bonnichsen, C.R.; Pellikka, P.A. 2015: Prosthetic Valve Thrombus Versus Pannus: Progress with Imaging. CIRCULATION. Cardiovascular Imaging 8(12)

Scherrer, A.U.; Bloemberg, G.; Zbinden, R.; Zinkernagel, A.S.; Fuchs, C.; Frauenfelder, S.; Rancic, Z.; Mayer, D.; Hasse, B. 2016: Prosthetic Vascular Graft Infections: Bacterial Cultures from Negative-Pressure-Wound-Therapy Foams do not Improve Diagnostics. Journal of Clinical Microbiology 54(8): 2190-2193

Abemayor, E. 2017: Prosthetic Voice Rehabilitation Following Laryngectomy: It's the Archer Not the Arrow. JAMA Otolaryngology--Head and Neck Surgery 143(1): 72

Camargos, G.d.V.; Sotto-Maior, B.S.; Silva, W.J.é d.; Lazari, P.C.; Del Bel Cury, A.A. 2016: Prosthetic abutment influences bone biomechanical behavior of immediately loaded implants. Brazilian Oral Research 30(1)

Huijbregts, H.J.T.A.M.; Khan, R.J.K.; Fick, D.P.; Jarrett, O.M.; Haebich, S. 2016: Prosthetic alignment after total knee replacement is not associated with dissatisfaction or change in Oxford Knee Score: a multivariable regression analysis. Knee 23(3): 535-539

Nair, A.; Sajeev, C.G.; Muneer, K. 2016: Prosthetic aortic valve dehiscence: a "rocking" catastrophe. Journal of Echocardiography 14(4): 171-172

Machernis, N.P.; Jain, R.; Anigbogu, M.; Ammar, K.A.; Brauer, E.; Khandheria, B.K. 2015: Prosthetic aortic valve endocarditis with pseudoaneurysm complicated by additional rupture of mitral-aortic intervalvular fibrosa. European Heart Journal 36(40): 2741

Korteland, N.M.; Bras, F.J.; van Hout, F.M.A.; Kluin, J.; Klautz, R.J.M.; Bogers, A.J.J.C.; Takkenberg, J.J.M. 2015: Prosthetic aortic valve selection: current patient experience, preferences and knowledge. Open Heart 2(1): E000237

Pereira, V.H.; Guardado, J.; Fernandes, M.; Lourenço, M.ár.; Machado, I.ên.; Quelhas, I.; Azevedo, O.; Lourenço, A.ón. 2015: Prosthetic aortic valve: a bone in the system. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 34(2): 137.E1-4

Lee, K.-T.; Mun, G.-H. 2015: Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. Journal of Surgical Oncology 112(5): 468-475

Quinn, T.T.; Miller, G.S.; Rostek, M.; Cabalag, M.S.; Rozen, W.M.; Hunter-Smith, D.J. 2016: Prosthetic breast reconstruction: indications and update. Gland Surgery 5(2): 174-186

Huri, G.; Familiari, F.; Salari, N.; Petersen, S.A.; Doral, M.Nedim.; McFarland, E.G. 2016: Prosthetic design of reverse shoulder arthroplasty contributes to scapular notching and instability. World Journal of Orthopedics 7(11): 738-745

Holban, A.M.; Iordanskii, A.; Grumezescu, A.M.; Bychkova, A.; Andronescu, E.; Mogoantă, L.ți.; Mogoșanu, G.D.; Iordache, F. 2015: Prosthetic devices with nanostructurated surfaces for increased resistance to microbial colonization. Current Pharmaceutical Biotechnology 16(2): 112-120

Loverix, L.; Juvonen, T.; Biancari, F. 2015: Prosthetic endocarditis after transcatheter aortic valve implantation: pooled individual patient outcome. International Journal of Cardiology 178: 67-68

Sadid-Zadeh, R.; Kutkut, A.; Kim, H. 2015: Prosthetic failure in implant dentistry. Dental Clinics of North America 59(1): 195-214

Heng, B.C.; Aubel, D.; Fussenegger, M. 2015: Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders. Current Opinion in Biotechnology 35: 37-45

Lee, G.Dong.; Kim, H.Ryul.; Choi, S.Hoon.; Kim, Y-Hee.; Kim, D.Kwan.; Park, S-Il. 2016: Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion. Journal of thoracic disease 8(1): 61-67

Barbarash, L.; Rutkovskaya, N.; Barbarash, O.; Odarenko, Y.; Stasev, A.; Uchasova, E. 2016: Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report. Journal of Medical Case Reports 10: 51

Garagoli, F.; Romeo, F.J.é; Lucas, L.; Kotowicz, V.; Belziti, C.és. 2017: Prosthetic heart valve thrombosis treated with slow infusion fibrinolytic therapy in patient with acute isquemic stroke. Archivos de Cardiologia de Mexico 87(2): 175-177

Lawley, C.M.; Lain, S.J.; Algert, C.S.; Ford, J.B.; Figtree, G.A.; Roberts, C.L. 2015: Prosthetic heart valves in pregnancy, outcomes for women and their babies: a systematic review and meta-analysis. Bjog: An International Journal of Obstetrics and Gynaecology 122(11): 1446-1455

Hessler, R.; Lunebourg, A.; Fisher, J-F.; Trachsel, S.; Cometta, A. 2014: Prosthetic hip infection due to Listeria monocytogenes: review of the literature and case report. Revue Medicale Suisse 10(450): 2164-2167

Ozan, Fırat.; Öncel, Eüp.Sabri.; Duygulu, F.; Çelik, İlhami.; Altay, Tşkın. 2015: Prosthetic hip joint infection caused by Rothia dentocariosa. International Journal of Clinical and Experimental Medicine 8(7): 11628-11631

Martín-Ares, M.ía.; Barona-Dorado, C.; Guisado-Moya, B.; Martínez-Rodríguez, N.; Cortés-Bretón-Brinkmann, J.; Martínez-González, J.é M.ª 2016: Prosthetic hygiene and functional efficacy in completely edentulous patients: satisfaction and quality of life during a 5-year follow-up. Clinical Oral Implants Research 27(12): 1500-1505

Highsmith, M.Jason.; Kahle, J.T.; Miro, R.M.; Orendurff, M.S.; Lewandowski, A.L.; Orriola, J.J.; Sutton, B.; Ertl, J.P. 2016: Prosthetic interventions for people with transtibial amputation: Systematic review and meta-analysis of high-quality prospective literature and systematic reviews. Journal of Rehabilitation Research and Development 53(2): 157-184

Arnáez Solís, Rén.; Martín Salas, C.; Acha Arrieta, M.Victoria. 2017: Prosthetic joint infection by Ruminococcus gnavus in a patient without associated digestive disease. Medicina clinica 148(2): e7-e8

Honnorat, E.; Seng, P.; Savini, Hélène.; Pinelli, P-Olivier.; Simon, F.; Stein, A. 2016: Prosthetic joint infection caused by Pasteurella multocida: a case series and review of literature. Bmc Infectious Diseases 16(1): 435

Gilarranz, R.; Chamizo, F.; Horcajada, I.; Bordes-Benítez, A. 2016: Prosthetic joint infection caused by Trueperella bernardiae. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy 22(9): 642-644

Tornero, E.; Soriano, A. 2015: Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR). Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 21(5): E43-E44

Dhawan, B.; Sebastian, S.; Malhotra, R.; Kapil, A.; Gautam, D. 2016: Prosthetic joint infection due to Lysobacter thermophilus diagnosed by 16S rRNA gene sequencing. Indian Journal of Medical Microbiology 34(1): 100-102

Blomfeldt, R.; Kasina, P.; Ottosson, C.; Enocson, A.; Lapidus, L.J. 2015: Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. International Orthopaedics 39(11): 2091-2096

Barbero, J.M.; Montero, E.; Vallés, A.; Plasencia, M.A.; Romanyk, J.; Gómez, J. 2016: Prosthetic joint infection in patients with hip fracture. Differences from infection of elective prosthesis. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 29(5): 273-277

Roger, P.-M.; Tabutin, J.; Blanc, V.; Léotard, S.; Brofferio, P.; Léculé, F.; Redréau, B.; Bernard, E. 2015: Prosthetic joint infection: a pluridisciplinary multi-center audit bridging quality of care and outcome. Medecine et Maladies Infectieuses 45(6): 229-236

Chen, A.F.; Heller, S.; Parvizi, J. 2014: Prosthetic joint infections. Surgical Clinics of North America 94(6): 1265-1281

De Angelis, G.; Mutters, N.T.; Minkley, L.; Holderried, F.; Tacconelli, E. 2015: Prosthetic joint infections in the elderly. Infection 43(6): 629-637

Henry, M.W.; Miller, A.O.; Kahn, B.; Windsor, R.E.; Brause, B.D. 2016: Prosthetic joint infections secondary to rapidly growing mycobacteria: Two case reports and a review of the literature. Infectious Diseases 48(6): 453-460

Saeed, K.; Dryden, M.; Bassetti, M.; Bonnet, E.; Bouza, E.; Chan, M.; Cortes, N.; Davis, J.S.; Esposito, S.; Giordano, G.ér.; Gould, I.; Hartwright, D.; Lye, D.; Marin, M.; Morgan-Jones, R.; Lajara-Marco, F.; Righi, E.; Romano, C.L.; Segreti, J.; Unal, S.; Williams, R.L.; Yalcin, A.N. 2017: Prosthetic joints: shining lights on challenging blind spots. International Journal of Antimicrobial Agents 49(2): 153-161

Vasso, M.; Schiavone Panni, A.; De Martino, I.; Gasparini, G. 2016: Prosthetic knee infection by resistant bacteria: the worst-case scenario. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 24(10): 3140-3146

Seo, Y.; Noh, Y.-S.; Wie, S.-H.; Chang, U.-I. 2016: Prosthetic knee joint infection due to Listeria monocytogenes bacteremia in a diabetic female. Korean Journal of Internal Medicine 31(3): 616-619

Zhang, X.; Wang, S.; Wei, J. 2015: Prosthetic left renocaval bypass for posterior nutcracker syndrome. Indian Journal of Surgery 77(Suppl. 1): 103-105

Kim, K.; Noh, K.; Paek, J.; Kwon, K-Rock.; Pae, A. 2015: Prosthetic management of a growing patient with Russell-Silver syndrome: a clinical report. Journal of Advanced Prosthodontics 7(5): 406-410

Saadat, F.; Mosharraf, R. 2013: Prosthetic management of an extensive maxillary alveolar defect with an implant-supported restoration. Journal of Dentistry 10(3): 256-263

Marion, L.R.; Hirsh, L.S. 2015: Prosthetic management of gingival recession around implants: lessons learned from staged-approach treatment planning. Compendium of Continuing Education in Dentistry 36(3): 180-188; Quiz 189, 190

Koralakunte, P.R.; Shamnur, S.N.; Iynalli, R.V.; Shivmurthy, S. 2015: Prosthetic management of hemimandibulectomy patient with guiding plane and twin occlusion prosthesis. Journal of Natural Science Biology and Medicine 6(2): 449-453

Chatterjee, A.; Ragher, M.; Patil, S.; Chatterjee, D.; Dandekeri, S.; Prabhu, V. 2015: Prosthetic management of malpositioned implant using custom cast abutment. Journal of Pharmacy and Bioallied Sciences 7(Suppl 2): S740-S745

Adhershitha, A.R.; Anilkumar, S.; Rajesh, C.; Mohan, D.C. 2016: Prosthetic management of posttraumatic external auditory canal atresia: a rare cause of conductive hearing loss. Journal of Indian Prosthodontic Society 16(4): 390-394

Beech, A.N.; Spicer, K.A.; Hodgson, M.; Farrier, J.N. 2017: Prosthetic management of pressure necrosis of the nasal septum caused by a continuous positive airway pressure machine. British Journal of Oral and Maxillofacial Surgery 55(3): 321-323

Stadnik, H.; Kościński, T.Maciej. 2016: Prosthetic materials for treating posterior vaginal wall prolapse and rectocele - own experience. Ginekologia Polska 87(11): 729-732

Canton, S.A.; Merigliano, S.; Pasquali, C. 2016: Prosthetic mesh "slim-cigarette like" for laparoscopic repair of ventral hernias: a new technique without transabdominal fixation sutures. Updates in Surgery 68(2): 199-203

Kannan, A.; Jahan, K.; Lotun, K.; Janardhanan, R. 2015: Prosthetic mitral valve obstruction: role of real-time three-dimensional transesophageal echocardiography in diagnosis. BMJ Case Reports

Cardoso, G.ça.; Aguiar, C.; Andrade, M.J.ão.; Patrício, L.; Freire, I.; Serrano, F.át.; Anjos, R.; Mendes, M. 2015: Prosthetic mitral valve thrombosis in pregnancy: from thrombolysis to anticoagulation. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 34(1): 71.E1-71.E5

Miranda, W.R.; Connolly, H.M.; Bonnichsen, C.R.; DeSimone, D.C.; Dearani, J.A.; Maleszewski, J.J.; Greason, K.L.; Wilson, W.R.; Baddour, L.M. 2016: Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. European Heart Journal. Cardiovascular Imaging 17(8): 936-943

Salminger, S.; Sturma, A.; Herceg, M.; Riedl, O.; Bergmeister, K.; Aszmann, O.C. 2015: Prosthetic reconstruction in high amputations of the upper extremity. Der Orthopade 44(6): 413-418

Salminger, S.; Mayer, J.A.; Sturma, A.; Riedl, O.; Bergmeister, K.D.; Aszmann, O.C. 2016: Prosthetic reconstruction of the upper extremity. Der Unfallchirurg 119(5): 408-413

Salminger, S.; Roche, A.D.; Hruby, L.A.; Sturma, A.; Riedl, O.; Bergmeister, K.D.; Aszmann, O.C. 2016: Prosthetic reconstruction to restore function in transcarpal amputees. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 69(3): 305-310

Seong, D-Jae.; Hong, S-Jin.; Ha, S-Ryong.; Hong, Y-Gi.; Kim, H-Won. 2016: Prosthetic reconstruction with an obturator using swing-lock attachment for a patient underwent maxillectomy: A clinical report. Journal of Advanced Prosthodontics 8(5): 411-416

Cumming, J.; Barr, S.; Howe, T.E. 2015: Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation. Cochrane Database of Systematic Reviews 1: Cd005260

Kondaka, S.; Rao, B.L.; Reddy, J.R.; Akula, R. 2016: Prosthetic rehabilitation in patient with achalasia cardia - A rare case report. Journal of International Society of Preventive and Community Dentistry 6(4): 383-386

Sikka, N.; Jain, R.; Kaushik, A.; Rani, R. 2014: Prosthetic rehabilitation of a child with velopharyngeal dysfunction - A case report. Journal of Oral Biology and Craniofacial Research 4(2): 140-143

Shashidhar, W.C.M.P.; Mahesh Gowda, C.E. 2015: Prosthetic rehabilitation of a gunshot wound defect with combination of fixed and removable prosthesis. Medical Journal Armed Forces India 71(Suppl 2): S605-S608

Goiato, M.C.; de Medeiros, R.A.; Vechiato Filho, A.J.é; da Silva, E.V.F.; Sônego, M.V.; de Carvalho, K.H.T.; Guiotti, A.ée.M.; de Carvalho Dekon, S.F.; Pesqueira, A.ér.A.; Dos Santos, D.M. 2015: Prosthetic rehabilitation of a patient after a partial mandibulectomy. Annals of Medicine and Surgery 4(2): 200-203

Shashidhar, M.P.; Thombre, H.K. 2015: Prosthetic rehabilitation of a serving soldier with custom made ocular prosthesis. Medical Journal Armed Forces India 71(Suppl 1): S248-S250

Jain, P.; Siwach, A.; Arora, G.; Agarwal, R. 2015: Prosthetic rehabilitation of a total laryngectomy patient. Journal of Indian Prosthodontic Society 15(4): 390-394

Law, M.Y.T.; Chung, R.W.C.; Lam, O.L.T. 2015: Prosthetic rehabilitation of an edentulous patient with an oronasal fistula. Journal of Prosthetic Dentistry 113(4): 347-349

Tso, T.V.; Tso, V.J.; Stephens, W.F. 2015: Prosthetic rehabilitation of an extensive midfacial and palatal postsurgical defect with an implant-supported cross arch framework: a clinical report. Journal of Prosthetic Dentistry 113(5): 498-502

Shetty, S.; Mohammad, F.; Shetty, R.; Shenoy, K. 2016: Prosthetic rehabilitation of an orbital defect for a patient with hemifacial atrophy. Journal of Indian Prosthodontic Society 16(1): 91-95

Andrei, O.C.; Mărgărit, R.; Tănăsescu, L.A.; Dăguci, L.Ţa.; Dăguci, C. 2016: Prosthetic rehabilitation of complete edentulous patients with morphological changes induced by age and old ill fitted dentures. Romanian Journal of Morphology and Embryology 57(2 Suppl): 861-864

Andreas Zenthöfer, A.; Rammelsberg, P.; Cabrera, T.; Hassel, A. 2015: Prosthetic rehabilitation of edentulism prevents malnutrition in nursing home residents. International journal of prosthodontics 28(2): 198-200

Shrivastava, K.J.; Shrivastava, S.; Agarwal, S.; Bhoyar, A. 2015: Prosthetic rehabilitation of large mid-facial defect with magnet-retained silicone prosthesis. Journal of Indian Prosthodontic Society 15(3): 276-280

Schnabl, D. 2015: Prosthetic rehabilitation of partially edentulous patients: fixed - removable - combined? Metal - ceramics - all - ceramics? Implants? Anything goes! Part 1: two example cases of a combined fixed-removable restoration. Swiss Dental Journal 125(2): 149-154; 162-167

Schnabl, D. 2015: Prosthetic rehabilitation of partially edentulous patients: fixed - removable - combined? Metal - ceramics - all - ceramics? Implants? Anything goes! Part 2: two case studies represent the fixed, respectively the combined fixed-removable prosthetic restoration by utilization of implants. Swiss Dental Journal 125(2): 155-161

Rathee, M.; Sikka, N.; Jindal, S.; Kaushik, A. 2015: Prosthetic rehabilitation of severe Siebert's Class IIi defect with modified Andrews bridge system. Contemporary Clinical Dentistry 6(Suppl 1): S114-S116

Babu, A.S.; Manju, V.; Nair, V.P.; Thomas, C.T. 2016: Prosthetic rehabilitation of surgically treated orbital defects - evisceration, enucleation, and exenteration: a case series. Journal of Indian Prosthodontic Society 16(2): 216-220

Ali, R.; Altaie, A.; Morrow, L. 2015: Prosthetic rehabilitation of the gagging patient using acrylic training plates. Dental Update 42(1): 52

Margonar, R.ér.; Queiroz, T.P.; Saito, C.él.T.M.H.; Luvizuto, E.R.; Betoni-Júnior, W.; de Oliveira, J.úl.C.S.; Marcantonio, Él. 2015: Prosthetic rehabilitation using short dental implants associated with homogenous bone graft. Journal of Craniofacial Surgery 26(3): 946-950

Yoon, H-In.; Han, J-Suk. 2016: Prosthetic rehabilitation with an implant-supported fixed prosthesis using computer-aided design and computer-aided manufacturing dental technology for a patient with a mandibulectomy: A clinical report. Journal of Prosthetic Dentistry 115(2): 133-136

Agranat, J.S.; Kitos, N.R.; Jacobs, D.S. 2016: Prosthetic replacement of the ocular surface ecosystem: impact at 5 years. British Journal of Ophthalmology 100(9): 1171-1175

Silveira, G.S.; de Almeida, N.ál.V.; Pereira, D.M.T.; Mattos, C.áu.T.; Mucha, J.é N. 2016: Prosthetic replacement vs space closure for maxillary lateral incisor agenesis: a systematic review. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 150(2): 228-237

Kumar, D.R.V.; Raju, D.S.; Naidu, L.; Deshpande, S.; Chadha, M.; Agarwal, A. 2015: Prosthetic status and prosthetic needs amongst geriatric fishermen population of Kutch coast, Gujarat, India. Roczniki Panstwowego Zakladu Higieny 66(2): 167-171

Vitale, S.Giovanni.; Laganà, A.Simone.; Gulino, F.Antonio.; Tropea, A.; Tarda, S. 2016: Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates in Surgery 68(4): 325-329

Jones Haywood, M. 2015: Prosthetic transvalvular regurgitation diagnosed with three-dimensional transesophageal echocardiography. Anesthesia and Analgesia 121(1): 65-68

Zaoui, K.; Schneider, M.H.; Neuner, O.; Federspil, P.A. 2016: Prosthetic treatment of nasal septal perforations : Results with custom-made silicone buttons. Hno 64(12): 897-904

Filius, M.A.; Cune, M.S.; Raghoebar, G.M.; Vissink, A.; Visser, A. 2016: Prosthetic treatment outcome in patients with severe hypodontia: a systematic review. Journal of Oral Rehabilitation 43(5): 373-387

Woo, Y.Joseph.; Greene, C.L. 2016: Prosthetic valve choice in middle-aged patients: guidelines and other guiding principles. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 49(5): 1468-1469

Sarı, C.; Durmaz, T.; Karaduman, B.D.; Keleş, T.; Bayram, H.üs.; Baştuğ, S.; Özen, M.B.; Bayram, N.A.; Bilen, E.; Ayhan, H.üs.; Kasapkara, H.ı A.; Bozkurt, E. 2016: Prosthetic valve endocarditis 7 months after transcatheter aortic valve implantation diagnosed with 3D TEE. Hellenic Journal of Cardiology: Hjc 57(2): 119-123

Olsen, N.T.; De Backer, O.; Thyregod, H.G.H.; Vejlstrup, N.; Bundgaard, H.; Søndergaard, L.; Ihlemann, N. 2015: Prosthetic valve endocarditis after transcatheter aortic valve implantation. CIRCULATION. Cardiovascular Interventions 8(4)

Ahmad, K.; Klaaborg, K.E.; Hjortdal, V.; Nørgaard, B.L.; Terkelsen, C.J.; Jensen, K.; Christiansen, E.H.øj.; Terp, K.A.; Andersen, G.; Hvitfeldt, S.; Andersen, H.R. 2016: Prosthetic valve endocarditis after transcatheter aortic valve implantation-diagnostic and surgical considerations. Journal of Thoracic Disease 8(10): E1213-E1218

Amat-Santos, I.J.; Ribeiro, H.B.; Urena, M.; Allende, R.; Houde, C.; Bédard, E.; Perron, J.; DeLarochellière, R.; Paradis, J.-M.; Dumont, E.; Doyle, D.; Mohammadi, S.; Côté, M.él.; San Roman, J.é A.; Rodés-Cabau, J. 2015: Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review. JACC. Cardiovascular Interventions 8(2): 334-346

Van Valen, R.; de Lind van Wijngaarden, R.A.F.; Verkaik, N.J.; Mokhles, M.M.; Bogers, A.J.J.C. 2016: Prosthetic valve endocarditis due to Propionibacterium acnes. Interactive Cardiovascular and Thoracic Surgery 23(1): 150-155

Neragi-Miandoab, S.; Westbrook, B.; Flynn, J.; Blakely, J.; Baribeau, Y. 2015: Prosthetic valve endocarditis five months following transcatheter aortic valve implantation and review of literature. Heart Surgery Forum 18(1): E20-E22

Pabilona, C.; Gitler, B.; Lederman, J.A.; Miller, D.; Keltz, T.N. 2015: Prosthetic valve endocarditis with valvular obstruction after transcatheter aortic valve replacement. Texas Heart Institute Journal 42(2): 172-174

Yousefzai, R.; Khandheria, B.K. 2015: Prosthetic valve endocarditis: multiple complications in one patient. European Heart Journal. Cardiovascular Imaging 16(8): 881

Separham, A.; Ghaffari, S.; Aslanabadi, N.; Sohrabi, B.; Ghojazadeh, M.; Anamzadeh, E.; Hajizadeh, R.; Davarmoin, G. 2015: Prosthetic valve thrombosis. Journal of Cardiac Surgery 30(3): 246-250

Bilal, M.; Khan, M.S.; Haseeb, A.; Khan, A.B. 2015: Prosthetic valve thrombosis in a patient with mitral valve replacement. JPMA. Journal of the Pakistan Medical Association 65(7): 802-803

Tarzia, V.; Guariento, A.; Bagozzi, L.; Bagno, A.; Bottio, T.; Gerosa, G. 2016: Prosthetic valve thrombosis: When prevention is better than treatment. American Heart Journal 174: E1-E2

Loureiro-Amigo, J.; Pons, S.; Sierra, M.; Meije, Y. 2017: Prosthetic valve with infective endocarditis caused by Propionibacterium avidum. A case report. Enfermedades Infecciosas y Microbiologia Clinica 35(3): 196-197

Kurlansky, P. 2015: Prosthetic valves and the unending quest for the holy grail. Journal of Thoracic and Cardiovascular Surgery 149(5): 1242-1243

Bonares, M.J.; Vaisman, A.; Sharkawy, A. 2016: Prosthetic vascular graft infection and prosthetic joint infection caused by Pseudomonas stutzeri. Idcases 6: 106-108

Oda, T.; Minatoya, K.; Kobayashi, J.; Okita, Y.; Akashi, H.; Tanaka, H.; Kawaharada, N.; Saiki, Y.; Kuniyoshi, Y.; Nishimura, K. 2015: Prosthetic vascular graft infection through a median sternotomy: a multicentre review †. Interactive Cardiovascular and Thoracic Surgery 20(6): 701

Chen, H.Y.; Berwick, Z.C.; Kemp, A.; Krieger, J.; Chambers, S.; Lurie, F.; Kassab, G.S. 2015: Prosthetic venous valve patient selection by validated physics-based computational models. Journal of Vascular Surgery. Venous and Lymphatic Disorders 3(1): 75-80

Hadjinicolaou, A.E.; Meffin, H.; Maturana, M.I.; Cloherty, S.L.; Ibbotson, M.R. 2015: Prosthetic vision: devices, patient outcomes and retinal research. Clinical and Experimental Optometry 98(5): 395-410

Humphrey, J.M.; Lacaille, S.N.J.; Patel, K.; Thompson, E.; Tulumba, S.; Healey, J.H.; Gilhuley, K.A.; Babady, N.E.; Kamboj, M.; Mead, P.A. 2015: Prosthetic-Joint-Associated Bordetella holmesii Infection. Open Forum Infectious Diseases 2(4): Ofv169

Karrouf, G.; Zaghloul, A.; Abou-Alsaud, M.; Barbour, E.; Abouelnasr, K. 2016: Prosthetics and Techniques in Repair of Animal's Abdominal Wall. Scientifica 2016: 9463186

Taylor, R.J.; Sherris, D.A. 2015: Prosthetics for nasal perforations: a systematic review and meta-analysis. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 152(5): 803-810

Anderson, S.; Stuckey, R.; Oakman, J.R. 2016: Prosthetists' and Orthotists' experience of their work and workspace - characterising the physical and organisational environment: Focus group findings. Prosthetics and Orthotics International 40(6): 703-712

Hafner, B.J.; Spaulding, S.E.; Salem, R.; Morgan, S.J.; Gaunaurd, I.; Gailey, R. 2017: Prosthetists' perceptions and use of outcome measures in clinical practice: Long-term effects of focused continuing education. Prosthetics and Orthotics International 41(3): 266-273

Bilton, D.T. 2013: Prosthetops wolybergensis sp. nov.--a giant amongst the 'minute moss beetles', with new data on other members of the genus (Coleoptera, Hydraenidae). Zootaxa 3666: 345-357

Boonsiriphant, P.; Hirsch, J.A.; Greenberg, A.M.; Genden, E.M. 2015: Prosthodontic Considerations in Post-cancer Reconstructions. Oral and Maxillofacial Surgery Clinics of North America 27(2): 255-263

Rynn, M.Howard.; Afshari, F.S.; Schneider, J.; Yuan, J.Chia-Chun.; Harlow, R.; Knoernschild, K.L.; Campbell, S.D.; Sukotjo, C. 2015: Prosthodontic Implant Club at UIC, Program Description and Survey Analysis. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(8): 665-671

Artopoulou, I.Ioanna.; Martin, J.W.; Chambers, M.S. 2016: Prosthodontic Management and Treatment Considerations for an HIV-Positive Patient with a Nonhealing Lesion of the Maxilla: A Clinical Case History Report. International Journal of Prosthodontics 29(4): 354-356

Dhakshaini, M.R.; Pushpavathi, M.; Garhnayak, M.; Dhal, A. 2015: Prosthodontic Management in Conjunction with Speech Therapy in Cleft Lip and Palate: A Review and Case Report. Journal of International Oral Health: Jioh 7(Suppl. 2): 106-111

Gurkar, H.; Venkatesh, O.Y.; Somashekar, J.M.; Gowda, M.H.L.; Dwivedi, M.; Ningthoujam, I. 2016: Prosthodontic Management of Xerostomic Patient: a Technical Modification. Case Reports in Dentistry 2016: 8905891

Siddiqui, M.Musaab.; Taylor, P.D. 2016: Prosthodontic Rehabilitation for a Patient with Ellis-Van Creveld Syndrome: A Case Report. European Journal of Prosthodontics and Restorative Dentistry 24(1): 36-39

Rajapur, A.; Mitra, N.; Prakash, V.J.; Rah, S.A.; Thumar, S. 2015: Prosthodontic Rehabilitation of Patients with Bell's Palsy: our Experience. Journal of International Oral Health: Jioh 7(Suppl 2): 77-81

Sethuram, A.K.; Arora, V.; Kumar Pal, A.; Singh Sandhu, H.; Sahoo, N.K.; Guruprasada, B.S. 2016: Prosthodontic Rehabilitation with a Telescopic Prosthesis of a Nonsyndromic Oligodontia Patient. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 25(3): 247-251

Zhang, X.X.; Peng, D.; Feng, H.L. 2015: Prosthodontic Treatment for Severe Oligodontia with Long-term Follow-up. Chinese Journal of Dental Research: the Official Journal of the Scientific Section of the Chinese Stomatological Association 18(3): 163-169

Hutten, M.C. 2016: Prosthodontic considerations for managing the older adult patient. General Dentistry 64(6): 18-22

Korduner, E.-K.; Collin Bagewitz, I.; Vult von Steyern, P.; Wolf, E. 2016: Prosthodontic decision-making relating to dentitions with compromised molars: the perspective of Swedish General Dental Practitioners. Journal of Oral Rehabilitation 43(12): 967-976

Păuna, M.Rodica.; Babiuc, I.; Farcaşiu, A.Titus. 2015: Prosthodontic management of an extreme atrophy of the mandible correlated with a prominent genial tubercle - a clinical report. Romanian Journal of Morphology and Embryology 56(2 Suppl): 867-870

Taruna, M.; Chittaranjan, B.; Sudheer, N.; Tella, S.; Abusaad, M. 2014: Prosthodontic perspective to all-on-4® concept for dental implants. Journal of Clinical and Diagnostic Research: Jcdr 8(10): Ze16-Ze19

Manfredini, D.; Poggio, C.E. 2017: Prosthodontic planning in patients with temporomandibular disorders and/or bruxism: a systematic review. Journal of Prosthetic Dentistry 117(5): 606-613

McKenna, G.; Hayes, M.; Burke, F.M. 2014: Prosthodontic rehabilitation for a patient with acromegaly. European Journal of Prosthodontics and Restorative Dentistry 22(3): 98-100

Livingstone, D.; Murthy, V.; Reddy, V.K.; Pillai, A. 2015: Prosthodontic rehabilitation of a patient with aggressive periodontitis. BMJ Case Reports

Garg, A. 2016: Prosthodontic rehabilitation of completely edentulous patient with partial glossectomy. Journal of Indian Prosthodontic Society 16(2): 204-207

Shrestha, B.; Fatmasari, F.; Thaworanunta, S.; Srithavaj, T. 2015: Prosthodontic rehabilitation of congenital auricular defect: a clinical report. Cleft Palate-Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association 52(2): 229-233

Singh, N.; Dhiman, R.K.; Kumar, D. 2015: Prosthodontic rehabilitation of extraoral and intraoral maxillofacial defects. Medical Journal Armed Forces India 71(Suppl 2): S556-S559

Bansal, R.; Kumar, M.; Garg, R.; Saini, R.; Kaushala, S. 2014: Prosthodontic rehabilitation of patient with flabby ridges with different impression techniques. Indian Journal of Dentistry 5(2): 110-113

Viswambaran, M.; Thiruvalluvan, N. 2015: Prosthodontic rehabilitation protocols for immediate implants. Medical Journal Armed Forces India 71(Suppl 2): S440-S443

Károlyházy, K.; Schmidt, Péter.; Bogdán, Sándor.; Hermann, Péter.; Arányi, Z. 2014: Prosthodontic treatment of an edentulous epileptic patient with an implant-retained overdenture. A case report. Ideggyogyaszati Szemle 67(9-10): 342-346

Jackson, M. 2015: Prosthodontics rehabilitation in velopharyngeal insufficiency. Advances in Oto-Rhino-Laryngology 76: 41-49

Gantos, M.A.; Manzotti, A.; Yuan, J.C.-C.; Afshari, F.S.; Marinis, A.; Syros, G.; Rynn, M.H.; Sukotjo, C. 2015: Prosthodontics treatment considerations for methamphetamine-dependent patients. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(1): 64-70

Kaku, M. 2016: Prosthodontics: a multidisciplinary field in dentistry. Journal of Prosthodontic Research 60(3): 143-144

Tiosavljević, D.; Djukić-Dejanović, S.; Turza, K.; Jovanović, A.; Jeremić, V. 2016: Prostitution as a Psychiatric Situation: Ethical Aspects. Psychiatria Danubina 28(4): 349-356

Fraser, B. 1995: Prostitution is not reasonable or desirable. Nursing Standard 1987) 9(45): 40-40

Vogel, L. 2015: Prostitution laws failing sex workers: CPHA. Cmaj: Canadian Medical Association Journal 187(2): E63-E64

Miana, G.A.; Riaz, M.; Shahzad-ul-Hussan, S.; Paracha, R.Z.; Paracha, U.Z. 2015: Prostratin: An Overview. Mini Reviews in Medicinal Chemistry 15(13): 1122-1130

Strappazzon, F.; Di Rita, A.; Cianfanelli, V.; D'Orazio, M.; Nazio, F.; Fimia, G.Maria.; Cecconi, F. 2016: Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy 12(6): 963-975

Carrington, E.M.; Zhang, J-Guo.; Sutherland, R.M.; Vikstrom, I.B.; Brady, J.L.; Soo, P.; Vremec, D.; Allison, C.; Lee, E.F.; Fairlie, W.Douglas.; Bouillet, P.; Grabow, S.; Ottina, E.; Herold, M.J.; Pellegrini, M.; Huang, D.C.S.; Tarlinton, D.M.; Strasser, A.; Lew, A.M.; Zhan, Y. 2015: Prosurvival Bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 112(13): 4044-4049

Muir, L.A.; Murry, C.E.; Chamberlain, J.S. 2016: Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle. Stem Cells and Development 25(20): 1559-1569

Coppola, M.; Corrado, G.; Coppola, V.; Cascone, P.; Martinelli, R.; Digilio, M.Cristina.; Pennacchio, F.; Rao, R. 2015: Prosystemin Overexpression in Tomato Enhances Resistance to Different Biotic Stresses by Activating Genes of Multiple Signaling Pathways. Plant Molecular Biology Reporter 33(5): 1270-1285

Patoleta, B.; Żabka, M. 2015: Proszynellus--a new jumping spider genus from Australia (Araneae: Salticidae). Zootaxa 3926(2): 257-267

Mall, T.; Eckstein, J.; Norris, D.; Vora, H.; Freese, N.H.; Loraine, A.E. 2016: ProtAnnot: an App for Integrated Genome Browser to display how alternative splicing and transcription affect proteins. Bioinformatics 32(16): 2499-2501

Ruiz-Blanco, Y.B.; Paz, W.; Green, J.; Marrero-Ponce, Y. 2015: ProtDCal: A program to compute general-purpose-numerical descriptors for sequences and 3D-structures of proteins. Bmc Bioinformatics 16: 162

Yap, E.-H.; Fiser, A. 2016: ProtLID, a Residue-Based Pharmacophore Approach to Identify Cognate Protein Ligands in the Immunoglobulin Superfamily. Structure 24(12): 2217-2226

Dhifli, W.; Diallo, A.B.é 2016: ProtNN: fast and accurate protein 3D-structure classification in structural and topological space. Biodata Mining 9: 30

Ngai, J.C.F.; Mak, P.-I.; Siu, S.W.I. 2016: ProtPOS: a python package for the prediction of protein preferred orientation on a surface. Bioinformatics 32(16): 2537-2538

Cheng, Y.; Perocchi, F. 2015: ProtPhylo: identification of protein-phenotype and protein-protein functional associations via phylogenetic profiling. Nucleic Acids Research 43(W1): W160-W168

Sedova, M.; Jaroszewski, L.; Godzik, A. 2016: Protael: protein data visualization library for the web. Bioinformatics 32(4): 602-604

Doweld, A.B. 2016: Protaeropsis, a new replacement generic name for fossil Sphenaster Jeffery, 1999 (Echinoidea: Spatangida) nec Wilcoxon, 1970 (Protista: Haptomonada). Zootaxa 4139(3): 421-423

Wang, C.; Wang, Z.; Che, Y. 2016: Protagonista lugubris, a cockroach species new to China and its contribution to the revision of genus Protagonista, with notes on the taxonomy of Archiblattinae (Blattodea, Blattidae). Zookeys 2016(574): 57-73

Bakchoul, T.; Jouni, R.; Warkentin, T.E. 2016: Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies. Journal of Thrombosis and Haemostasis: Jth 14(9): 1685-1695

Chaney, M.A.; Devin Roberts, J.; Wroblewski, K.; Shahul, S.; Gaudet, R.; Jeevanandam, V. 2016: Protamine Administration Via the Ascending Aorta May Prevent Cardiopulmonary Instability. Journal of Cardiothoracic and Vascular Anesthesia 30(3): 647-655

Kakisis, J.D.; Antonopoulos, C.N.; Moulakakis, K.G.; Schneider, F.; Geroulakos, G.; Ricco, J.B. 2016: Protamine Reduces Bleeding Complications without Increasing the Risk of Stroke after Carotid Endarterectomy: a Meta-analysis. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 52(3): 296-307

Woronow, D. 2015: Protamine and Bleeding Avoidance Strategies. Journal of the American College of Cardiology 66(12): 1411-1412

Sharma, S.; Jyoti, K.; Sinha, R.; Katyal, A.; Jain, U.K.; Madan, J. 2016: Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells. Materials Science and Engineering. C Materials for Biological Applications 67: 378-385

Jiang, W.-j.; Zhang, J.; Xia, X.-y.; Xu, H.-q. 2015: Protamine gene polymorphisms and male infertility. Zhonghua Nan Ke Xue 21(12): 1134-1137

Liu, M.; Feng, B.; Shi, Y.; Su, C.; Song, H.; Cheng, W.; Zhao, L. 2015: Protamine nanoparticles for improving shRNA-mediated anti-cancer effects. Nanoscale Research Letters 10: 134

Olsson, A.; Alfredsson, J.; Håkansson, E.; Svedjeholm, R.; Berglund, J.; Berg, S.ör. 2016: Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass. Scandinavian Cardiovascular Journal: Scj 50(1): 58-63

Kim, Y.J.; Wang, Y.; Gupta, R.; Kim, S.W.; Min, C.W.; Kim, Y.C.; Park, K.H.; Agrawal, G.K.; Rakwal, R.; Choung, M.-G.; Kang, K.Y.; Kim, S.T. 2015: Protamine sulfate precipitation method depletes abundant plant seed-storage proteins: a case study on legume plants. Proteomics 15(10): 1760-1764

González-Aramundiz, Jé.Vicente.; Peleteiro Olmedo, M.; González-Fernández, África.; Alonso Fernández, Mía.José.; Csaba, N.Stefánia. 2015: Protamine-based nanoparticles as new antigen delivery systems. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 97(Pt A): 51-59

Elumalai, R.; Patil, S.; Maliyakkal, N.; Rangarajan, A.; Kondaiah, P.; Raichur, A.M. 2015: Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers. Nanomedicine: Nanotechnology Biology and Medicine 11(4): 969-981

Wu, W.; Cheng, H.; Bu, R. 2015: Protamine-containing insulin allergy and renal dysfunction in a patient with type 2 diabetes. Journal of Diabetes Investigation 6(5): 591-593

Scheicher, B.; Schachner-Nedherer, A-L.; Zimmer, A. 2015: Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 75: 54-59

Sköld, A.E.; van Beek, J.J.P.; Sittig, S.P.; Bakdash, G.; Tel, J.; Schreibelt, G.; de Vries, I.J.M. 2015: Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets. Cancer Immunology Immunotherapy: Cii 64(11): 1461-1473

Puras, G.; Martínez-Navarrete, G.; Mashal, M.; Zárate, J.; Agirre, M.; Ojeda, E.; Grijalvo, S.; Eritja, R.; Diaz-Tahoces, A.; Avilés-Trigueros, M.; Fernández, E.; Pedraz, J.L. 2015: Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: the Role of Protamine. Molecular Pharmaceutics 12(10): 3658-3671

Lim, J.L.; van der Pol, S.M.A.; Baron, W.; McCord, J.M.; de Vries, H.E.; van Horssen, J. 2016: Protandim Protects Oligodendrocytes against an Oxidative Insult. Antioxidants 5(3)

Kaspric, N.; Picard, B.; Reichstadt, M.; Tournayre, J.ér.ém.; Bonnet, M. 2015: ProteINSIDE to Easily Investigate Proteomics Data from Ruminants: Application to Mine Proteome of Adipose and Muscle Tissues in Bovine Foetuses. Plos one 10(5): E0128086

Qamar, J.; Khan, M.A.M.; Nazir, Z. 2016: Protean and intangible manifestation of renal stones in children. International Journal of Surgery 36(Part D): 647-648

Ardalan, M. 2014: Protean faces of infective endocarditis in renal transplant recipients. Nephro-Urology Monthly 6(6): E18657

Bartel, B. 2015: Proteaphagy-Selective Autophagy of Inactive Proteasomes. Molecular Cell 58(6): 970-971

Shubin, A.V.; Demidyuk, I.V.; Lunina, N.A.; Komissarov, A.A.; Roschina, M.P.; Leonova, O.G.; Kostrov, S.V. 2015: Protease 3C of hepatitis a virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death. Bmc Cell Biology 16: 4

Lidfeldt, J.; Bendahl, P.är.-O.; Forsare, C.; Malmström, P.; Fernö, M.år.; Belting, M. 2015: Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status. Plos one 10(8): E0134932

Tamkovich, S.; Bryzgunova, O. 2016: Protease Activity and Cell-Free DNA in Blood Plasma of Healthy Donors and Breast Cancer Patients. Journal of Immunoassay and Immunochemistry 37(2): 141-153

Kan, H.; Imamura, M.; Uchida, T.; Hiraga, N.; Hayes, C.Nelson.; Tsuge, M.; Abe, H.; Aikata, H.; Makokha, G.Naswa.; Chowdhury, S.; Miki, D.; Ochi, H.; Ishida, Y.; Tateno, C.; Chayama, K. 2016: Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing. Journal of Infectious Diseases 214(11): 1687-1694

Boender, T.Sonia.; Hamers, R.L.; Ondoa, P.; Wellington, M.; Chimbetete, C.; Siwale, M.; Labib Maksimos, E.E.F.; Balinda, S.N.; Kityo, C.M.; Adeyemo, T.A.; Akanmu, A.Sulaimon.; Mandaliya, K.; Botes, M.E.; Stevens, W.; Rinke de Wit, T.F.; Sigaloff, K.C.E. 2016: Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. Journal of infectious diseases 214(6): 873-883

McGivern, D.R.; Masaki, T.; Lovell, W.; Hamlett, C.; Saalau-Bethell, S.; Graham, B. 2015: Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle. Journal of Virology 89(10): 5362-5370

Voigt, J.; Woestemeyer, J. 2015: Protease Inhibitors Cause Necrotic Cell Death in Chlamydomonas reinhardtii by Inducing the Generation of Reactive Oxygen Species. Journal of Eukaryotic Microbiology 62(6): 711-721

De La Rosa, I.; Munjal, I.M.; Rodriguez-Barradas, M.; Yu, X.; Pirofski, L.-A.; Mendoza, D. 2016: Protease Inhibitors do not Affect Antibody Responses to Pneumococcal Vaccination. Clinical and Vaccine Immunology: Cvi 23(6): 524-529

Sargin Altunok, E.; Sayan, M.; Akhan, S.; Aygen, B.; Yildiz, O.; Tekin Koruk, S.; Mistik, R.; Demirturk, N.; Ural, O.; Kose, Şük.; Aynioglu, A.; Korkmaz, F.; Ersoz, G.ül.; Tuna, N.; Ayaz, C.; Karakecili, F.; Keten, D.; Inan, D.; Yazici, S.; Koculu, S.; Yildirmak, T. 2016: Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 50: 1-5

Bagnis, C.I.; Stellbrink, H.-J.ür. 2015: Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review. Infectious Diseases and Therapy 2015

Waldner, B.J.; Fuchs, J.E.; Schauperl, M.; Kramer, C.; Liedl, K.R. 2016: Protease Inhibitors in View of Peptide Substrate Databases. Journal of Chemical Information and Modeling 56(6): 1228-1235

Yau, M-Kwan.; Lim, J.; Liu, L.; Fairlie, D.P. 2016: Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert opinion on therapeutic patents 26(4): 471-483

Kim, H.N.; Kim, Y.R.; Ahn, S.M.; Lee, S.K.; Shin, H.K.; Choi, B.T. 2015: Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier. Journal of Neurochemistry 135(3): 577-588

Kamato, D.; Thach, L.; Getachew, R.; Burch, M.; Hollenberg, M.D.; Zheng, W.; Little, P.J.; Osman, N. 2016: Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes. Cellular Signalling 28(1): 110-119

Lin, C.; Rezaee, F.; Waasdorp, M.; Shi, K.; van der Poll, T.; Borensztajn, K.; Spek, C.A. 2015: Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis. Oncotarget 6(34): 35304-35314

Barnes, J.A.; Singh, S.; Gomes, A.V. 2004: Protease activated receptors in cardiovascular function and disease. Molecular and Cellular Biochemistry 263(1): 227-239

Labudda, M.; Różańska, E.żb.; Szewińska, J.; Sobczak, M.ła.; Dzik, J.M. 2016: Protease activity and phytocystatin expression in Arabidopsis thaliana upon Heterodera schachtii infection. Plant Physiology and Biochemistry (Paris) 109: 416-429

Agrawal, K.; Kale, S.L.; Arora, N. 2015: Protease activity of Per a 10 potentiates Th2 polarization by increasing IL-23 and OX40L. European Journal of Immunology 45(12): 3375-3385

Wang, Y.; Xu, Q.; Lu, H.; Lin, L.; Wang, L.; Xu, H.; Cui, X.; Zhang, H.; Li, T.; Hua, Y. 2015: Protease activity of PprI facilitates DNA damage response: Mn2+-dependence and substrate sequence-specificity of the proteolytic reaction. PloS one 10(3): e0122071

Domingo, C.S.; Soria, M.; Rojas, A.M.; Fissore, E.N.; Gerschenson, L.ía.N. 2015: Protease and hemicellulase assisted extraction of dietary fiber from wastes of Cynara cardunculus. International Journal of Molecular Sciences 16(3): 6057-6075

Ozturkoglu-Budak, S.; Wiebenga, A.; Bron, P.A.; de Vries, R.P. 2016: Protease and lipase activities of fungal and bacterial strains derived from an artisanal raw ewe's milk cheese. International Journal of Food Microbiology 237: 17-27

Vergnolle, N. 2016: Protease inhibition as new therapeutic strategy for Gi diseases. Gut 65(7): 1215-1224

Ma, H.; Xiao-Peng, T.; Yang, S.-L.; Lu, Q.-M.; Lai, R. 2016: Protease inhibitor in scorpion (Mesobuthus eupeus) venom prolongs the biological activities of the crude venom. Chinese Journal of Natural Medicines 14(8): 607-614

Harper, K.N. 2016: Protease inhibitor monotherapy for long-term management of HIV infection. Aids 30(5): N5

Paton, N.I.; Stöhr, W.; Arenas-Pinto, A.; Fisher, M.; Williams, I.; Johnson, M.; Orkin, C.; Chen, F.; Lee, V.; Winston, A.; Gompels, M.; Fox, J.; Scott, K.; Dunn, D.T.; Fisher, M.; Clarke, A.; Hadley, W.; Stacey, D.; Johnson, M.; Byrne, P.; Williams, I.; De Esteban, N.; Pellegrino, P.; Haddow, L.; Arenas-Pinto, A.; Orkin, C.; Hand, J.; De Souza, C.; Murthen, L.; Crawford-Jones, A.; Chen, F.; Wilson, R.; Green, E.; Masterson, J.; Lee, V.; Patel, K.; Howe, R.; Winston, A.; Mullaney, S.; Gompels, M.; Jennings, L.; Beeching, N.; Tamaklo, R.; Fox, J.; Teague, A.; Jendrulek, I.; Tiraboschi, J.; Wilkins, E.; Clowes, Y.; Thompson, A.; Brook, G.; Trivedi, M.; Aderogba, K.; Jones, M.; DeBurgh-Thomas, A.; Jones, L.; Reeves, I.; Mguni, S.; Chadwick, D 2015: Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial. LANCET. HIV 2(10): E417-E426

Torres-Cornejo, A.; BenMarzouk-Hidalgo, O.J.; Viciana, P.; Sánchez, B.; López-Ruz, M.A.; López-Cortés, L.F.; Gutiérrez-Valencia, A. 2016: Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22(1): 98.E7-98.E10

Ripamonti, D. 2016: Protease inhibitor monotherapy was non-inferior and cost-effective as maintenance therapy compared to triple therapy in viral load suppressed patients with HIV-1 infection. Evidence-Based Medicine 21(5): 184

Okumura, L.M. 2016: Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 20(4): 405

Yee, T.T.; Amrolia, P.J.; Lee, C.A.; Mir, N.; Giangrande, P.L. 1997: Protease inhibitors and unusual bleeding in haemophiliacs. Haemophilia: the Official Journal of the World Federation of Hemophilia 3(3): 220-221

Han, S.; Li, Y.Y.; Chan, B.P. 2015: Protease inhibitors enhance extracellular collagen fibril deposition in human mesenchymal stem cells. Stem Cell Research and Therapy 6: 197

Bruyand, M.; Le Marec, F.; Lavole, A.; Leffondre, K.; Spano, J.P.; Le Moing, V.; Tattevin, P.; March, L.; Cadranel, J.; Bonnet, F.; Guiguet, M. 2015: Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study. Aids 29(9): 1105-1109

Li, Y.-S.; Liu, H.-W.; Zhu, R.; Xia, Q.-Y.; Zhao, P. 2016: Protease inhibitors in Bombyx mori silk might participate in protecting the pupating larva from microbial infection. Insect Science 23(6): 835-842

Duarte-Rojo, A.; Fischer, S.E.; Adeyi, O.; Zita, D.; Deneke, M.G.; Selzner, N.; Chen, L.; Malespin, M.; Cotler, S.J.; McGilvray, I.D.; Feld, J.J. 2016: Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C. Journal of Viral Hepatitis 23(5): 340-347

Zhou, Y.; Vedantham, P.; Lu, K.; Agudelo, J.; Carrion, R.; Nunneley, J.W.; Barnard, D.; Pöhlmann, S.; McKerrow, J.H.; Renslo, A.R.; Simmons, G. 2015: Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research 116: 76-84

Schaerer, V.; Haubitz, S.; Kovari, H.; Ledergerber, B.; Ambrosioni, J.; Cavassini, M.; Stoeckle, M.; Schmid, P.; Decosterd, L.; Aouri, M.; Böni, J.; Günthard, H.F.; Furrer, H.; Metzner, K.J.; Fehr, J.; Rauch, A.; Aubert, V.; Barth, J.; Battegay, M.; Bernasconi, E.; Böni, J.; Bucher, H.C.; Burton-Jeangros, C.; Calmy, A.; Cavassini, M.; Egger, M.; Elzi, L.; Fehr, J.; Fellay, J.; Furrer, H.; Fux, C.A.; Gorgievski, M.; Günthard, H.; Haerry, D.; Hasse, B.; Hirsch, H.H.; Hösli, I.; Kahlert, C.; Kaiser, L.; Keiser, O.; Klimkait, T.; Kouyos, R.; Kovari, H.; Ledergerber, B.; Martinetti, G.; de Tejada, B.M.; Metzner, K.; Müller, N.; Nadal, D.; Pantaleo, G.; Rauch, A.; Regenass, S.; Rickenbach, M.; Rudin, C.; Schöni-Affolter, F.; Schmid, P.; Sc 2015: Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Medicine 16(10): 599-607

Lupo, F.; Russo, R.; Iolascon, A.; Ieluzzi, D.; Siciliano, A.; Toniutto, P.; Matté, A.; Piovesan, S.; Raffetti, E.; Turrini, F.; Dissegna, D.; Donato, F.; Alberti, A.; Zuliani, V.; Fattovich, G.; De Franceschi, L. 2016: Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients. Liver International: Official Journal of the International Association for the Study of the Liver 36(1): 49-58

McKee, C.M.; Ding, Y.; Zhou, J.; Li, C.; Huang, L.; Xin, X.; He, J.; Allen, J.E.; El-Deiry, W.S.; Cao, Y.; Muschel, R.J.; Xu, D. 2015: Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. Oncotarget 6(6): 3784-3796

Selbonne, S.; Francois, D.; Raoul, W.; Boulaftali, Y.; Sennlaub, F.; Jandrot-Perrus, M.; Bouton, M.-C.; Arocas, V.ér. 2015: Protease nexin-1 regulates retinal vascular development. Cellular and Molecular Life Sciences: Cmls 72(20): 3999-4011

Holinstat, M.; Bray, P.F. 2016: Protease receptor antagonism to target blood platelet therapies. Clinical Pharmacology and Therapeutics 99(1): 72-81

Vass, R.H.; Zeinert, R.D.; Chien, P. 2016: Protease regulation and capacity during Caulobacter growth. Current Opinion in Microbiology 34: 75-81

Salvesen, G.S.; Hempel, A.; Coll, N.S. 2016: Protease signaling in animal and plant-regulated cell death. Febs Journal 283(14): 2577-2598

Sandersjöö, L.; Jonsson, A.; Löfblom, J. 2017: Protease substrate profiling using bacterial display of self-blocking affinity proteins and flow-cytometric sorting. Biotechnology Journal 12(1)

Lima, L.A.; Cruz Filho, R.F.; dos Santos, Jário.G.; Silva, W.C. 2015: Protease with collagenolytic activity produced by Bacillus sp. DPUA 1728 from Amazonian soil. Brazilian journal of microbiology: 46(4): 1217-1223

Li, S.-Y.; Cheng, H.; Qiu, W.-X.; Liu, L.-H.; Chen, S.; Hu, Y.; Xie, B.-R.; Li, B.; Zhang, X.-Z. 2015: Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo. Acs Applied Materials and Interfaces 7(51): 28319-28329

Jacob, J.A. 2016: Protease-Activated Fluorescent Probe Shows Promise as a Cancer Imaging Device. JAMA 315(12): 1217-1218

Abdel-Magid, A.F. 2016: Protease-Activated Receptor 1 (PAR-1) Antagonists as Potential Treatment for Acute Coronary Syndrome. Acs Medicinal Chemistry Letters 7(10): 881-883

Antoniak, S.; Cardenas, J.C.; Buczek, L.J.; Church, F.C.; Mackman, N.; Pawlinski, R. 2017: Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology 136(4): 258-268

Antoniak, S.; Tatsumi, K.; Bode, M.; Vanja, S.; Williams, J.C.; Mackman, N. 2017: Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice. Journal of Innate Immunity 9(2): 181-192

Al-Khafaji, K.; Mutyala, M.; Al-Khafaji, N.; Harper, Y.; Ismail, I.; Hakim, H.; Arora, R.R. 2017: Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis. American Journal of Therapeutics 24(6): E730-E736

Kouzoukas, D.E.; Ma, F.; Meyer-Siegler, K.L.; Westlund, K.N.; Hunt, D.E.; Vera, P.L. 2016: Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1. Plos one 11(3): E0152055

Norman, J.E.; Cunningham, M.R.; Jones, M.L.; Walker, M.E.; Westbury, S.K.; Sessions, R.B.; Mundell, S.J.; Mumford, A.D. 2016: Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking. Arteriosclerosis Thrombosis and Vascular Biology 36(5): 952-960

Tricoci, P. 2017: Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary Intervention. Interventional Cardiology Clinics 6(1): 57-66

Shin, Y.-S.; Kim, H.W.; Kim, C.D.; Kim, H.-W.; Park, J.W.; Jung, S.; Lee, J.-H.; Ko, Y.-K.; Lee, Y.H. 2015: Protease-Activated Receptor-2 Is Associated with Terminal Differentiation of Epidermis and Eccrine Sweat Glands. Annals of Dermatology 27(4): 364-370

Suzuki, N.; Mihara, H.; Nishizono, H.; Tominaga, M.; Sugiyama, T. 2015: Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte. Digestive Diseases and Sciences 60(12): 3570-3578

Andersen, H.H. 2016: Protease-Activated Receptor-2: a Multifaceted Molecular Transducer in the Human Skin. Annals of Dermatology 28(6): 771-772

Rosero, R.A.; Villares, G.J.; Bar-Eli, M. 2016: Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection. Frontiers in Genetics 7: 112

Cromm, P.M.; Spiegel, J.; Küchler, P.; Dietrich, L.; Kriegesmann, J.; Wendt, M.; Goody, R.S.; Waldmann, H.; Grossmann, T.N. 2016: Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase. Acs Chemical Biology 11(8): 2375-2382

Cheng, Y.; Huang, F.; Min, X.; Gao, P.; Zhang, T.; Li, X.; Liu, B.; Hong, Y.; Lou, X.; Xia, F. 2016: Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells. Analytical Chemistry 88(17): 8913-8919

Kaur, S.; Sharma, P. 2015: Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An in Vitro Study. Probiotics and Antimicrobial Proteins 7(2): 172-180

Gao, C.; Vargo, K.B.; Hammer, D.A. 2016: Protease-Triggered, Integrin-Targeted Cellular Uptake of Recombinant Protein Micelles. Macromolecular Bioscience 16(9): 1398-1406

Johnson, J.J.; Miller, D.L.; Jiang, R.; Liu, Y.; Shi, Z.; Tarwater, L.; Williams, R.; Balsara, R.; Sauter, E.R.; Stack, M.S. 2016: Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma. Journal of Biological Chemistry 291(13): 6936-6945

Smith, T.H.; Coronel, L.J.; Li, J.G.; Dores, M.R.; Nieman, M.T.; Trejo, J. 2016: Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-Arrestins. Journal of Biological Chemistry 291(35): 18453-18464

LeBeau, A.M.; Denmeade, S.R. 2015: Protease-activated pore-forming peptides for the treatment and imaging of prostate cancer. Molecular Cancer Therapeutics 14(3): 659-668

Hou, Y.; Zhou, J.; Gao, Z.; Sun, X.; Liu, C.; Shangguan, D.; Yang, W.; Gao, M. 2015: Protease-activated ratiometric fluorescent probe for pH mapping of malignant tumors. Acs Nano 9(3): 3199-3205

Lin, C.; von der Thüsen, J.; Daalhuisen, J.; ten Brink, M.; Crestani, B.; van der Poll, T.; Borensztajn, K.; Spek, C.A. 2015: Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis. Journal of Cellular and Molecular Medicine 19(6): 1346-1356

He, R-Qing.; Tang, X-Feng.; Zhang, B-Li.; Li, X-Dong.; Hong, M-Na.; Chen, Q-Zhi.; Han, W-Qing.; Gao, P-Jin. 2016: Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta. Biochemical and Biophysical Research Communications 473(2): 517-523

Lekic, T.; Klebe, D.; McBride, D.W.; Manaenko, A.; Rolland, W.B.; Flores, J.J.; Altay, O.; Tang, J.; Zhang, J.H. 2015: Protease-activated receptor 1 and 4 signal inhibition reduces preterm neonatal hemorrhagic brain injury. Stroke 46(6): 1710-1713

Tillu, D.V.; Hassler, S.N.; Burgos-Vega, C.C.; Quinn, T.L.; Sorge, R.E.; Dussor, G.; Boitano, S.; Vagner, J.; Price, T.J. 2015: Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 156(5): 859-867

Xie, L.; Duan, Z.; Liu, C.; Zheng, Y.; Zhou, J. 2015: Protease-activated receptor 2 agonist increases cell proliferation and invasion of human pancreatic cancer cells. Experimental and Therapeutic Medicine 9(1): 239-244

Bao, Y.; Hou, W.; Yang, L.; Kong, X.; Du, M.; Zheng, H.; Gao, Y.; Hua, B. 2015: Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer pain. Regional Anesthesia and Pain Medicine 40(2): 158-165

Sun, Z.; Cao, B.; Wu, J. 2015: Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathway. Experimental and Molecular Pathology 98(3): 382-389

Al-Eryani, K.; Cheng, J.; Abé, T.; Maruyama, S.; Yamazaki, M.; Babkair, H.; Essa, A.; Saku, T. 2015: Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells. Human Pathology 46(7): 991-999

Kolpakov, M.A.; Rafiq, K.; Guo, X.; Hooshdaran, B.; Wang, T.; Vlasenko, L.; Bashkirova, Y.V.; Zhang, X.; Chen, X.; Iftikhar, S.; Libonati, J.R.; Kunapuli, S.P.; Sabri, A. 2016: Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury. Journal of Molecular and Cellular Cardiology 90: 21-29

Lindahl, T.L.; Macwan, A.S.; Ramström, S. 2016: Protease-activated receptor 4 is more important than protease-activated receptor 1 for the thrombin-induced procoagulant effect on platelets. Journal of Thrombosis and Haemostasis: Jth 14(8): 1639-1641

French, S.L.; Hamilton, J.R. 2016: Protease-activated receptor 4: from structure to function and back again. British Journal of Pharmacology 173(20): 2952-2965

Moschonas, I.C.; Goudevenos, J.A.; Tselepis, A.D. 2015: Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives. International Journal of Cardiology 185: 9-18

Tanaka, M.; Yoneyama, M.; Shiba, T.; Yamaguchi, T.; Ogita, K. 2016: Protease-activated receptor-1 negatively regulates proliferation of neural stem/progenitor cells derived from the hippocampal dentate gyrus of the adult mouse. Journal of Pharmacological Sciences 131(3): 162-171

Moss, C.R.; Gilbert, C.A.; Gabriel, S.A.; Gu, Q. 2015: Protease-activated receptor-2 inhibits BK channel activity in bronchopulmonary sensory neurons. Neuroscience Letters 589: 13-18

Bar-Shavit, R.; Maoz, M.; Kancharla, A.; Jaber, M.; Agranovich, D.; Grisaru-Granovsky, S.; Uziely, B. 2016: Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy. Methods in Cell Biology 132: 341-358

Wojtukiewicz, M.Z.; Hempel, D.; Sierko, E.; Tucker, S.C.; Honn, K.V. 2015: Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis. Cancer Metastasis Reviews 34(4): 775-796

Hempel, D.; Sierko, E.; Wojtukiewicz, M.Z. 2016: Protease-activated receptors - biology and role in cancer. Postepy Higieny i Medycyny Doswiadczalnej 70: 775-786

Akiyama, T.; Lerner, E.A.; Carstens, E. 2015: Protease-activated receptors and itch. Handbook of Experimental Pharmacology 226: 219-235

Guenther, F.; Melzig, M.F. 2015: Protease-activated receptors and their biological role - focused on skin inflammation. Journal of Pharmacy and Pharmacology 67(12): 1623-1633

Nieman, M.T. 2016: Protease-activated receptors in hemostasis. Blood 128(2): 169-177

Palygin, O.; Ilatovskaya, D.V.; Staruschenko, A. 2016: Protease-activated receptors in kidney disease progression. American Journal of Physiology. Renal Physiology 311(6): F1140-F1144

Christensen, J.; Alfredson, H.åk.; Andersson, G. 2015: Protease-activated receptors in the Achilles tendon-a potential explanation for the excessive pain signalling in tendinopathy. Molecular Pain 11: 13

Sung, T.S.; Kim, H.U.; Kim, J.H.; Lu, H.; Sanders, K.M.; Koh, S.D. 2015: Protease-activated receptors modulate excitability of murine colonic smooth muscles by differential effects on interstitial cells. Journal of Physiology 593(5): 1169-1181

Grisaru-Granovsky, S.; Salah, Z.; Maoz, M.; Tevet, A.; Margalioth, E.; Samueloff, A.; Altarescu, G.; Bar-Shavit, R. 2015: Protease-activated-receptor 1 polymorphisms correlate with risk for unexplained recurrent pregnancy loss: a pilot study querying an association beyond coagulation. European Journal of Obstetrics Gynecology and Reproductive Biology 185: 13-18

Gutowski, S.M.; Shoemaker, J.T.; Templeman, K.L.; Wei, Y.; Latour, R.A.; Bellamkonda, R.V.; LaPlaca, M.C.; García, A.és.J. 2015: Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes. Biomaterials 44: 55-70

Foster, G.A.; Headen, D.M.; González-García, C.; Salmerón-Sánchez, M.; Shirwan, H.; García, A.és.J. 2017: Protease-degradable microgels for protein delivery for vascularization. Biomaterials 113: 170-175

Malolo, F.-A.ée.E.; Bissoue Nouga, A.; Kakam, A.; Franke, K.; Ngah, L.; Flausino, O.; Mpondo Mpondo, E.; Ntie-Kang, F.; Ndom, J.C.; Bolzani, V.d.S.; Wessjohann, L. 2015: Protease-inhibiting, molecular modeling and antimicrobial activities of extracts and constituents from Helichrysum foetidum and Helichrysum mechowianum (compositae). Chemistry Central Journal 9: 32

van Rijt, S.H.; Bölükbas, D.A.; Argyo, C.; Datz, S.; Lindner, M.; Eickelberg, O.; Königshoff, M.; Bein, T.; Meiners, S. 2015: Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. Acs Nano 9(3): 2377-2389

Kitakaze, K.; Mizutani, Y.; Sugiyama, E.; Tasaki, C.; Tsuji, D.; Maita, N.; Hirokawa, T.; Asanuma, D.; Kamiya, M.; Sato, K.; Setou, M.; Urano, Y.; Togawa, T.; Otaka, A.; Sakuraba, H.; Itoh, K. 2016: Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model. Journal of Clinical Investigation 126(5): 1691-1703

Rozema, D.B.; Blokhin, A.V.; Wakefield, D.H.; Benson, J.D.; Carlson, J.C.; Klein, J.J.; Almeida, L.J.; Nicholas, A.L.; Hamilton, H.L.; Chu, Q.; Hegge, J.O.; Wong, S.C.; Trubetskoy, V.S.; Hagen, C.M.; Kitas, E.; Wolff, J.A.; Lewis, D.L. 2015: Protease-triggered siRNA delivery vehicles. Journal of Controlled Release: Official Journal of the Controlled Release Society 209: 57-66

Natarajan, K.; Gottipati, K.R.; Berhane, K.; Samten, B.; Pendurthi, U.; Boggaram, V. 2016: Proteases and oxidant stress control organic dust induction of inflammatory gene expression in lung epithelial cells. Respiratory Research 17(1): 137

Musante, L.; Tataruch, D.; Gu, D.; Liu, X.; Forsblom, C.; Groop, P.-H.; Holthofer, H. 2015: Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy. Journal of Diabetes Research 2015: 289734

Casas-Godoy, L.; Sandoval, G. 2016: Proteases and their Inhibitors: from Basic to High Throughput Screening. Combinatorial Chemistry and High Throughput Screening 19(8): 636-643

Pulz, L.H.; Strefezzi, R.F. 2017: Proteases as prognostic markers in human and canine cancers. Veterinary and Comparative Oncology 15(3): 669-683

Saftig, P.; Bovolenta, P. 2015: Proteases at work: cues for understanding neural development and degeneration. Frontiers in Molecular Neuroscience 8: 13

Ricard-Blum, S.; Vallet, S.D. 2016: Proteases decode the extracellular matrix cryptome. Biochimie 122: 300-313

Gonçalves, R.N.; Gozzini Barbosa, S.D.; da Silva-López, R.E. 2016: Proteases from Canavalia ensiformis: Active and Thermostable Enzymes with Potential of Application in Biotechnology. Biotechnology Research International 2016: 3427098

Romberger, D.J.; Heires, A.J.; Nordgren, T.M.; Souder, C.P.; West, W.; Liu, X.-d.; Poole, J.A.; Toews, M.L.; Wyatt, T.A. 2015: Proteases in agricultural dust induce lung inflammation through PAR-1 and PAR-2 activation. American Journal of Physiology. Lung Cellular and Molecular Physiology 309(4): L388-L399

Vandooren, J.; Opdenakker, G.; Loadman, P.M.; Edwards, D.R. 2016: Proteases in cancer drug delivery. Advanced Drug Delivery Reviews 97: 144-155

Lalmanach, G. 2016: Proteases in the limelight: Both ordinary digestive enzymes and smart signaling pathway regulators. Biochimie 122: 1-4

Inácio, F.ío.D.; Ferreira, R.O.; de Araujo, C.A.V.; Brugnari, T.; Castoldi, R.; Peralta, R.M.; de Souza, C.G.M. 2015: Proteases of Wood Rot Fungi with Emphasis on the Genus Pleurotus. Biomed Research International 2015: 290161

Kleyman, T.R.; Myerburg, M.M. 2014: Proteases, ENaCs and cystic fibrosis. Journal of Physiology 592(23): 5145

Hoelen, H.; Zaldumbide, A.; van Leeuwen, W.F.; Torfs, E.C.W.; Engelse, M.A.; Hassan, C.; Lebbink, R.J.; de Koning, E.J.; Resssing, M.E.; de Ru, A.H.; van Veelen, P.A.; Hoeben, R.C.; Roep, B.O.; Wiertz, E.J.H.J. 2015: Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97. Plos one 10(6): E0128206

Amanullah, A.; Upadhyay, A.; Chhangani, D.; Joshi, V.; Mishra, R.; Yamanaka, K.; Mishra, A. 2017: Proteasomal Dysfunction Induced by Diclofenac Engenders Apoptosis Through Mitochondrial Pathway. Journal of Cellular Biochemistry 118(5): 1014-1027

Ravi, D.; Beheshti, A.; Abermil, Néra.; Passero, F.; Sharma, J.; Coyle, M.; Kritharis, A.; Kandela, I.; Hlatky, L.; Sitkovsky, M.V.; Mazar, A.; Gartenhaus, R.B.; Evens, A.M. 2016: Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma. Cancer Research 76(11): 3319-3331

Savchuk, O.I.; Orlovsky, M.O.; Iarmoliuk, I.S.; Goncharov, S.V.; Dosenko, V.E.; Skibo, G.G. 2015: Proteasomal activity in brain tissue following ischemic stroke in Wistar rats. Fiziolohichnyi Zhurnal 61(5): 11-20

Samanovic, M.I.; Tu, S.; Novák, O.ře.; Iyer, L.M.; McAllister, F.E.; Aravind, L.; Gygi, S.P.; Hubbard, S.R.; Strnad, M.; Darwin, K.H. 2015: Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide. Molecular Cell 57(6): 984-994

Inobe, T.; Nozaki, M. 2016: Proteasomal degradation of damaged polyubiquitin. Biochemical and Biophysical Research Communications 471(1): 34-40

Braunstein, I.; Zach, L.; Allan, S.; Kalies, K.-U.; Stanhill, A. 2015: Proteasomal degradation of preemptive quality control (pQC) substrates is mediated by an AIRAPL-p97 complex. Molecular Biology of the Cell 26(21): 3719-3727

McNaughton, M.; Pitman, M.; Pitson, S.M.; Pyne, N.J.; Pyne, S. 2016: Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-Ai prostate cancer cells. Oncotarget 7(13): 16663-16675

Gierisch, M.E.; Pfistner, F.; Lopez-Garcia, L.A.; Harder, L.; Schäfer, B.W.; Niggli, F.K. 2016: Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue. Journal of Biological Chemistry 291(52): 26922-26933

Lee, K.C.; Bramley, R.L.; Cowell, I.G.; Jackson, G.H.; Austin, C.A. 2016: Proteasomal inhibition potentiates drugs targeting DNA topoisomerase Ii. Biochemical Pharmacology 103: 29-39

Nardi, F.; Hoffmann, T.M.; Stretton, C.; Cwiklinski, E.; Taylor, P.M.; Hundal, H.S. 2015: Proteasomal modulation of cellular SNAT2 (SLC38A2) abundance and function by unsaturated fatty acid availability. Journal of Biological Chemistry 290(13): 8173-8184

Kaiser, M.-L.; Römisch, K. 2015: Proteasome 19S RP binding to the Sec61 channel plays a key role in ERAD. Plos one 10(2): E0117260

Yadranji Aghdam, S.; Mahmoudpour, A. 2016: Proteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy. International Journal of Nephrology 2016: 3846573

Sbardella, D.; Tundo, G.Raffaella.; Sciandra, F.; Bozzi, M.; Gioia, M.; Ciaccio, C.; Tarantino, U.; Brancaccio, A.; Coletta, M.; Marini, S. 2015: Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution. Plos one 10(7): E0132455

Shukla, N.; Somwar, R.; Smith, R.S.; Ambati, S.; Munoz, S.; Merchant, M.; D'Arcy, P.; Wang, X.; Kobos, R.; Antczak, C.; Bhinder, B.; Shum, D.; Radu, C.; Yang, G.; Taylor, B.S.; Ng, C.K.Y.; Weigelt, B.; Khodos, I.; de Stanchina, E.; Reis-Filho, J.S.; Ouerfelli, O.; Linder, S.; Djaballah, H.; Ladanyi, M. 2016: Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors. Cancer Research 76(15): 4525-4534

Maher, P. 2014: Proteasome Assay in Cell Lysates. Bio-Protocol 4(2)

Díaz-Ruiz, A.; Guzmán-Ruiz, R.ío.; Moreno, N.R.; García-Rios, A.; Delgado-Casado, N.; Membrives, A.; Túnez, I.; El Bekay, R.; Fernández-Real, J.é M.; Tovar, S.; Diéguez, C.; Tinahones, F.J.; Vázquez-Martínez, R.; López-Miranda, J.é; Malagón, M.ía.M. 2015: Proteasome Dysfunction Associated to Oxidative Stress and Proteotoxicity in Adipocytes Compromises Insulin Sensitivity in Human Obesity. Antioxidants and Redox Signaling 23(7): 597-612

Shirozu, R.; Yashiroda, H.; Murata, S. 2016: Proteasome Impairment Induces Recovery of Mitochondrial Membrane Potential and an Alternative Pathway of Mitochondrial Fusion. Molecular and Cellular Biology 36(2): 347-362

Vana, P.G.; LaPorte, H.M.; Wong, Y.M.; Kennedy, R.H.; Gamelli, R.L.; Majetschak, M. 2016: Proteasome Inhibition After Burn Injury. Journal of Burn Care and Research: Official Publication of the American Burn Association 37(4): 207-215

Yue, Q.; Zhen, H.; Huang, M.; Zheng, X.; Feng, L.; Jiang, B.; Yang, M.; Wu, W.; Liu, X.; Guo, D. 2016: Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells. Plos one 11(7): E0159034

Pashevin, D.O.; Nagibin, V.S.; Tumanovska, L.V.; Moibenko, A.A.; Dosenko, V.E. 2015: Proteasome Inhibition Diminishes the Formation of Neutrophil Extracellular Traps and Prevents the Death of Cardiomyocytes in Coculture with Activated Neutrophils during Anoxia-Reoxygenation. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 82(6): 290-298

Choy, M.M.; Zhang, S.L.; Costa, V.V.; Tan, H.C.; Horrevorts, S.; Ooi, E.E. 2015: Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection. Plos Neglected Tropical Diseases 9(11): E0004058

Guo, N.; Peng, Z.; Zhang, J. 2016: Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells in Vitro and in Vivo. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 26(5): 839-844

Huang, W.; Zhou, Q.; Yuan, X.; Ge, Z.-M.; Ran, F.-X.; Yang, H.-Y.; Qiang, G.-L.; Li, R.-T.; Cui, J.-R. 2016: Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells. Journal of Cancer 7(9): 1133-1141

Kaplan, G.S.; Torcun, C.C.; Grune, T.; Ozer, N.K.; Karademir, B. 2017: Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect. Free Radical Biology and Medicine 103: 1-13

de Bruin, G.; Xin, B-Tao.; Florea, B.I.; Overkleeft, H.S. 2016: Proteasome Subunit Selective Activity-Based Probes Report on Proteasome Core Particle Composition in a Native Polyacrylamide Gel Electrophoresis Fluorescence-Resonance Energy Transfer Assay. Journal of the American Chemical Society 138(31): 9874-9880

Gonos, E. 2014: Proteasome activation as a novel anti-aging strategy. Free Radical Biology and Medicine 75(Suppl 1): S7

Chondrogianni, N.; Voutetakis, K.; Kapetanou, M.; Delitsikou, V.; Papaevgeniou, N.; Sakellari, M.; Lefaki, M.; Filippopoulou, K.; Gonos, E.S. 2015: Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases. Ageing Research Reviews 23(Part A): 37-55

Guo, J.; Hao, J.; Jiang, H.; Jin, J.; Wu, H.; Jin, Z.; Li, Z. 2017: Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Cancer Letters 386: 161-167

Ortega-Atienza, S.; Green, S.E.; Zhitkovich, A. 2015: Proteasome activity is important for replication recovery, CHK1 phosphorylation and prevention of G2 arrest after low-dose formaldehyde. Toxicology and Applied Pharmacology 286(2): 135-141

Zhu, Z.; Zhang, L.; Shi, G. 2015: Proteasome as a Molecular Target of Microcystin-LR. Toxins 7(6): 2221-2231

Yedidi, R.S.; Fatehi, A.K.; Enenkel, C. 2016: Proteasome dynamics between proliferation and quiescence stages of Saccharomyces cerevisiae. Critical Reviews in Biochemistry and Molecular Biology 51(6): 497-512

Lehrbach, N.J.; Ruvkun, G. 2016: Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1. Elife 5

Caniard, A.; Ballweg, K.; Lukas, C.; Yildirim, A.Ö; Eickelberg, O.; Meiners, S. 2015: Proteasome function is not impaired in healthy aging of the lung. Aging 7(10): 776-792

Kammerl, I.E.; Meiners, S. 2016: Proteasome function shapes innate and adaptive immune responses. American Journal of Physiology. Lung Cellular and Molecular Physiology 311(2): L328-L336

Haynes, K.A.; Smith, T.K.; Preston, C.J.; Hegde, A.N. 2015: Proteasome inhibition augments new protein accumulation early in long-term synaptic plasticity and rescues adverse Aβ effects on protein synthesis. Acs Chemical Neuroscience 6(5): 695-700

Roelofs, J. 2015: Proteasome inhibition by bortezomib: a left hook and a right punch. Ebiomedicine 2(7): 619-620

Brouwer, A.J.; Herrero Álvarez, N.; Ciaffoni, A.; van de Langemheen, H.; Liskamp, R.M.J. 2016: Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides. Bioorganic and Medicinal Chemistry 24(16): 3429-3435

Dettmer, S.; Theile, D.; Schäfer, J.; Seckinger, A.; Burhenne, Jürgen.; Weiss, J. 2016: Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines. Naunyn-Schmiedeberg's Archives of Pharmacology 389(10): 1091-1101

Sun, Y.; Ponz-Sarvise, M.; Chang, S.-S.; Chang, W.-C.; Chen, C.-H.; Hsu, J.L.; Hung, M.-C. 2015: Proteasome inhibition enhances the killing effect of BikDD gene therapy. American Journal of Translational Research 7(2): 319-327

Rastogi, N.; Duggal, S.; Singh, S.K.; Porwal, K.; Srivastava, V.K.; Maurya, R.; Bhatt, M.L.B.; Mishra, D.P. 2015: Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-gingerol in cervical cancer cells. Oncotarget 6(41): 43310-43325

Schlossarek, S.; Singh, S.R.; Geertz, B.; Schulz, H.; Reischmann, S.; Hübner, N.; Carrier, L. 2014: Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy. Frontiers in Physiology 5: 484

Zhou, W.; Zhu, W.; Ma, L.; Xiao, F.; Qian, W. 2015: Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein. Oncology letters 10(5): 2899-2904

Ji, M.-M.; Lee, J.M.; Mon, H.; Xu, J.; Tatsuke, T.; Kusakabe, T. 2016: Proteasome inhibitor MG132 impairs autophagic flux through compromising formation of autophagosomes in Bombyx cells. Biochemical and Biophysical Research Communications 479(4): 690-696

Zhu, W.; Zhan, D.; Wang, L.; Ma, D.; Cheng, M.; Wang, H.; Zhao, J.; Cai, Y.; Cheng, Z. 2016: Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway. Oncology Reports 36(2): 845-852

Zhang, Y.; Cheng, J.; Zhang, J.; Wu, X.; Chen, F.; Ren, X.; Wang, Y.; Li, Q.; Li, Y. 2016: Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation. Biochemical and Biophysical Research Communications 477(4): 761-767

Yui, J.C.; Van Keer, J.; Weiss, B.M.; Waxman, A.J.; Palmer, M.B.; D'Agati, V.D.; Kastritis, E.; Dimopoulos, M.A.; Vij, R.; Bansal, D.; Dingli, D.; Nasr, S.H.; Leung, N. 2016: Proteasome inhibitor associated thrombotic microangiopathy. American Journal of Hematology 91(9): E348-E352

Conley, B.A.; Donovan, E.; Muir, C.; Morris, J.; Colevas, A.D.; Gius, D.; Trehu, E.; Sausville, E.; Wright, J.; Vanwaes, C. 2016: Proteasome inhibitor bortezomib & re-irradiation (rRT) with scheduled treatment break in patients (pts) with head/neck squamous carcinoma (HNSCC). Journal of Clinical Oncology 23(16_Suppl): 5592-5592

Hsu, S.-M.; Yang, C.-H.; Shen, F.-H.; Chen, S.-H.; Lin, C.-J.; Shieh, C.-C. 2015: Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis. Mediators of Inflammation 2015: 847373

Lamothe, B.; Cervantes-Gomez, F.; Sivina, M.; Wierda, W.G.; Keating, M.J.; Gandhi, V. 2015: Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia. Blood 125(2): 407-410

Lan, D.; Wang, W.; Zhuang, J.; Zhao, Z. 2015: Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein. Molecular Medicine Reports 11(3): 1655-1660

Asakura, T.; Yamaguchi, N.; Ohkawa, K.; Yoshida, K. 2015: Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. International Journal of Oncology 46(5): 2251-2260

Nahi, H.; Våtsveen, T.K.; Lund, J.; Heeg, B.M.S.; Preiss, B.; Alici, E.; Møller, M.B.; Wader, K.F.; Møller, H.E.H.; Grøseth, L.A.; Østergaard, B.; Dai, H.Y.; Holmberg, E.; Gahrton, G.ös.; Waage, A.; Abildgaard, N. 2016: Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21. European Journal of Haematology 96(1): 46-54